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ABSTRACT
Chlamydophila abortus targets the ovine placenta, causing tissue damage,
inflammation and abortion. C. abortus is the main infectious cause of abortion in
ewes in the UK and results in major economic losses to the sheep industry. A
pregnant mouse model was developed to investigate immune responses and disease
pathogenesis for comparison with the ovine disease.
Pregnant mice were inoculated at mid-gestation with C. abortus to investigate
progression and pathogenesis of infection. This resulted in abortion on days 6-8 post¬
infection (p.i.). Infected cells were identified at the maternal-foetal interface on days
3 and 5 p.i. and chlamydial inclusions were scattered throughout the trophoblastic
labyrinth of the placenta between days 3 and 7 p.i.. Infected areas were accompanied
by a maternal mononuclear inflammatory cellular infiltrate, including
polymorphonuclear neutrophils, B cells and CD4 and CD8 T cells. C. abortus
organisms were cultured from both maternal and foetal tissues, higher numbers
present in placenta, the target organ.
A Thl type immune response was characterised in the mouse model, similar to that
in ovine infections. A dominant IgG2a antibody response was identified and IFN-y
and TNF-a expression were detected in both sera and supernatants from stimulated
splenocytes. IFN-y mRNA and TNF-a mRNA expression were detected by in situ
hybridisation in mouse tissues infected with C. abortus. A latent/subclinical
persistent infection did not appear to develop in non-pregnant mice infected with C.
abortus and abortion did not occur in the subsequent pregnancy, in contrast to that in
ovine infections. Repeat abortion did not occur in the pregnancy subsequent to
abortion in mice, similar to the situation observed in sheep. Mice were also immune
to secondary infection in the pregnancy subsequent to abortion.
Infection of pregnant mice resulted in abortion as observed in infected ewes, and a
similar Thl immune response is elicited in both sheep and mice. This model will





1.1 Introduction to Chlamydiae
Chlamydiae are obligate intracellular bacteria that infect epithelial cells and
monocyte/macrophages of a wide host range resulting in a broad spectrum of
diseases (summarised in Table 1.1). Chlamydia trachomatis is the world's leading
cause of preventable blindness and sexually transmitted disease in man.
Chlamydophila pneumoniae can cause respiratory infections and may lead to chronic
diseases, such as atherosclerosis and arthritis. Animal infections vary from abortion
in ruminants and pigs as a result of Chlamydophila abortus infection, to
conjunctivitis in guinea pigs following infection with Chlamydophila caviae, which
acts as a key model for C. trachomatis infections. Guinea pigs with primary
infections develop immunity to reinfection of the eyes or the genital tract (Ahmad et
al., 1977; Mount et al., 1973) and this showed that both humoral and cell-mediated
immunity are required for resolution of genital tract infection (Rank et al., 1981;
Rank & Batteiger, 1989; Rank et al., 1989).
Chlamydophila psittaci is a worldwide pathogen of both wild and domesticated birds
(Grimes & Wyrick, 1991; Meyer, 1967) causing acute, subacute, chronic or
subclinical infections of the respiratory system. Both animal pathogens C. abortus
and C. psittaci are zoonotic, meaning infection of humans is possible, the latter
resulting in psittacosis, which is the most important animal chlamydiosis
transmissible to man (Longbottom & Coulter, 2003). C. abortus can infect pregnant
women and this can be life threatening to both the mother and the foetus (Buxton,
1986; Hyde & Benirschke, 1997; Meijer et al., 2004), although infection of women is
relatively rare compared to avian chlamydiosis, which is a significant occupational
health risk to those people working in the poultry and pet industries (Vanrompay et
al., 1995).
The family Chlamydiaceae was classified as four different species within one genus,
Chlamydia. Following re-classification in 1999, the order Chlamydiales now
comprises four distinct families, the Simkaniaceae, Parachlamydiaceae,
Waddliaceae and Chlamydiaceae (Everett et al., 1999a). The family Chlamydiaceae
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is divided into two genera, Chlamydia and Chlamydophila and nine species (Table
1.1). This distinction is based on limited phenotypic, morphological and genetic
criteria (Corsaro et al., 2003; Everett et al., 1999a).
Members of the family Chlamydiaceae have greater than 90% 16S rRNA identity.
The complete 16S and 23S rRNA genes of Chlamydophila are >95% identical. This
genus is readily identified and distinguished from the other genus by ribosomal
signature sequences, or by inspection of the ribosomal intergenic spacer (Everett &
Andersen, 1999). The nomenclature proposed by Everett and Andersen (Everett &
Andersen, 1999) has not been completely accepted in the chlamydial field (Everett &
Andersen, 2001; Schachter et al., 2001) as suggested by its lack of use in the
literature, particularly by the human research community. However, those working in
the animal research field have adopted this new nomenclature, as it has reduced
much confusion. The new classification will be adopted throughout this thesis.
3
Table 1.1 The Family Chlamydiaceae (Kerr et a!., 2005)
Species Host Disease/symptoms
Chlamydia trachomatis Humans Chronic conjunctivitis (trachoma)
Sexually transmitted disease; pelvic
inflammatory disease; infertility
Chlamydia muridarum Mice, hamsters Respiratory and genital tract infection
(model for C. trachomatis infection in
humans)
Chlamydia suis Pigs Intestinal, respiratory and reproductive
disease
Chlamydophila pneumoniae Humans, Pneumonia, bronchitis, pharyngitis; also
koalas, reptiles, associated with atherosclerosis, reactive
amphibians arthritis and asthma
Chlamydophila psittaci Birds, poultry Respiratory disease (zoonotic pathogen)
Chlamydophila abortus Ruminants, pigs Abortion (zoonotic pathogen)
Chlamydophila pecorum Ruminants, Enteric disease; pneumonia; conjunctivitis;
pigs, koala polyarthritis; metritis and encephalomyelitis
Chlamydophila felis Cats Conjunctivitis (zoonotic pathogen)
Chlamydophila caviae Guinea pig Ocular and genital tract infection (model for
C. trachomatis infection in humans)
Chlamydiae are deeply separated from other bacteria on a phylogenetic scale, which
forms the basis for a distinct bacterial division and they are themselves exceptionally
diverse (Thomas et al., 1997). The chlamydial envelope has similarities with that of
other Gram-negative organisms: an inner membrane, a periplasmic space and an
outer membrane containing proteins and lipopolysaccharide (LPS) (Stephens &
Lammel, 2001). However, differences to other Gram-negative bacteria include the
structure of LPS; in Chlamydia, it is truncated, terminating in 3-deoxy-D-manno-
octulosonic acid (Stephens & Lammel, 2001). Chlamydiae have little or no
detectable peptidoglycan, although a full set of peptidoglycan synthesis genes has
been identified following genome analysis (Stephens et al., 1998). One of the main
problems of molecular research into this intracellular pathogen is the lack of a
suitable gene transfer system. However, the identification of a cryptic plasmid in
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Chlamydia species may provide a vector with a potential region for the insertion of
foreign DNA, to allow transformation (Thomas et ai, 1997).
1.2 Developmental cycle of Chlamydia
Chlamydiae undergo a biphasic developmental cycle (Figure 1.1) that consists of
two distinct morphological forms, the elementary body (EB) and the reticulate body
(RB), which are specifically adapted to extracellular and intracellular environments
respectively (Longbottom & Coulter, 2003). The EB, which is the infectious form, is
small in size (200-300 nm), dense, metabolically inactive and stable within the
extracellular environment. RBs are noninfectious, larger in size (500-1000 nm),
metabolically active and less electron-dense than EBs.
INFECTION (EBS)
Figure 1.1 Basic developmental cycle of the Chlamydiales (adapted from
(Everett, 2000))
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EBs give rise to primary infection of susceptible hosts by attaching to the
cytoplasmic membrane of mucosal epithelial cells. EBs are endocytosed into a
membrane-bound vacuole, called the chlamydial inclusion (Field & Barnes, 1992).
Despite their lack of petidoglycan, EBs have a rigid cell wall structure, which is due
to the presence of a major protein (MOMP - major outer membrane protein) cross-
linked with other cysteine-rich proteins present in the cell envelope (Everett &
Hatch, 1991). The EB is highly resistant to lysis due to this complex of outer
membrane proteins cross-linked by disulphide bonds, protecting the bacterium from
otherwise damaging extracellular environmental factors (Stephens & Lammel, 2001).
Upon entry, the EB, which resides within the intracytoplasmic inclusion, transforms
into the larger, non-infectious RB approximately 6-8 hours post-infection (p.i.). The
RB is metabolically active and is capable of synthesizing its own macromolecules.
Until recently, chlamydiae were thought to lack the cell machinery and enzymes
necessary for adenosine tri-phosphate (ATP) production (Beatty et ai, 1994a).
Recent studies have revealed two potential ATP/ADP translocases and genes that
may permit minimal amounts of ATP generation (Hatch, 1998). Chlamydial RBs
multiply by binary fission within the inclusion before reorganising back into EBs at
24-48 hours p.i. (depending on species), resulting in an intracytoplasmic inclusion
filled with EBs, RBs, and intermediate forms. EBs are released 48-72 hours later,
depending on the species, by lysis or by fusion of the inclusion with the host cell
membrane, allowing infection of further cells (Escalante-Ochoa et al., 1998).
1.3 Chlamydophila abortus infections
C. abortus (formerly Chlamydia psittaci serotype 1) infects the placenta of sheep,
causing a disease in sheep known as ovine enzootic abortion (OEA) or enzootic
abortion of ewes (EAE) (Aitken, 2000b; Longbottom & Coulter, 2003). In Northern
Europe it is the most common infectious cause of abortion in lowland flocks
intensively managed at lambing time, and has a major economic impact on
agricultural industries worldwide. Although there are no recent figures on the
economic impact of the disease, losses have been previously estimated at £15-20
6
million per annum in the UK (Wood, 1992). The organism frequently causes a
similar disease in goats, and also in cattle, pigs and horses, but such infections are
thought to be less common.
1.4 Transmission and prevalence of C. abortus infection
The main routes of transmission of C. abortus are through ingestion of organisms
shed in vaginal fluids and placental membranes at the time of abortion or lambing, or
through inhalation of aerosols from the environment. EBs can remain viable in the
external environment for several days, or possibly for several months depending on
environmental conditions (Aitken et al., 1990). This is due to the rigidity of the cell
envelope, which is both osmotically stable and poorly permeable. There is some
evidence of venereal transmission (Papp & Shewen, 1996b), but this is unlikely to
contribute much to the epidemiology of EAE because of UK management practices,
where there is little contact between ewes and rams during the lambing season
(Appleyard et al., 1985). Another potential route of transmission is through direct
infection of the foetus via the placenta, although it is unclear what contribution this
might make to the epidemiology of EAE (Buxton et al., 1990).
An initial outbreak within a flock that may give rise to only a few abortions, can lead
to over 30% of the ewes aborting or giving birth to stillborn or weak offspring in the
following year (Aitken, 2000b). In subsequent lambing seasons the incidence of
abortion is likely to remain at 5-10% if affected animals are left untreated. There was
a resurgence of OEA in south east Scotland in the late 1970s (Linklater & Dyson,
1979), as a result of intensive management, increased sheep movement and vaccine
breakdown, and this led to the spread of disease to other areas of Britain.
1.5 Clinical symptoms associated with C. abortus infections
Infection of pregnant ewes with C. abortus up to 5-6 weeks prior to parturition leads
to clinical disease, and results in either abortion in the final 2-3 weeks of gestation, or
the birth of stillborn or weak lambs that frequently die in the first few days of their
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life (Aitken et al., 1990). Infection of ewes within the last 5-6 weeks of pregnancy
often leads to the development of a latent infection, where ewes appear to be
uninfected until the next lambing season (Aitken et al., 1990). Similarly, surviving
lambs born to infected mothers may be affected by enzootic abortion in their first
pregnancy (Wilsmore et al., 1990b). Although, there are generally no premonitory
indications of the impending abortions, vaginal discharges can be observed for up to
48 hours prior to lamb loss. These discharges can continue for 2-3 weeks, adding to
the environmental spread of infection (Nietfeld, 2001).
In contrast to Toxoplasma gondii infections in pregnant sheep (Blewett & Watson,
1983), the timing of infection with C. abortus, whether early or mid-gestation, does
not influence the pattern and progress of disease (Buxton et al., 1990). Pathological
changes are not detected in the placenta until day 90 of pregnancy irrespective of the
timing of infection with C. abortus (Buxton et al., 1990). Aborted placental tissue is
thickened and necrotic, with inflammatory exudate present.
Experimental infection of ewes may cause a febrile response and enlargement of
lymph nodes. Papp et al. (Papp et al., 1993) suggest that Chlamydophila first enters
the draining lymph node then spreads to the circulatory system and other tissues.
Persistent infections may be present in lymph nodes, as a result of limited
multiplication of the organism in infected lymph nodes. However, the organism may
be present in a form (intermediate) undetectable by culture or immunohistochemistry
(Section 1.7).
Infection of foetuses can occur before day 90 of gestation, as shown by culture of C.
abortus from a foetus on day 75 of gestation, and detection of antibody in foetuses at
both 75 and 95 days gestation (Buxton et al., 1990). Sheep possess a non-invasive
placenta, as described in Section 1.9.1, in which antibody cannot pass from mother
to foetus, the detection of antibody suggesting direct infection of foetuses from the
infected ewes. Later in pregnancy, there was a significant increase in
immunoglobulin (Ig) M and IgG-positive cells in spleen and lymph nodes of foetuses
from infected ewes (Buxton et al., 1990) demonstrating the presence of an early
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humoral response in the foetus, which is similar to that observed in T. gondii
infection of pregnant ewes (Buxton & Finlayson, 1986). Further evidence of a foetal
immune response was demonstrated by T and B cell stimulation in the foetal lymph
nodes.
1.6 Immunity to chlamydial abortion
Ewes develop protective immunity following abortion, that prevents C. abortus-
induced abortions in subsequent pregnancies (Wilsmore et al., 1990b). Most ewes
are seldom clinically affected following abortion and remain fertile. However,
immunity is not necessarily sterile, as some ewes have chronically infected
reproductive tracts and can continue to shed infectious organisms seasonally for up
to three years, increasing the spread of disease to other sheep within the flock (Papp
et al., 1994). A small percentage of aborted ewes may develop secondary infections
such as metritis (Papp et al., 1993).
Papp et al. (1998) have demonstrated that ewes that had aborted in year one can have
two subsequent successful pregnancies (years two and three) with the production of
live, healthy offspring. They infected four ewes in the first pregnancy only and the
other four ewes were infected in all 3 pregnancies. Papp et al. (Papp et al., 1998)
detected C. abortus by immunocytology in vaginal and cervical swabs, which were
collected during the oestrus cycle, from the 8 chronically infected ewes, with no
differences detected between those infected once or three times. Interestingly, higher
numbers of organisms were present at the time of oestrus than at other sample times
in all sheep (Papp et al., 1998), which will lead to further spread of C. abortus.
Obviously identification and removal/segregation of these ewes is a central control
strategy (see Section 1.12). High levels of antibody responses were detected post¬
abortion, suggesting continued exposure to the organism despite only detecting it
near oestrus (Papp et al., 1994). Protective immunity is predominantly a T helper 1
(Thl) type response, as discussed in depth in Section 1.11.
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1.7 Persistent chlamydial infections
Abortion due to C. abortus contaminates the surrounding environment and infects
susceptible animals that come into contact with infected tissues/aerosols (McEwan,
1951). EAE then develops in subsequent pregnancies of ewes that are infected in a
non-pregnant state. EAE also develops in the subsequent pregnancies of ewes that
are infected late in the gestation period (in the last 5 or 6 weeks of pregnancy). C.
abortus must therefore have the ability to establish a persistent infection that does not
stimulate protective immunity at the time of infection. It has been suggested that C.
abortus may reside in lymphoid organs during the latent phase of infection (Papp et
al., 1993).
Persistent, subclinical or latent states can be maintained for several months following
infection of non-pregnant ewes, probably under control of the proinflammatory
cytokine interferon-gamma (IFN-y; see Section 1.11.2.3) (Brown & Entrican, 1996),
before the onset of pregnancy triggers recrudescence of infection (McCafferty,
1990). During the subsequent pregnancy an unknown signal leads to stimulation and
multiplication of the organism, and disease symptoms are manifested. However, C.
abortus is undetectable by any means in latently infected ewes (Jones et al., 1995),
and organisms are not identified until day 90 of the subsequent pregnancy. C.
abortus must be reactivated in some way in this pregnancy, resulting in clinical
symptoms in the placenta, and ultimately abortion. A combination of hormonal
changes and immunosuppressive factors associated with pregnancy are likely to lead
to this recrudescence of C. abortus and abortion.
C. abortus is auxotrophic for the amino acid, tryptophan. Indolamine 2,3-
dioxygenase (IDO) expression induced by IFN-y breaks down L-tryptophan and
depletes intracellular tryptophan pools (Byrne et al., 1986). IFN-y binds to target
molecules (receptors) on the surface of epithelial cells and it has been suggested that
IFN-y inhibits the growth of C. abortus by inducing the production of IDO, which
reduces the availability of tryptophan. This led to the production of persistent
chlamydial forms that could be reactivated by the removal of IFN-y or the addition of
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excess tryptophan (Beatty et al., 1994b). The depletion of tryptophan may lead to
competition between host cells and Chlamydia for the essential amino acid, and
result in chlamydiostasis (Graham et al., 1995).
Trophoblast cells, the main target of C. abortus, are reported to constitutively express
IDO and degrade tryptophan (Entrican et al., 2004). Tryptophan catabolism appears
to be an important mechanism for regulation of inflammatory responses during
pregnancy, resulting in T cell tolerance and survival of the semi-allogeneic foetus.
IFN-y production decreases during pregnancy, which may explain the lack of control
of infection and the reactivation of a latent Chlamydophila infection. The anti¬
inflammatory cytokines, interleukin (IL)-4 and IL-10, down-regulate IFN-y during
pregnancy in mice (Krishnan et al., 1996). This has yet to be proven in sheep but if it
is the case, down-regulation of IFN-y may lead to chlamydiae being reactivated from
their latent state, allowing colonisation of the placenta and disruption of the
maternal-foetal junction, resulting in abortion.
Persistent or latent infections may develop as a result of an inadequate or sub-optimal
T helper type 1 (Thl) response leading to a delay in the clearance of the pathogen
and the production of a chronic response resulting in tissue damage (Yang &
Brunham, 1999). For example, IL-10 (a Th2 cytokine) knockout (KO) mice
exhibited strong Thl and delayed-type hypersensitivity (DTH) responses that
resolved pulmonary experimental infection without tissue damage (Yang et al.,
1996), whereas IFN-y (a Thl cytokine) KO mice exhibited poor Thl and DTH
responses and were unable to clear the infection (Wang et al., 1999). Control of C.
abortus in the persistent state is therefore linked to the balance of EFN-y and the
availability of tryptophan during pregnancy (Brown et al., 2001).
1.8 Diagnosis of C. abortus infection in sheep
The first sign of C. abortus infection in a flock is generally abortion in the final 2-3
weeks of gestation, with the production of dead lambs and necrotic placental tissue.
Earlier diagnosis of C. abortus infections in ewes is required before abortion occurs
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to allow appropriate control measures to be made. In conjunction with this, infected
and potentially infected ewes need to be treated to limit or prevent further spread of
infection.
The presence of EBs in smears of potentially infected tissue samples or swabs from
potentially infected ewes are detected by staining them with modified Ziehl-Neelsen
(Aitken & Longbottom, 2004) C. abortus can also be isolated from infected placental
cotyledons and vaginal swabs by culture in embryonated hens' eggs or in cell culture
(Aitken & Longbottom, 2004). After growth, chlamydial inclusions can be visualised
by staining either smears of yolk sac grown material or infected cell monolayers with
Giemsa (Aitken & Longbottom, 2004).
Polymerase chain reaction (PCR) on samples prepared from infected cotyledons and
swabs is an option if culture is not available (Aitken, 2000b; Amin, 2003b; Hartley et
al., 2001; Herring, 1991). However there is a possibility of false negative results due
to the presence of inhibitors in the tissues (Caul & Sillis, 1998). PCR offers the
advantage of distinguishing between C. pecorum, which is commonly found in
faeces and can therefore contaminate diagnostic samples, and C. abortus infection by
restriction fragment length polymorphism (RFLP) analysis of amplified PCR
products (Anderson et al., 1996; Denamur et al., 1991; Everett et al., 1999b). New
PCR-tests are being developed, based on C. abortus-specific gene sequences to
increase specificity and sensitivity.
Following abortion, maternal antibodies are produced in response to C. abortus
infection (ewes seroconvert), coinciding with the development of protective
immunity (Section 1.11), therefore serological diagnosis is only useful
retrospectively (Amin, 2003a). Serological diagnosis of EAE has been mainly based
on the complement fixation test (CET). However the CFT is neither particularly
sensitive nor specific since antibodies to other chlamydial species and enterobacterial
pathogens may be detected as a result of antigenic cross-reactivity (Rodolakis et al.,
1998). The CFT was first developed and used in the 1950s (Stamp et al., 1952),
detecting antibodies to the genus-specific LPS antigen, which possesses several
12
epitopes, including a surface-exposed, immunoaccessible, genus-specific epitope.
The broad specificity and the low sensitivity of the test have led to the development
of other diagnostic techniques such as enzyme-linked immunosorbent assays
(ELISA) and the afore-mentioned PCR. An optimal balance between sensitivity and
specificity is required, due to the cross-reactivity with C. pecorum and lack of
clinical signs associated with C. abortus infections.
A wide range of C. aortas-specific ELISAs have been produced, based on
solublised proteins (Anderson et al., 1995) or monoclonal antibodies (mAbs), which
recognise specific MOMP regions (Salti-Montesanto et al., 1997). ELISAs have also
been developed based on recombinant protein fragments of the polymorphic outer
membrane protein (POMP) family (Buendia et al., 2001; Longbottom et al., 2001).
One example is an indirect ELISA based on a recombinant protein fragment of
POMP91B, which was more sensitive and specific than the CFT (Longbottom et al.,
2001). The polymorphic membrane protein (pmp) gene family code for a cluster of
surface-exposed immunogenic proteins, which are genus-specific (Longbottom et al.,
1996; Souriau et al., 1994). They have been suggested as possible serodiagnostic
candidates, due to their strong reactivity in immunoblotting experiments with sera
from ewes infected with C. abortus (Cevenini et al., 1991; Longbottom et al., 1996)
but not with sera from ewes infected with C. pecorum (Layachi et al., 1993; Souriau
et al., 1994).
1.9 Immunopathogenesis of C. abortus infection
One of the most fascinating aspects of C. abortus infection is the lack of any
pathology until after day 90 of gestation (a normal gestation period is approximately
143 days), irrespective of the timing of infection (Buxton et al., 1990). Following an
initial infection, it is thought that the organism establishes first in the tonsil, or by
passing through the mucosa of the abomasum and small intestine, from where it is
disseminated by blood and lymph to other organs (Jones & Anderson, 1988).
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1.9.1 Placentation
Epitheliochorial, syndesmochorial, endotheliochorial and hemochorial placental
types have been distinguished, denominating the layers between the foetal
trophoblast and the maternal endometrial surface (Benirschke, 2002). Table 1.2
shows the characteristic features of human, mouse and sheep placentation, followed
by a description of ovine and murine placentation in Sections 1.9.2 and 1.9.5,
respectively.
Table 1.2 Placenta classifications








Ruminant placentation is cotyledonary, non-deciduate and synepitheliochorial
(Entrican, 2002) (Table 1.2). The association between maternal and foetal tissues of
the ovine placenta is less intimate in comparison to other types of placentation such
as the single layer of contact between maternal and foetal vascular systems that
occurs in the discoid hemochorial placenta of mice and humans (Engelhardt & King,
1996).
The uterine placenta of sheep is modified by invasion and fusion of binucleate cells,
and is therefore generally referred to as synepitheliochorial. Cotyledons on the foetal
side of the placenta are associated with rounded elevations of the uterine
endometrium called caruncles and this unit is called a placentome (Studdert, 1968;
Longbottom & Coulter, 2003). Caruncles are round thickenings in the uterine












site within the uterus to form attachments with foetal membranes. Contact between
the foetal chorion and maternal epithelium is maintained by microvillous
interdigitation in the placentome, through penetration of chorionic villi into maternal
crypts (Engelhardt & King, 1996). Approximately 75 to 125 placentomes are present
in the placenta of a pregnant ewe (Benirschke, 2002). Haematomas form at about day
60 of pregnancy, as a result of normal physiological invasion of the caruncular
stroma by chrorionic villi coinciding with haemorrhage from blood vessels (Studdert,
1968).
A large number of binucleate cells are present within the ovine placenta. Binucleate
cells arise early as part of the foetal trophoblast from cells that fail to undergo
cytokinesis following nuclear division in the foetal trophectodermal epithelium
(Wooding, 1982). Binucleate cells migrate across the maternal-foetal junction
(Wooding, 1982) and then invade and fuse with uterine epithelial cells or caruncular
epithelial cells to form chimeric trinucleate cells or other binucleate cells (Engelhardt
& King, 1996). Binucleate cells appear to play a central role in the formation of
structures and secretions at the maternal-foetal interface, which may play a crucial
role in establishment and maintenance of pregnancy (Wooding, 1982). One of the
major cellular functions of binucleate cells is the secretion of the placental hormone,
lactogen. Ovine placental lactogen is secreted in large quantities from about day 50
of gestation and foetuses also accumulate high levels. Progesterone and other
progestins, oestrogens and placental lactogen are the major hormones in the placenta
(Section 1.10).
1.9.3 Infection of the ovine placenta with C. abortus
Maternal haematomas develop in ovine placentas at the maternal-foetal interface in
the hilus of the placentome on day 60 of gestation (Studdert, 1968; Longbottom &
Coulter, 2003). This results from leakage of blood at the septal tips of the maternal
caruncle, and probably corresponds to the time that chlamydial organisms pass from
mother to foetus. Despite the development of these haematomas and their possible
role in infection, pathological changes, as a result of C. abortus infection, are not
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evident until day 90. There may not be sufficient release of organisms from the
maternal blood to induce any changes prior to this time point, or the placenta may be
resistant to infection until day 90 of gestation. Hormonal and immunological
variations linked to the pregnancy status are likely to play a role in C. abortus
infection and abortion.
Initial placental lesions are a consequence of replication of the organism in inclusion
bodies in the trophoblast cells of the chorionic epithelium (Papp et al., 1993).
Following establishment of infection in the foetal trophoblastic epithelial cells,
infection spreads out into the intercotyledonary regions of the chorion, resulting in
epithelial damage, oedema and inflammation. This inflammation is a result of
infiltration by neutrophils, macrophages, lymphocytes and plasma cells. Not all of
the placentomes become infected, and the level of inflammation and necrosis in the
cotyledons and membranes is variable (Buxton et al., 2002). Necrosis and
inflammation within the endometrial epithelium indicate the further spread of
infection. Ultimately, the damage caused by infection in the placentomes
compromises the maternal-foetal exchange of nutrients and oxygen, which
contributes to foetal death and abortion (Buxton et al., 2002). Foetal infection is also
possible and is characterised by focal necrosis in the liver. Small foci of necrosis may
also be found in the lung, spleen, brain and lymph nodes (Buxton et al., 2002),
implying that the maternal-foetal interface is disrupted in some way, allowing the
organism to reach the foetus (Buxton et al., 1990).
1.9.4 Use of animal models
Animal models have been used for many years to study many aspects of disease and
immunity. Mouse models have proved exceptionally useful in terms of manipulation
of immune systems to investigate functions of particular cells. The best defined
model of immunity to Chlamydia is infection of the murine genital tract with the
mouse pneumonitis (MoPn) strain (C. muridarum) (Cain & Rank, 1995; Qiu et al.,
2004; Yang et al., 1996). Animal models have also allowed a faster and cheaper
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method of screening vaccine studies (Rekiki et al., 2003; Hechard et al., 2003a;
Hechard et al., 2003b).
Murine models have been used to study C. trachomatis genital infections during
pregnancy (Pal et al., 1999). Such animal models have investigated the role of C.
trachomatis on the outcome of pregnancy and on the mechanisms that may be
involved in the pathogenesis of the disease. The effects of C. trachomatis on
pregnancy remain controversial within animal models, the outcome depending on
factors such as the infecting inoculum, the time of gestation, and the susceptibility of
the host. Pal et al. (1999) described a wide range of clinical manifestations, from
asymptomatic infection to abortion, produced in C. trachomatis-infected mice. There
are obvious differences between humans and mice, thus there are limitations as with
any model system. However, mice have been successfully used to characterise the
effects of Chlamydia on pregnancy. Studies have shown that the host response varies
between mouse strains, and that this has an influence on the outcome of infection
(Pal et al., 2001; Ramsey et al., 2000).
1.9.5 Mouse placentation
The hemochorial placenta of rodents is the most invasive type of placenta and is
similar to that of humans, in contrast to the non-invasive ruminant placenta
(Engelhardt & King, 1996). The majority of mouse placentas are separated from each
other, although there are exceptions. Mouse placentas are flat, spherical structures
and are smooth on the foetal side, where they are covered by cuboidal amitotic
epithelium (Benirschke, 2002).
Mouse placentae are composed of folded villous tissues with very thin foetal
capillaries covered by the trophoblast cell layer, termed the placental labyrinth, and
these are immersed in the maternal sinusoidal blood (Gude, 1982; Ward & Devor-
Henneman, 2000), as shown in Figure 1.2. This region constitutes the major site of
maternal/foetal exchange, enhanced by maternal blood directly bathing the surface of
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Figure 1.2 Subsection of murine placenta illustrating the main features of a
mouse placenta. It is composed of separate cellular layers: the maternal decidua,
the spongiotrophoblast (near the giant cells), the giant cell layer and the labyrinth
bathed in maternal blood. The chorionic plate is the area closest to the foetus,
where the yolk sac is inserted.
The foetal labyrinth is the major portion of the placental disk, as shown in Figure
1.2, and has very thin foetal capillaries that are supported by a tiny amount of
connective tissue. This labyrinth area increases to over half of the total placental
volume between days 12 and 17 post-coitum (dpc). Embryonic trophoblast cells and
embryonic blood vessels lined by embryonic endothelium are present in the foetal
labyrinth. Nucleated erythrocytes are present within these vessels and maternal
mature erythrocytes are in the spaces lined by embryonic labyrinth trophoblasts in
this area (Ward & Devor-Henneman, 2000). The umbilical cord originates in the
chorionic plate, which is situated closest to the foetus, and foetal capillaries derived
from umbilical blood vessels branch and interconnect with sinuses containing
maternal blood, surrounded by trophoblast cells in the labyrinth (Zuckermann &
Head, 1986). There are three different types of trophoblast cells found in the mouse
placenta: giant cells, spongiotrophoblast and labyrinthine trophoblast (Figure 1.2).
Other cells present include foetal and maternal blood cells, maternal decidual cells,
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foetal endothelial and mesenchymal cells and macrophages (Zuckermann & Head,
1986). The trophoblast cells are involved in physiological exchange and hormonal
production and the visceral yolk sac placenta acts as the major site of maternal/foetal
exchange (Ward & Devor-Henneman, 2000).
Spongiotrophoblast cells produce steroid hormones (oestrogen, progesterone,
lactogen and chorionic gonadotrophin), and other factors used in maternal-foetal
communication, as maternal blood vessels run through this cell layer. These cells
have also been shown to be phagocytic for maternal red blood cells, which may be a
mechanism for iron transport to the foetus (Ward & Devor-Henneman, 2000). There
are also endometrial glands, fibrinoid and trophoblast cells present. Another layer of
trophoblast-derived cells between the spongiotrophoblast and the decidua is present,
which contains giant cells. Giant cells are the primary sites of attachment to the
endometrium, surrounding the entire membranes, and composing the
trophospongium. Giant cells are found at the interface and connect the foetal placenta
to the maternal decidua. The conceptus is separated from the maternal tissue by a
continuous layer of giant cells by day 8 dpc. Giant cells of varying sizes are observed
during the gestation period as a result of the cells discontinuing their mitotic activity
and gradually increasing in size (Muntener & Hsu, 1977b). Giant cells are no longer
formed after day 10 dpc therefore as the placenta grows, the layer of giant cells
becomes narrower. These cells acquire endocrine function, immune functions and act
as a source of cytokine production (Cross, 2001).
The maternal portion of the placenta is termed the decidua, containing large
polygonal cells, which are rich in glycogen and lipids, and maternal blood cells
within blood vessels. Irregular masses of an eosinophilic, homogenous substance
called fibrinoid are present in new placenta, which increases with the age of the
placenta, between the giant cell zone and the decidua (Muntener & Hsu, 1977a).
Immunoglobulins cross this barrier from murine mother to foetus, contrasting with
the lack of Ig transfer between the ewe and foetus in the ovine placenta (Field &
Barnes, 1992; Ward & Devor-Henneman, 2000).
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Granulated metrial gland (GMG) cells are found in the uterine stroma, their
distribution depending on the development stage of the placenta (Stewart & Peel,
1978). They are thought to be associated with the development of the foetus (Peel &
Bulmer, 1977). The position of the granulated cells in the implantation site and their
association with maternal vessels, allows easy access to the foetal placenta. It has
also been suggested that metrial gland cells have associations other than the
implantation site as these cells have been detected in blood vessels elsewhere,
suggesting that they have a function at all stages throughout pregnancy.
1.9.6 Mouse models of C. abortus infection
Experimental infection of pregnant mice with C. abortus results in infection of the
placenta and abortion occurs as observed in ovine infections (Buendia et al., 1998;
Buzoni-Gatel & Rodolakis, 1983). Obviously there are distinct differences in
placenta structure and lengths of pregnancy in sheep (epitheliochorial, 143 days) and
mice (hemochorial, 21 days), yet the same outcome results from infection with C.
abortus in the two distinct animal groups.
The first C. abortus pregnant mouse model, developed by Buzoni-Gatel and
Rodolakis (1983) was shown to differentiate abortion and intestinal chlamydiae
isolates of ovine origin following footpad inoculation. In this study, the abortion
isolate (AB7) was suggested to be more virulent than the intestinal isolate,
demonstrated by its ability to colonise the spleen and popliteal lymph node, and this
has since been demonstrated in the ovine host (Huang et al., 1990a). This model has
been used to compare virulence of chlamydial strains (Rodolakis et al., 1989), as
well as being used in pathological (Sanchez et al., 1996) and protection studies
(Buzoni-Gatel & Rodolakis, 1983; de Sa et al., 1995).
Buendia et al. (Buendia et al., 1998) described an increase in chlamydial antigen and
infectious foci in the liver of pregnant mice in comparison to non-pregnant mice
following infection with C. abortus. Initial studies investigated the anatomical
progression of C. abortus within the placenta, demonstrating that decidual cells at the
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boundary of the maternal-foetal interface were the first cells to be infected.
Neutrophil infiltration and necrosis at the materno-foetal interface are characteristic
of chlamydial infections in sheep (Buxton et al., 2001; Buxton et al., 2002; Navarro
et al., 2004) and this has also been demonstrated in the mouse model (Buendia et al.,
1998). Infection was observed to spread to the layer of giant cells, with complete
colonisation of the maternal placenta occurring after day 15 of pregnancy. Foetal
labyrinth trophoblast cells were infected from day 18 of gestation onwards, a similar
progression of infection from the maternal to the foetal side of the placenta to that
observed during ovine infection. Neutrophil infiltration is characteristic of both
mouse and sheep infections, which is likely to be one of the pathogenic mechanisms
that leads to abortion (Buendia et al., 1998).
Granulated metrial gland (GMG) cells are the most numerous lymphoid cells in the
uteroplacental area in murine pregnancy (Sanchez et al., 1996). These cells contain
granules with cytotoxic molecules (perforins and serine esterases), which are a
suggested defence mechanism against intracellular pathogens. C. abortus did not
invade GMG cells until day 15 of gestation, which coincides with their apparent loss
of function. Although there are differences between sheep and mouse placentae
immune cells found and the type of immune response, there are cells in the
endometrial tissues of sheep (y8 TCR+CD8+) analogous to the GMG cells of
pregnant mice (Buendia et al., 1998).
Since C. abortus targets the placenta, it has been speculated that the susceptibility of
GMG cells to infection could affect the degree of infection that is established
(Sanchez et al., 1996). Trophoblast cells are also suggested to play a role in the
maternal immune response to bacterial infection at the utero-placental interface
(Guleria & Pollard, 2000). This has been demonstrated by trophoblast responsiveness
to colony-stimulating factor (CSF)-l, which is synthesised in high concentrations by
the uterine epithelium during pregnancy. In Listeria monocytogenes mouse
infections, CSF-1 was required to recruit neutrophils to the site of infection in the
decidua basalis, and in its absence infection remained uncontrolled (Guleria &
Pollard, 2000). Therefore, in mice, the trophoblast may act as a pregnancy-specific
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component of the innate immune system, which may have relevance in C. abortus
infections given the influx of neutrophils to sites of infections (Buendia et al., 1998).
1.10 Hormonal influences on C. abortus infections
Hormones involved in pregnancy are likely to play a crucial role in inducing abortion
following C. abortus infection, and progesterone, 17(3-oestradiol and prostaglandin
E2 (PGE2) are all central to pregnancy (Longbottom & Coulter, 2003; Entrican et al.,
2001). Progesterone is necessary for the maintenance of normal pregnancy and is
produced in chorionic epithelial cells in the latter part of pregnancy. It then interacts
with oestradiol and PGE2 to control the onset of parturition. Progesterone has been
referred to as the 'hormone of pregnancy' (Ragusa et al., 2004) because it is involved
in preparing the endometrium for implantation and facilitating endometrium
development and it is also critical for the survival of a foetus. In addition, this
hormone prevents the rejection of the foetal semi-allograft.
Progesterone levels decrease in chlamydial infected placentas, whereas the
concentrations of oestradiol increase in the amniotic and peripheral plasma, and
PGE2 concentrations increase in the amniotic and allantoic fluids (Leaver et al.,
1987; Leaver et al., 1989). The changes in hormonal levels during pregnancy may
increase susceptibility to infection, and promote placental infection at about day 90
of gestation (Buxton et al., 1990) and it has been suggested that this hormone
imbalance is an underlying cause of abortion (Buxton & Henderson, 1999). Indeed, a
study of C. trachomatis infection in rats demonstrated that progesterone enhanced
susceptibility to disease while oestradiol decreased susceptibility (Kaushic et al.,
2000). Since multiplication of chlamydial organisms takes place in the foetal
chorionic epithelial cells, the main source of progesterone in the latter stages of
pregnancy, damage to this area is likely to play a role in altering the hormonal
balance, which is necessary for the maintenance of normal pregnancy, resulting in
premature labour.
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Hormones also affect T cell reactivity and cytokine production. For example,
progesterone is involved in the development of T helper type 2 (Th2) cells that
produce IL-4 and IL-5, 17(3-oestradiol enhances IL-10 and IFN-y secretion by
antigen-stimulated clones and PGE2 biases the cytokine production of dendritic cells
towards IL-10, reducing IL-12 production (Entrican, 2002). The shift in immune
response toward a Th2 pattern may benefit the foetus, whereas development of
proinflammatory response (Thl) may be harmful (Ragusa et al., 2004). Thus, in
pregnant animals, the inflammatory response due to the invading organisms in
association with changes in hormone levels alters the placental environment and
endangers the developing foetus (Buxton et al., 2002; Entrican et al., 2001).
1.11 Immune responses to C. abortus
Both cell-mediated and humoral immune responses are involved in immunity to
chlamydial infections (Buzoni-Gatel et al., 1987; Williams et al., 1984). Knockout
mouse experiments have been used to demonstrate the role of B cells in C.
trachomatis infections, with B cell-deficient mice being more susceptible to re¬
infection than wildtype (WT) mice (Williams et al., 1997). However, the cellular
response is more efficient in decreasing subsequent infection in this model, implying
that the cell mediated immune response plays a more significant role in the resolution
of chlamydial infection than the humoral response. Immunity to C. abortus infections
has been demonstrated by the transfer of primed splenic T cells and by the transfer of
sera from immune mice (Buzoni-Gatel et al., 1987), highlighting the importance of
both cell mediated immunity and humoral immunity, although as is well known, the
former plays a more dominant role in the resolution of infections. CD4+ T cells are
the predominant responding cell type in murine C. trachomatis infections, while it
has been suggested that CD8+ T cells assume this role in the host defense against
murine C. abortus infections (de Oca et al., 2000a).
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Table 1.3 shows a summary of the major immune cells and their general role in
controlling infections. The following sections then describe the role of various cell
types in the specific control of Chlamydia infections, focusing on C. abortus
infections.
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Table 1.3 Overview of immune cell types and functions
Cell Classification Stimuli Function





















Host defence; phagocytosis; Ag
presentation; cytokine release;












IL-5; eotaxin; IgA; IgE Allergy-mediating cell; helminth
defence; cytokine release





mediator release; secretion of
IL-4 and IL-13






B cell Lymphocyte Foreign antigens; self-
antigens; IL-4; IL-10;
IFN-y; IL-2




T cell Lymphocyte Antigen presentation;
co-stimulatory
receptors; IL-4; IL-12
Direct killing of targeted cells;
stimulation of cell-mediated and
humoral immunity (see later for
more details on subsets)
Natural killer cell Lymphocyte Antibody; lack of target
cell MHC I; IFN-a; IFN-
P; IL-12; TNF-a
Host defence against viral
infection and cancer; cytolytic
activity; cytokine release;
primary role in innate immunity
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1.11.1 Humoral response
It is well documented that ewes seroconvert post-abortion (Aitken, 2000a;
Longbottom et al., 2001; Longbottom et al., 2002) (described in Section 1.8),
although the contributory role of antibody in resolving primary infections remains
unclear (Longbottom and Coulter, 2003). Antibody has also been readily detected
both in serum and secretions from animals infected in the genital tract with C.
trachomatis, although the role of antibody in primary infections is contrasting in the
guinea pig and mouse models of chlamydial infection (Rank, 1999). A definitive role
for the humoral response in the resolution of infection was confirmed in the guinea
pig model (Rank et al., 1979) whereas antibody was not necessary for the resolution
of infection in mice (Ramsey et al., 1988).
In contrast, B cells have been ascribed an important role in the early response to C.
abortus infection in mice. B cell-deficient mice were more susceptible to C. abortus
infection shown by increased mortality, significantly higher levels of infection and
an exacerbated inflammatory response which led to thrombi and necrosis in infected
tissues compared to WT mice (Buendia et al., 2002a). However, Buendia et al.
(2002a) demonstrated that, following re-infection after a low-level primary infection,
B-cell deficient mice were protected from this secondary challenge and T cells were
primed even in the absence of B cells, shown by an increased IFN-y response. This
was also demonstrated by Johansson and Lycke (Johansson & Lycke, 2001) and
Morrison et al. (Morrison et al., 2000) in a genital tract model infection with C.
trachomatis. Morrison et al. (2000) reported the significant role of B cells in
resistance to chlamydial reinfection in this C. trachomatis genital tract mouse model.
Depletion of CD4+ T cells in WT mice had a limited effect on resistance to re¬
infection whereas depletion of CD4+T cells in immune B cell-deficient mice resulted
in mice being unable to resolve a secondary chlamydial infection, showing the
importance of both CD4+ T cells and B cells (Morrison et al., 2000). It may be that
antibodies act to enhance Thl activation via FcR-mediated processes, such as the
enhanced uptake and processing and presentation of antigens, in resistance to re¬
infection (Moore et al., 2002, 2003). This also highlights the requirement of potential
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protective vaccines to elicit both humoral and cell-mediated immune responses
(Moore et al., 2003).
Studies in Fc-receptor (FcR) KO mice have shown that antibodies have a major role
in resistance to re-infection with C. trachomatis (Moore et al., 2002), suggesting that
FcR-dependent effector functions may represent the major mechanisms by which
antibodies participate in control of re-infections. FcRs bind the Fc portion of
immunoglobulin and function as important vehicles for antibodies to enhance the
phagocytosis of pathogens, to initiate intracellular degradation and removal, and for
antigen processing/presentation for immune elicitation. Binding of FcRs by antigen-
antibody complexes can activate immune cells bearing the receptors, such as
phagocytes, macrophages, polymorphonuclear neutrophils (PMNs), natural killer
(NK) cells, eosinophils and mast cells (Moore et al., 2002). FcR-mediated immune
processes have also been examined in vitro and showed that specific anti-chlamydial
antibodies augmented macrophage killing of infected cells by antibody-dependent
cellular cytotoxicity (ADCC) and macrophage inhibition of growth of chlamydiae in
co-cultures (Moore et al., 2002).
Antibody responses in the ovine immune response to C. abortus comprise whole IgG
and IgM responses in sera (Papp et al., 1994) and IgG and IgA have also been
detected in vaginal secretions from chronically infected ewes (Papp & Shewen,
1997). Subclasses of serum antibodies can be used as an indicator of type 1 or 2 T
cell dominance (Finkelman et al., 1990). In mice, the type 1 (Thl) cytokine IFN-y
enhances IgG2a production by B cells but inhibits IgGl (Stevens et al., 1988),
therefore IgG2a is reflective of a type 1 T cell response (Snapper & Paul, 1987).
Increased IgG2a production compared to IgGl has been demonstrated in C. abortus
infected mice (Del Rio et al., 2000).
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1.11.2 Cell-mediated response
1.11.2.1 Delayed type hypersensitivity
Early research on C. abortus immune responses demonstrated the importance of cell
mediated immunity in resolving infection. Delayed type hypersensitivity (DTH) is
important for resistance to EAE, and EFN-y, which controls infection, has an
important role in DTH. Delayed type hypersensitivity may therefore play a role as a
direct effector mechanism in the generation of immunity as well as maintaining
persistence in sheep. Ewes that have aborted have positive DTH reactions, compared
to no DTH responses in non-pregnant infected ewes (Dawson et al., 1986; Wilsmore
et al., 1986). Sheep with poor DTH responses following vaccination were more
likely to abort post-challenge, suggesting DTH could be used as a measure of
immunity.
1.11.2.2 The role of CD4 and CD8 T cells in Chlamydia infections
The induction and recruitment of specific T cells into the infected environment is
necessary for controlling chlamydial infections (Igietseme et al., 2002). Early studies
of efferent lymph collected from infected sheep revealed that CD4+ and CD8+ T cell
populations were present (Huang et al., 1990a), and this occurs in both naive and
immune sheep (Entrican et al., 1998). The relative importance of both CD4+ and
CD8+ T cells during primary infection has been in dispute for many years, although
CD4+ cells appear to be more dominant and have been shown to produce LFN-y in
vitro in response to challenge with chlamydial antigen (Byrne et al., 1989). The role
of IFN-y in control of infections is discussed in more detail in Section 1.11.3.1,
On the other hand, Beatty and others (1994a,b) have suggested that Chlamydia-
infected cells are lysed by specific cytotoxic T lymphocytes (CTLs; CD8+ T cells).
CD8+ T cells could also be ascribed a cytotoxic role after recognition of C. abortus
antigen complexed with major histocompatability complex (MHC) class I, and via
production of the cytokine IFN-y (Beatty et al., 1994a,b). Although this evidence
implies that CD8+T cells do not act in a cytotoxic manner, but act in a similar way to
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CD4+ T cells by enhancing IFN-y expression (Buzoni-Gatel et al., 1992). Infection of
mice with other chlamydial species such as C. trachomatis, which causes human
genital tract infection, leads to recruitment of both CD4+ and CD8+ lymphocyte
populations to sites of infection in the uterus (Reddy et al., 2004). Elimination of
CD4+ and CD8+ T cells in MoPn infection significantly increased pathogen load in
the lungs and decreased antigen-induced IFN-y by both CD4+ and CD8+ T cells
(Magee et al., 1995). Depletion of CD4+ cells led to a significant increase in
mortality, whereas depletion of CD8+ cells did not, although higher mortality was
observed than in non-depleted mice. Irrespective of their roles, both T cell
populations lead to the upregulation of cytokines, IFN-y and tumour necrosis alpha
(TNF-a), which are involved in immunity to C. abortus (Buxton et al. 2002; Byrne et
al., 1986; Entrican et al., 2001).
Two responder phenotypes of CD4+ T cells exist, defined by the different cytokine
patterns that they express. Thl cells, induced by infection with intracellular bacteria
and viruses, secrete cytokines such as IFN-y, IL-2, IL-12, and TNF-a. Th2 cells,
normally induced in response to allergens and helminth parasites, secrete cytokines
such as IL-4, IL-5, IL-10 and IL-13 (Mosmann & Coffman, 1989). Once a T cell
response starts to develop along a Thl or Th2 phenotype it becomes increasingly
polarised. In sheep, C. abortus is controlled by a Thl type immune response, with
IFN-y and TNF-a playing major roles (Buxton et al., 2002; Entrican et al., 2001).
Ruminants may be simultaneously infected with gastrointestinal nematodes and C.
abortus in the field. Buendia et al. (Buendia et al., 2002b) conducted co-infection
studies in mice with C. abortus and Nippostrongylus brasiliensis, a rodent
gastrointestinal nematode used extensively in experimental models of parasite-
induced Th2 responses (Finkelman et al., 1997; Holland et al., 2005) to determine
the effect of a previously established immune response to parasite infection on the
response to C. abortus infection. Mice that were previously infected with N.
brasiliensis had an increased susceptibility to C. abortus infection, demonstrated by
increased infection levels and lower IFN-y production compared to mice infected
with only C. abortus, suggesting that an already established Th2 response alters the
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normal Thl response induced in response to C. abortus infections in mice (Buendia
et al., 2002b).
1.11.3 Inflammatory response to C. abortus infections
1.11.3.1 Cytokine response
Two inflammatory cytokines, EFN-y and TNF-a, which are produced in response to
C. abortus infections, are thought to contribute to the pathology of EAE and also to
threaten the maintenance of pregnancy in sheep (Entrican, 2002). Mononuclear cells
expressing mRNA encoding TNF-a were shown to be abundant in infected placental
tissues, particularly in the inflammatory exudates associated with the chorionic
epithelium, although very few cells expressed mRNA encoding IFN-y (Buxton et al.,
2002).
IFN-y, produced by both CD4+ and CD8+ T cell subsets, is crucially involved in
controlling chlamydial infections (Loomis & Starnbach, 2002; Rottenberg et al.,
2000). IFN-y can activate the microbicidal activity of host macrophages and the
macrophages can cause destruction of chlamydial-infected cells in vitro, suggesting
its importance in host resistance (McCafferty et al., 1994; Igietseme, 2002). It has
been demonstrated that C. abortus multiplication can be restricted by IFN-y in ovine
cells in vitro (Graham et al., 1995). IFN-y is expressed in placental tissue during
normal pregnancy, but it can be cytotoxic for human trophoblast cells at high
concentrations (Yui et al., 1994). Therefore, an increase in IFN-y expression in
response to chlamydial infection within placenta tissue may be detrimental to both
the maternal and foetal host tissue as well as to the invading organisms. EFN-y
inhibits growth of Chlamydia both in vitro (Entrican et al., 1998) and in vivo (Lampe
et al., 1998). It seems highly likely that the presence of IFN-y controls the growth of
C. abortus within host tissues, despite the low incidence of placental cells expressing
IFN-y mRNA, and simultaneously impairs foetal survival by impairing the function
of placental trophoblast cells due to a decrease in tryptophan, which in turn damages
placental cell functions and contributes to abortion. Macrophage production of
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inflammatory mediators is triggered by IFN-y and this causes fibroblast proliferation,
thereby enhancing the synthesis of collagen (Beatty et al., 1993), which is also likely
to contribute to pathology in infected sheep. IFN-y inhibition of multiplication results
in inapparent persistent infections, and this is likely to also play a role in the
immunopathogenesis associated with Chlamydia infections (Rottenberg et al., 2002).
IFN-y-gene KO mouse models have been developed, and alongside in vitro studies,
have proved extremely useful in demonstrating the essential role of EFN-y in
controlling all chlamydial infections (Dalton et al., 1993; Lampe et al., 1998;
Rottenberg et al., 2000). Cotter et al. (Cotter et al., 1997) demonstrated the
importance of the role of IFN-y in resolving C. trachomatis infection in the MoPn
model system, using mice in which the gene for IFN-y had been disrupted. Wildtype
mice infected with C. trachomatis MoPn showed systemic dissemination of a small
number of organisms to major organs from day 7-14 p.i. and the infection resolved
within 3 weeks. However, the ability to resolve infection was impaired in IFN-y KO
mice, where a prolonged and more pronounced systemic dissemination of Chlamydia
was observed, as demonstrated by significantly higher numbers of organisms
cultured from spleen tissue (Cotter et al., 1997).
TNF-a is thought to play a crucial role in immunity to Chlamydia through the
activation of phagocytic cells that rapidly degrade infected cells or extracellular EBs
(Igietseme et al., 2002). A high concentration of TNF-a at the maternal-foetal
interface is incompatible with pregnancy (Dealtry et al., 2000) and TNF-a has been
linked to spontaneous embryo loss in pregnant mice (Yui et al., 1994). Therefore,
TNF-a released in response to chlamydial infection (possibly to the LPS component)
may contribute to the placental damage that leads to abortion as well as playing a
role in controlling the disease (Buxton et al., 2002).
IL-12 is important for initial clearance of bacteria, while IFN-y is important for long-
term resolution of infection (Kaushic et al., 2000). The role of dendritic cells in
immunity to chlamydial infection has been demonstrated through the production of
IL-12. IL-12 promotes a Thl type response, by acting on NK cells to stimulate the
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production of IFN-y (Lu & Zhong, 1999; Scheerlinck et al., 1998; Tseng & Rank,
1998). However, IL-12 is not necessarily essential for controlling C. abortus
infections as IL-12 KO mice mounted a protective Thl immune response against the
infection, by the production of both IFN-y and IgG2a (Del Rio et al., 2001). CD4+ T
cell infiltration was reduced in IL-12 KO mice compared to WT mice, although the
number of CD8+ cells was slightly higher, which is consistent with a role for CD8+ T
cells in the protective response leading to the production of IFN-y (Del Rio et al.,
2001).
In summary, a CD4 Thl immune response is thought to be the principal component
of the protective response to chlamydial infection, with IFN-y and TNF-a being
major cytokines involved in the response (Buxton et al., 2002; Zhong et al., 2000).
Both antibodies and CD8+ T cell subsets are also major components of the protective
immune response, the former as a memory response during re-infection, and the
latter contributing via cytokine production, rather than by cytotoxicity,
complementing the CD4+ Thl driven response (Igietseme et al., 2002).
1.11.3.2 Role of PMNs in chlamydial infections
Pronounced neutrophil infiltration is observed in the placenta of mice infected with
C. abortus and those of sheep infected under natural conditions (Buendia et al.,
1999; Buxton et al., 1990; Wong et al., 1985). PMNs have previously been reported
to play a role in the resolution of C. trachomatis infections (Barteneva et al., 1996),
and neutrophil infiltration of the uterus is not unique to chlamydial infections; for
example, Brucella abortus and L. monocytogenes infections also cause infiltration of
PMNs in the murine placenta (Redline et al., 1988; Tobias et al., 1993). Neutrophils
could be beneficial to the host by ingesting the organism and clearing the infection.
Alternatively they could be detrimental by causing placental damage, inflammation
and necrosis as a result of recruitment of other cell types, and thereby be involved in
inducing abortion.
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PMNs are suggested to play an essential role in the response to primary infection
with C. abortus (Buendia et al., 1999). Studies showed that depletion of PMNs
resulted in earlier abortions and a higher mortality rate in mice infected with C.
abortus (Buendia et al., 1999). Depleted mice expressed widespread necrosis of the
uteroplacental units in contrast to virtually no necrosis in non-depleted mice.
Register et al. (Register et al., 1986) and Yong et al. (Yong et al., 1986)
demonstrated the ability of PMNs to destroy Chlamydia in vitro. However, PMNs
are suggested to have a limited role in the secondary response, demonstrated by no
clinical signs in both WT and depleted mice upon secondary infection with C.
abortus (de Oca et al., 2000b). Neutrophils also appear to play an immunoregulatory
role, by secreting cytokines such as TNF-a, IFN-y and IL-12, which in turn activate a
Thl response that could lead to control of the infection (Ellis & Beaman, 2004).
1.12 Treatment and control methods
Current control methods for EAE are limited. Clinically affected and in contact
pregnant animals are preferably treated with long-acting oxytetracycline, which
when given at later stages of infection can prevent abortion (Aitken et al., 1982;
Rodolakis et al., 1980). Oral tylosin is also frequently administered (Rodolakis et al.,
1980). Treatment of a whole flock in which ewes are aborting for the first time can
reduce losses, as antibiotics inhibit chlamydial growth and limit additional placental
damage (Aitken et al., 1982). However, with these drugs alone, complete elimination
of the infection is not possible and the severity of existing damage cannot be
reduced. They may also affect the development of immunity.
Spread of infection needs to be restricted in an outbreak within a flock, for example
by isolating animals for a defined time period until their uterine discharges clear up.
Appropriate measures for disposal of infected tissues are also important in order to
prevent further infection of the flock. Two schemes exist in Britain, the Sheep and
Goat Health Scheme in England and Wales, and the Premium Sheep Health Scheme
in Scotland to ensure that farmers obtain Chlamydia-free sheep when purchasing
replacement ewes for introduction into a clean flock. Sera from participating flocks
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are screened for the presence of antibodies to C. abortus, and if results are negative,
flocks can be accredited as EAE-free (Aitken & Longbottom, 2004).
1.13 Vaccines - old, new and developing
In the UK, the first successful EAE vaccine was developed at the Moredun Research
Institute (MRI), Edinburgh in the 1950s (Littlejohn et al., 1952; McEwen et al.,
1951). The vaccine, which was developed by McEwen et al. (1951), was based on
formalin-inactivated whole organisms derived from infected placental material, but
this proved impractical due to the large amounts of material required for this.
Subsequent studies were conducted using egg grown material of a single C. abortus
isolate (A22), yolk-sac derived. This vaccine was formaldehyde-inactivated, Falba-
adjuvanted and became commercially available in 1958 by the Wellcome Foundation
Ltd. It was effective in controlling EAE for approximately 20 years when abortion
started reappearing in vaccinated flocks, shown in field trials by Linklater and Dyson
(1979). A second C. abortus isolate, S26/3 (isolated from a vaccinated flock in 1979)
was subsequently added to the original isolate, A22, in 1982, however this modified
vaccine did not show complete protection and was eventually withdrawn in 1992.
In the early 1980s, a mutant temperature sensitive vaccine (IB isolate of C. abortus)
was developed (Rodolakis & Souriau, 1983) that is still used in several countries
today. The vaccine, IB, was produced from a virulent AB7 isolate by
nitrosoguanidine mutagenesis, producing a live attenuated strain that can grow at
35°C but not at 39.5°C, the body temperature of a sheep, and it induces a strong and
specific immune response.
The live vaccine (Enzovax, Intervet UK Ltd) is one of two commercial vaccines
available in the UK, the other being an inactivated whole organism vaccine
(Mydiavac, Novartis Animal Health UK Ltd). Both commercial vaccines offer good
protection against EAE and limit the shedding of infectious organisms. However, as
with other live attenuated vaccines, there are safety issues, including possible
reversion to pathogenicity as this may result in disease and abortion in the host.
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There is also a risk of C. abortus causing serious disease and abortion in pregnant
women (Buxton, 1986). Additionally, the live attenuated vaccine cannot be
administered to pregnant ewes, or to ewes that are undergoing treatment with
antibiotics, whereas the inactivated vaccine can be used in these situations. Although
since the inactivated vaccine contains mineral oil as the adjuvant, care must be taken
when handling and administering as it can cause tissue necrosis if self-injected.
These disadvantages associated with the two commercial vaccines have led to a
search for improved alternative vaccines based on subunit components.
Reasonably successful vaccine studies have been conducted using purified EBs
(Anderson et al., 1990) and chlamydial outer membrane complex (COMC)
preparations in sheep (Tan et al., 1990), guinea pigs (Batteiger et al., 1993) and mice
(Pal et al., 1997). Subunit vaccine research has focused largely on MOMP, as this is
the immunodominant protein expressed on the surface of EBs and RBs and it
incorporates both T and B cell epitopes, which are necessary for induction of a
protective immune response (Igietseme et al., 2002; Pal et al., 2001). MOMP has
been shown to establish protection against subcutaneous challenge with infectious
organisms and inactivated EBs also gave protection against C. abortus infection (Tan
et al., 1990).
Although vaccination with purified COMCs and purified MOMP preparations has
been reasonably successful, there are problems associated with the bulk growth of C.
abortus required for their preparation. The alternative of the more cost-effective
recombinant protein vaccines has become a main focus of vaccine research,
particularly those based on MOMP. Studies conducted by Herring and others
(Herring et al., 1998) using C. abortus recombinant MOMP, expressed as insoluble
inclusion bodies in a bacterial overexpression system, showed some protection
against C. abortus infection, although results were inconsistent. An increasing
number of studies are focusing on proteins other than MOMP, facilitated by the
availability of the C. abortus genome sequence (Thomson et al., in press). Recent
identification of the POMP family (Longbottom et al., 1998b) of the protective
COMC has provided new vaccine targets because of their presence in the outer
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membrane. POMPs have been shown to be surface-exposed (Buendia et al., 1997;
Longbottom et al., 1998a; Tanzer et al., 2001), glycosylated (Vretou et al., 2001) and
to induce antigen-specific T cell responses (Goodall et al., 2001; Halme & Surcel,
1997), all of these factors contributing to their highly immunogenic nature. Analysis
of the genome sequence has shown that the six polymorphic membrane protein
(pmp) genes originally identified belong to a much larger family of pmp genes that
are present in all of the Chlamydiaceae sequenced genomes (Longbottom and
Coulter, 2003). Recent sequencing of the C. abortus genome will aid future
chlamydial vaccine research, with particular attention on the outer membrane
proteins that have been identified. These proteins are translated and localised to the
membrane surface and are likely to play a role in chlamydial pathogenesis
(Longbottom and Livingstone, in press).
In addition to subunit and recombinant protein vaccines, some attention has focused
on development of MOMP-based DNA vaccines as a way of inducing a protective
response against chlamydial infections (de Sa et al., 1995). DNA vaccination holds
advantages over other vaccine types, as the vaccine antigen is produced de novo by
the host cell and production is easier due to elimination of the need to cultivate
infectious organisms (Krishnan, 2000). Other advantages include the improved
stability of the vaccines at room temperature (RT), cheaper production costs and they
are safer than live attenuated vaccines. DNA vaccination induces both cellular and
humoral immune responses, although stimulation of the cell mediated response is
more crucial in the resolution of chlamydial infections (Su & Caldwell, 1995).
Although in general DNA vaccination has been more successful in mice than in large
animals or humans (Babiuk et al., 2003).
An exception is the successful protection of turkeys against Chlamydia psittaci
infection using gene-gun based DNA immunisations (Vanrompay et al., 1999a;
Vanrompay et al., 1999b; Vanrompay et al., 2001). Delivery of plasmid DNA
incorporating the MOMP gene of the avian C. psittaci strain into the dermis
produced protection against infection and both T-helper and B cell memory
responses were primed, showing that DNA vaccination is a promising strategy
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capable of preventing severe clinical signs and lesions (Vanrompay et al., 1999b).
Recently, Hechard et al. (2002, 2003) have conducted a DNA vaccination
experiment using a dna-K-encoding (heat shock protein) plasmid in pregnant and
non-pregnant mice, exemplifying the value of animal models for vaccine assessment.
Weak humoral responses were induced but this was insufficient to mediate specific
protection in pregnant and non-pregnant mice against C. abortus infection (Hechard
et al., 2002, 2003).
Identification of new chlamydial antigens that can be used as recombinant proteins or
peptides in subunit or multicomponent vaccines is necessary to produce cheaper,
safer and more stable alternatives. It is equally important to consider the route and
method of delivery of potential vaccines, as well as identification of suitable
adjuvants, to ensure that the antigens are correctly processed and presented to the
immune system to evoke the necessary protective immune response (Entrican et al.,
2001; Longbottom and Livingstone, in press). Chlamydial research to date suggests
that an efficacious vaccine should induce a systemic CD4+ Thl response, as well as a
humoral response to enhance the memory response following secondary infection.
1.14 Project proposal and aims
At MRI, Chlamydia research has concentrated on the ovine host, studying immune
responses and pathology, and assessing vaccine efficacy. Although it is invaluable to
be able to conduct studies in the natural host for C. abortus, disadvantages associated
with this include expensive animal and husbandry costs, primarily because of the
long period of gestation in sheep. As a consequence, the number of parameters that
can be examined is limited in an experiment, such as routes of inoculation and
adjuvants. A mouse model of chlamydial infection offers advantages over the use of
the ovine host to assess vaccines and vaccine candidates. A pregnant mouse model
system will reduce the time and expense associated with initial vaccine trials due to
the shorter gestation period of a mouse compared to that in sheep and larger numbers
of mice can be vaccinated. This allows a wider range of parameters to be examined,
particularly as there are many more reagents available for mice than sheep. A non-
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pregnant mouse model exists at MRI in which the protective efficacy of vaccines can
be assessed by the recovery of infectious organisms from tissues. However, since C.
abortus targets the placenta and causes abortion, a pregnant mouse model is more
appropriate for assessing vaccine efficacy by a reduction in the number of abortions.
The overall aim of this project was to develop a pregnant mouse model of chlamydial
abortion that can ultimately be used for assessing the effectiveness of protein and
DNA-based vaccination strategies in controlling the disease caused by the zoonotic
pathogen C. abortus. To achieve this, the key objective was to define the immune
response and pathology associated with C. abortus infection in pregnant mice to
allow comparison with infection in sheep in order to fully validate the model.
Initially it was necessary to determine if abortion occurs in pregnant mice following
infection with C. abortus (isolate S26/3), as occurs in infected sheep. Subsequent
studies were then undertaken to investigate whether latent or persistent infections
develop following C. abortus infection of non-pregnant mice, as demonstrated by a
possible recrudescence of infection and abortion once mice become pregnant. If the
location of the organism can be identified in mice during the latent or persistent
phase, this would provide vital information for the ovine chlamydial research field.
Another key objective was to determine if C. abortus infected mice are immune to
secondary infection and abortion in the following pregnancy post-abortion, as occurs
in sheep. Provision of further information regarding aspects of the protective immune
response is of benefit to chlamydial research. In order to fully validate the use of a
mouse model to assess vaccines against EAE, it is necessary to compare chlamydial
disease in the pregnant mouse model to that in sheep and identify similarities
between the two species in terms of abortion, disease progression, development of





2.1 Source of chemicals
All chemicals and solutions were purchased from Fisher Scientific UK Ltd or Sigma-
Aldrich, UK unless otherwise stated.
2.2 Preparation of inoculum
2.2.1. McCoy cell culture
Mouse fibroblast McCoy cells (Mycoplasma-free) were used for cell culture of
chlamydial organisms from stocks of egg-grown C. abortus isolate S26/3. This was
first isolated from a vaccinated ewe that aborted in Scotland in 1979 (Linklater &
Dyson, 1979). McCoy cells were grown in RPMI 1640 (Gibco BRL, UK) growth
medium, containing 5% (v/v) heat inactivated foetal bovine serum (FBS; Sigma Ltd.,
UK), 0.2 M Hepes, 0.2% (v/v) sodium bicarbonate, 25 units (U)/ml Nystatin, 5 pg/ml
Gentamycin and 0.2 mg/ml Streptomycin (Gibco BRL, UK) in 225 cm2 tissue culture
flasks (Co-Star, USA). When confluent, the cells were passaged by discarding the
medium and rinsing the flask twice with sterile phosphate buffered saline (PBS) that
had been pre-warmed to 37°C. A trypsin/versene mixture (T/V; 1:4 T:V) was added
to cover the monolayer for 10 seconds (s), before the excess was poured off, leaving
a thin covering over the cells. The flask was incubated at 37°C until the cells were
seen to dislodge from the flask. 7.5 ml RPMI growth medium was added to inhibit
further action of trypsin on the cells. Cells were sub-cultured (ratio of 1:5) and added
to new 225 cm2 flasks with 50 ml RPMI growth medium and were incubated at 37°C
in a humidified atmosphere of 5% CO2 (37°C, 5% CO2) for 3 days.
Cells were infected with Chlamydia by incubation with RPMI infection medium (2%
FBS, 0.2 M Hepes, 0.2% sodium bicarbonate, 25 U/ml nystatin, 5 pg/ml gentamycin,
0.2 mg/ml streptomycin and 1 /xg/ml cycloheximide) containing C. abortus (S26/3
isolate). Flasks were incubated at 37°C for 3-7 days. Chlamydial cultures used for the
preparation of inoculum were harvested approximately 4-5 days post-infected,
titrated (Section 2.2.2) and stored in chlamydial transport medium (CTM; 0.2 M
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sucrose, 7 mM potassium dihydrogen phosphate, 5 mM L-glutamic acid, 0.0016%
(w/v) phenol red) at -20°C until required.
2.2.2. Titration of C. abortus
For production of challenge inoculum to infect mice, titrations of the S26/3 isolate of
C. abortus were carried out on coverslip cultures of McCoy cells. The procedure was
followed up to trypsinisation of cells from the flask, as described in Section 2.2.1.
Following this, 10 ml of RPMI growth medium was added to the detached cells, and
100 jU,l of the cell suspension was added in a 1:1 ratio with 0.08% trypan blue to
determine the cell concentration, where dead cells take up the blue stain while viable
cells do not. The number of viable cells was counted in an Improved Neubauer
haemocytometer under a light microscope at x20 magnification. The cells were then
diluted in RPMI growth medium to 2 x 105 cells/ml to obtain a monolayer overnight,
or to 1 x 10 cells/ml to obtain a monolayer over 3 days. One ml of the cell
suspension was pipetted into each Trac bottle (Sterilin, UK) containing a 1 x 16 mm
glass coverslip. Air bubbles were removed to prevent cell growth on the underside of
the coverslip and the "Tracs" were incubated for the appropriate number of days at
37°C, 5% C02.
Ten-fold dilutions of the inoculum (S26/3; 4th passage yolk sac, 10th passage tissue
culture) were prepared in RPMI infection medium. Growth medium was discarded
from confluent coverslips and 1 ml of each dilution of the inoculum was added to
Tracs in duplicate, and centrifuged twice at 1100 xg for 15 min at RT to increase
infectivity. Tracs bottles were then incubated for 3 days at 37°C, 5% C02. To detect
chlamydia] EBs, the coverslips were fixed in 100% methanol for 5 minutes (min) and
were then transferred to 5% Giemsa-Gurr (BDH, UK) for 20 min to stain the cells.
After rinsing the coverslips in tap water, and dehydrating and clearing through a
series of graded acetone-xylene solutions (100% acetone; 2:1 acetone:xylene; 1:1
acetone:xylene; 1:2 acetone:xylene and 100% xylene), the coverslips were mounted
in DPX (BDH, UK) on microscope slides. Coverslips were examined by light
microscopy (x400) and the number of chlamydial inclusions present was recorded,
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and the number of inclusion forming units (EFUs)/ml was calculated using the
following formula:
IFUs/ml = n (mean of two Tracs) x reciprocal dilution factor
The inoculum was stored at -20°C in sterile CTM until required (as previously
described by (Anderson, 1986; Anderson & Baxter, 1986; McClenaghan et al.,
1984).
2.3 Infection of mice
2.3.1 Mouse strains and mating procedure
Adult (56- to 60-day-old) CBA (H-2K; inbred) and Porton (outbred) were obtained
from Harlan Olac Ltd, Oxford, UK and MRI, Edinburgh (in-house breeding),
respectively. The mouse strains used in each experiment are described in Chapters
3-6. Virgin females were mated with males (at a ratio of 1:1 or 1:2) of the same
strain over 5 days in accordance with the murine oestrus cycle. Male mice were
added to female cages, left overnight for approximately 16 hours (h), when females
were checked for the presence of a vaginal plug. The presence of a vaginal plug
designated day 0 of pregnancy.
2.3.2 Chlamydial infection of mice
Routinely, pregnant mice were challenged with 106 EFUs of C. abortus at
mid-gestation (day 11), as described by Buendia et al. (Buendia et al., 1998). The
inoculum was thawed and sonicated (Ultrasonic processor, Jencons Limited, UK) to
ensure resuspension of Chlamydia and then diluted to 5 x 10 IFUs/ml with 0.1 M
PBS. Mice were inoculated by intra-peritoneal (i.p.) injection of 106EFUs C. abortus
in 0.2 ml 0.1 M PBS. Control mice in each experiment were injected (i.p.) with 0.2
ml of 0.1 M PBS. Following challenge, mice were weighed and clinically scored
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every day for any clinical signs, such as stary coats, tottering gait and weight loss
(Table 2.1).
Table 2.1 Clinical scoring system
Presumed febrile response
(as determined by the
appearance of the coat)
Dehydration
(determined by weight loss)
General
demeanour
0 = sleek, glossy coat 0 = weight maintained at
pre-infection level
0 = bright/active
1 = ruffled coat 1 = 10% weight loss 1 =hunched
2 = stary, stiff coat 2 = 20% weight loss 1 = tottering gait
1 = reluctant to move
Mice were checked each day for any of the above symptoms and scored in
accordance with Home Office regulations. A cumulative score of 5 results in the
mouse being killed, as does a score of 4 for more than two consecutive days. Note
that the general demeanour scores are additive so that a mouse could score up to 3 in
this category.
2.4 Tissue collection at necropsy
Generally, liver, spleen, uterus and/or foetoplacental units (depending on pregnancy
status) were removed from each animal. Samples were collected into various
fixatives for histological and immunohistochemical studies and into CTM to assess
infection levels through bacterial recovery. Spleen tissues were collected for
immunological assays. Specific details of the necropsies are described for each
experiment in Chapters 3-6.
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2.5 Collection of blood samples
Blood samples were taken pre-infection (day 10 of pregnancy) by tail snips. Fifty fx 1
(less than 10% of total volume) of blood was removed from each animal. Blood
samples were also taken at necropsy by cardiac puncture. Samples were
microcentrifuged at 13000 xg for 10 min and the sera were collected and stored at
-20°C for testing for specific antibodies and cytokines.
2.6 Processing of fixed tissues
Liver, spleen and reproductive tissues were fixed in 10% formal saline (4%
formaldehdye, 145 mM NaCl) for 5-7 days for histological studies and
immunolabelling of chlamydial antigen. Samples collected into zinc salts fixative
(ZSF; 0.5% Zinc acetate, 0.5% ZnCh, 0.05% Calcium acetate, 0.1 M Tris, pH 7-7.4)
and 4% w/v paraformaldehyde (in PBS) were fixed for 6-8 h at RT, trimmed and
then fixed for a further 24 h (h) at RT. Tissues were processed by dehydrating
through graded alcohols and then embedding in paraffin wax at 56°C. Sections were
cut as required for histological and immunohistochemical analysis.
2.7 Culture of chlamydial organisms from infected tissues
Liver and placental/uterine tissues were stored in 4 ml CTM at -20°C. Immediately
prior to culturing, samples were thawed and sonicated to disrupt tissues and release
EBs. Ten-fold dilutions of sonicated tissues were prepared in RPMI infection
medium and duplicate samples were cultured on McCoy cells in Trac bottles, as
described in Section 2.2.2, Inclusions were stained with Giemsa and counted, with
results expressed as numbers of IFUs/g of tissue.
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2.8 Immunohistochemical analysis
2.8.1 Haematoxylin and eosin staining
For histological analysis, haematoxylin and eosin (H & E; Cellpath, UK) staining
was conducted on formalin-fixed tissues. Tissue sections were examined by light
microscopy to identify any pathological changes associated with infection.
2.8.2 Detection of chlamydial antigen
The presence of chlamydial antigen in tissue sections was assessed using an avidin-
biotin-peroxidase complex (ABC; Vector Laboratories, Peterborough, UK) protocol,
as previously described (Buxton et al., 1996).
Sections (5 jum; on Superfrost slides; Merck, Leicester, England) of 10% formalin-
fixed tissues were dewaxed in xylene and dehydrated in a series of alcohols (100%,
75% and 50% ethanol). Sections were rinsed in distilled water (dH20) before 2x5
min washes in wash buffer (pH 7.5, 0.02 M sodium phosphate, 0.15 M NaCl, 0.045%
Tween 80). All blocking steps and antibody dilutions were prepared in high salt
buffer (HSB; 0.02 M sodium phosphate, 0.55 M NaCl). Non-specific binding was
blocked with normal goat serum (Vector Laboratories) (1:4 in HSB) for 30 min at
RT. Sheep sera, collected from C. abortus-infected animals, were used as the
primary antibody and 100 pi of this was incubated overnight at 4°C (1/200 in HSB).
Control sections were incubated with HSB only overnight at 4°C. Sections were
washed for 2 x 5 min, followed by the addition of the secondary, goat anti-sheep
biotinylated antibody (1/800 in HSB) to all sections for 30 min at RT. Sections were
then immersed in 1% H2O2 (in methanol) for 30 min at RT to remove endogenous
peroxidase activity. The ABC procedure was then followed according to
manufacturer's instructions (Vector Laboratories), with avidin-biotin-peroxidase
solution incubation for 30 min at RT. The reaction was developed with 0.05%
diaminobenzidine tetrahydrochloride (DAB). Sections were washed with water and
counterstained with haematoxylin and mounted under coverslips.
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2.8.3 Detection and phenotypic characterisation of immune cells in ZSF
sections
Monoclonal antibodies were used to determine the presence of immune cell
subpopulations in liver, spleen and foetal-placental units. Optimal dilutions of each
antibody (see Table 2.2) were applied to sections of tissues fixed in ZSF, which
limits disruption to histological structure and epitopes (Gonzalez et al., 2001).
Sections (5 pm) of fixed, paraffin embedded material were cut onto Superfrost Plus
slides and dried overnight at 37°C. Sections were de-waxed in xylene and taken
through graded alcohols (100% to 75%) into dH20 for 5 min each. Slides were
assembled into Sequenza racks, using PBS-0.05% Tween 80 (Polyoxyethylene-
sorbitan monolaurate; PBST80) to seal the slides within the racks. Sections were
washed for 2 x 5 min with PBST80, followed by blocking non-specific binding with
100 pi of normal goat serum per section (1:4 in HSB) for at least 30 min.
Monoclonal antibodies (lOOpl diluted in HSB, see Table 2.2) were added to each
section and incubated overnight at 4°C; 100 pi HSB only was also added to
duplicates of tissue sections as negative controls. Sections were washed 2x5 min
with PBST80, and endogeneous peroxidase activity was removed by incubation with
1% H202 in methanol for 30 min at RT. Biotinylated goat anti-rat antibody (mouse
adsorbed) (Caltag laboratories) (1/4000 of 100 pi) was added as the secondary step
for 30 min at RT. The ABC solution (100 pi) was added and bound antibody was
visualised by DAB as described for chlamydial antigen detection (Section 2.8.2),
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Table 2.2 Monoclonal antibody information for immunohistochemistry
protocols
Antibody Cell type Supplier Dilution
Rat anti-Ly-6G Granulocytes Caltag 1/250
Rat anti-CD45R B cells Caltag 1/750 liver/spleen
(B220) 1/250 placenta
Rat anti-CD3 T cells (CD4+ and
CD8+)
Caltag Various
Rat anti-CD4 CD4+ T cells BD Pharmingen and
Caltag
Various
Rat anti-CD8 CD4+ T cells BD Pharmingen and
Caltag
Various
Rat anti-Ly49G2 NK cells BD Pharmingen 1/100
2.8.4 T cell immunohistochemistry on frozen sections
Immunolabelling of T cell populations was carried out on snap-frozen tissue sections
because the relevant determinants are not preserved in ZSF sections. This work was
conducted as a Short-Term Scientific Mission (STSM) funded by the COST Action
855 at the University of Murcia [Histologia y Anatomia Patologica, Facultad de
Veterinaria, Campus Universitario de Espinardo, Spain] under the supervision of
Assistant Professors Antonio Buendia and Maria Rosa Caro. The aim of this STSM
was to characterise CD4+ and CD8+ T cell and NK cell populations in mouse tissues
using immunohistochemistry on frozen sections.
2.8.4.1 Freezing tissue samples
Freezing of tissue samples was carried out at MRI, and the frozen samples were
transported to the University of Murcia on dry ice. Liver and placenta samples were
removed from infected mice (Chapter 6), immersed in OCT compound (Cryomatrix,
Thermo-Shandon), frozen in liquid nitrogen and stored at -70°C.
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2.8.4.2 T cell immunohistochemistry protocol
Frozen sections of liver and placenta were cut at 5 pm using a cryostat and were
stored at -70°C until required. Sections were fixed in acetone for 30 min at RT and
slides were washed for 5 min at RT with 0.05 M Tris-buffered saline (TBS).
Endogenous peroxidase activity was inhibited by incubation with phenylhydrazine
for 40 min at RT (0.05% in TBS) and sections were washed 3x5 min in TBS.
Sections were pre-incubated with 1/100 normal rabbit serum plus 4 drops of D-
avidin to prevent non-specific binding to tissues (Vector Laboratories) for 30 min at
30°C. Either rat anti-mouse CD4, rat anti-mouse CD8 or rat anti-mouse Ly-49G2
(Table 2.2) were incubated for 1 h at 30°C (1/100 dilution in TBS plus 4 drops of D-
biotin; Vector Laboratories). Negative controls were incubated with TBS plus biotin
for 1 h at 30°C. Following 2x5 min wash in TBS, sections were incubated with
biotinylated rabbit anti-rat, mouse adsorbed antibody (Vector Laboratories) at a
dilution of 1/250 in TBS, 1% BSA, for 30 min at 30°C. Sections were washed 3x5
min in TBS, ABC solution was added to the slides for 30 min at 30°C. Following
this, sections were washed 2x5 min in TBS and 1x5 min in TB (without NaCl).
DAB plus H2O2 was then added and incubated for 5 min at RT in the dark and the
reaction was stopped by adding tap water for 5 min. Slides were counterstained with
haematoxylin and mounted with glycerol gelatin.
2.9 Antibody detection
2.9.1 Enzyme-linked immunosorbent assays (ELISAs)
Blood samples were collected pre-infection by tail snips and post-infection by
cardiac puncture to identify antibody isotypes produced in response to C. abortus
infection. Sera were collected by microcentrifugation at 13000 xg for 10 min and
stored at -20°C until required. Each well of a 96-well flat-bottomed plate (Greiner
Bio-one, Germany) was coated with 100 pi of a 6 pg/ml stock of urografin-purified
EBs (the kind gift of Morag Livingstone, MRI) in 0.1 M carbonate coating buffer,
pH 9.6, overnight at 4°C. The plate was then washed 3x5 min PBS-0.05% Tween
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20 (PBST20) and non-specific binding was blocked by addition of 200 pi 10% non¬
fat dried milk (NFDM) in 0.2 M carbonate buffer, pH 9.6, for 1 h at 37°C and the
plate was washed three times with PBST20. One hundred pi of serum samples (1/100
dilution) in 5% NFDM/PBST20 were added to triplicate wells, incubated at 37°C for
1 h and then washed 3x5 min with PBST. 100 pi goat anti-mouse IgGl, IgG2a or
IgM antibody, conjugated to horse-radish peroxidase (HRP) (Serotec, UK) (all at
1/1000) in 5% Marvel/PBST20 was added to each well and the plate was incubated
at 37°C for 1 h. Following 3x5 min washes, the bound antibody was detected by
addition of 100 pl/weli of o-phenylenediamine dihydrochloride (OPD; Sigma-Fast
OPD) substrate for approximately 10 min, and the reaction was stopped with
50 pl/well 3 M sulphuric acid. Optical densities (ODs) were read at 492 nm in a
microtitre plate reader (Labsystems iEMS Reader MF, UK).
2.9.2 Western blotting
2.9.2.1 Preparation and running of SDS-PAGE gels
Western blots were performed to determine the specificity of the antibody responses.
Firstly, discontinuous sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) was carried out, as described by Laemmli (Laemmli, 1970) using a
10% polyacrylamide separating gel (0.375 M tris-HCl, pH 8.8) and a 4% stacking gel
(0.125 M tris-HCl, pH 6.8). Three hundred pg of EBs were suspended in Laemmli
sample buffer containing 2% (w/v) SDS and 5% (v/v) 2-mercaptoethanol, boiled for
3 min and added to a large central well. Ten pi of molecular mass standards (Mark
12, Invitrogen UK) was also included. Gels were run at a constant voltage of 200
volts (V) for approximately 50 min.
2.9.2.2 Semi-dry blotting
Proteins separated by SDS-PAGE were transferred onto nitrocellulose membranes
(Schleicher and Schuell, Dassel, Germany) using a BioRad Semi-Dry Blotter
(Transblot SD Semi-Dry Transfer Cell) at a constant voltage of 12 V for 20-30 min.
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The transfer sandwich consisted of 2 filters (BioRad extra thick blot paper) soaked in
Semi-Dry Transfer Buffer (25 mM Tris, 190 mM Glycine, 20% (v/v) methanol) on
either side of the nitrocellulose membrane and gel. Bands were visualised by
incubation with Ponceau S Stain for 2 min to confirm the success of protein transfer
and to mark protein tracks and molecular marker positions.
2.9.2.3 Antibody binding and detection
Following protein transfer, membranes were incubated in 10% Marvel in TBS, pH
7.6 overnight at 4°C to block non-specific adsorption to the membranes. Membranes
were added to a Biorad multiscreen system and 500-600 fi\ of serum samples (1/100
dilution) in 5% NFDM/ TBS-0.1% Tween 20 (TBST) were added to individual wells
within the system for 1 h at RT. Samples were removed by vacuum suction and wells
were washed with TBST for 3 x 5 min. HRP-conjugated goat anti-mouse IgGl,
IgG2a or IgM (Serotec, UK) diluted to 1/1000 in 5% Marvel/TBST was incubated at
RT for 1 h. Following 3x5 min washes with TBST, DAB substrate was added for
10-15 min or until a colour reaction appeared to detect proteins recognised by the
antibody. The colour reaction was stopped by washing the membrane with tap water.
2.10 Cytokine analysis
To evaluate the presence of the inflammatory cytokines, IFN-y and TNF-a, serum
samples were collected pre- and post-infection and analysed using commercial
murine ELISA kits (Biosource International, Belgium). Cell culture supernatant
derived from mouse splenocytes stimulated with C. abortus-specific antigens (see
Section 2.14) was also analysed by ELISA to determine the specificity of the
response. Procedures were carried out according to the manufacturer's instructions.
ODs were read at 492 nm in a microtitre plate reader.
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2.11 In situ hybridisation
2.11.1 Summary of probe preparation
RNA probes for mRNA detection of IFN-y and TNF-a were prepared as summarised
in Figure 2.1, and described in more detail in Sections 2.11.2 and 2.11.3.
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IFN-y TNF-a
DIG-labelled RNA probes concentrations
optimised for in situ hybridisation
Figure 2.1 Summary flowchart of riboprobe preparation
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2.11.2 IFN-y mRNA production
2.11.2.1 IFN-y message
IFN-y message was obtained from mouse splenocytes stimulated with Concanavilin
A (Con A). Splenocytes were prepared under aseptic conditions, as described in
Section 2.12, and suspended at a density of 5 x 106 cells/ml. One ml of cells was
added to each well of a 24-well plate (IWAKI, UK) containing 100 pi of Con A at 5
pg/ml, 2.5 pg/ml or 1.25 pg/ml. The plate was incubated at 37°C, in a humidified
atmosphere of 5% CO2 for 48 hours. Following incubation, the plate was centrifuged
at 488 xg for 5 min, the supernatant was discarded and the cells resuspended in
600 pi guanidinium isothiocyanate to lyse the cells, and they were stored at -70°C
until required.
2.11.2.2 RNA extraction and cDNA production of IFN-y
RNA was isolated from the lysed cells using an RNeasy® Kit (Qiagen, UK), as
described by the manufacturer's instructions. In brief, samples were homogenised
using QIAshredder columns (Qiagen) according to the manufacturer's instructions.
Ethanol was added to provide the appropriate binding conditions, and the sample was
bound to a silica-gel-based membrane. Contaminants were washed away and high-
quality RNA was eluted in 30 pi of water and quantified by spectrophotometry.
Reverse transcription of RNA was carried out using the AB-gene Reverse jT™ First
Strand Synthesis Kit (AB-gene, UK) according to the manufacturer's instructions.
Briefly, the RNA template (1 pg) and first strand primer (anchored oligo dT,
500 ng/pl) were incubated at 70°C for 5 min to denature RNA. A positive control
RNA (1 pg) sample provided in the kit was included. Following this, first strand
synthesis buffer, 5 mM dNTP mix plus reverse-iT™ RTase blend were added and
incubated for 30 min at 47°C. Reactions were then incubated at 75°C to inactivate the
RTase blend, and the concentration of the transcribed cDNA was determined by
spectrophotometry.
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2.11.2.3 IFN-y DNA preparation
2.11.2.3.1 Primer and PCR design
Primers were designed for PCR amplification of IFN-y cDNA using sequence
information obtained from Medline and DNAstar PrimerSelect programmes
(Accession number XM_125899). The primer sequences are shown below:
Forward: 5' -ATGAACGCTACACACTGCATCTTGG-3'
Reverse: 5'-TCAGCAGCGACTCCTTTTCCG-3'.
The PCR was optimised to produce a 468 base pair (bp) product. PCR was carried
out in 100 pi reaction mixture volumes containing 300 nM concentrations of each
primer, 250 pM of each dNTP, PCR buffer (10 mM Tris-HCl, 1.5 mM MgCl2,
50 mM KC1, pH 8.3) and 2.5 U/lOOpl Taq DNA polymerase (Roche), with 1 ng
cDNA template. Reactions were overlayed with sterile mineral oil to prevent
evaporation. PCR conditions were as follows: 2 min denaturation at 94°C for 1 cycle;
followed by 10 s denaturation at 94°C, 1 min annealing at 50°C, 1 min extension at
72°C for 30 cycles; and a final 7 min extension at 72°C for 1 cycle. The samples were
then cooled to 4°C.
2.11.2.3.2 Agarose gel electrophoresis
PCR products were analysed by conventional agarose gel electrophoresis. One
percent (w/v) agarose gels were prepared in TAE electrophoresis buffer (40 mM
Tris-acetate, pH 8.0, 1 mM EDTA) containing 0.5 pg/ml ethidium bromide
(Promega, UK). Gels were run in TAE buffer at a constant voltage of 75 V. Ten pi of
PCR product plus 2 pi DNA loading buffer (30% glycerol, 0.25% Bromophenol
blue, 0.05% xylene cyanol) were run alongside molecular size markers (1 kb marker,
Promega). DNA fragments were visualised by UV illumination using a Hybaid
transilluminator (Hybaid, UK) or an Alphalmager (GRI Alphalnnotech, UK).
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2.11.2.3.3 Purification of DNA fragments from agarose gels
PCR products of 468 bp were excised from the agarose gel and purified using
QIAquick gel extraction kit (Qiagen), according to the manufacturer's instructions
and based on the protocol of Vogelstein and Gillespie (Vogelstein & Gillespie,
1979). Concentrations of fragments were determined by spectrophotometry and by
analysis of insert alongside a DNA molecular marker at known concentrations
(OX174/HaeIII, MBI Fermentas, UK).
2.11.2.4 Ligation of PCR products into pGEM-T cloning vector
Purified PCR products were cloned into the pGEM-T®, a T-cloning vector
(Promega), which contains promoters for SP6 and T7 RNA polymerases. Use of Taq
DNA polymerase (a non-proof reading enzyme) maintains a single deoxyadenosine
at the 3' end of the PCR product, which allows ligation with single 3'-T overhangs of
the T vector. The gel-purified PCR products were ligated into pGEM-T overnight at
4°C at various molar ratios of insert:vector [6:1, 3:1, 1:1 and 1:3]. Insert DNA was
incubated with T4 DNA ligase buffer (30 mM Tris-HCl, pH 7.5, 10 mM MgCL,
10 mM DTT, 1 mM ATP), containing 50 ng of vector, insert DNA at varying ratios,
and 1 Weiss U/pl T4 DNA ligase (Promega) in a total reaction volume of 10 pi. The
following formula was used to estimate the amount of insert DNA required for the
ligation reaction:
ng insert required = [(ng vector/ vector size (kb))] x insert size (kb) x molar
ratio of insert:vector
Ligation mixes (IFNG1) were then transformed into competent XL-1 blue cells
(Section 2.11.2.5)
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2.11.2.5 Transformation of competent cells
PCR fragments and restriction endonuclease digested fragments were ligated into
pGEM-T and transformed into Epicurian Coli® XL-1 Blue competent cells
(Escherichia coli strain; Stratagene, UK). This was for the purpose of propagation
and storage, and for the production of sufficient plasmid IFNG1 DNA to linearise for
in vitro transcription from the T7 and SP6 promoters incorporating digoxigenin
(DIG) UTP to produce RNA probes.
The transformation was carried out according to the manufacturer's instructions.
Briefly, XLl-Blue cells (retrieved from -70°C) were thawed on ice and 50 pi aliquots
were dispensed into pre-chilled eppendorf tubes. Twenty-five ng of ligated DNA or
0.1 ng of a positive control was added to aliquots of cells, and these were incubated
on ice for 20 min. Cells were then transformed by heat shock at 42°C for exactly
45 s. Cells were then placed on ice for a further 2 min immediately after the heat
shock before adding 0.9 ml SOC medium (2% (w/v) tryptone, 0.5% (w/v) yeast
extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgC^, 10 mM MgSCL, 20 mM
glucose). Transformants were then allowed to recover by shaking incubation for 1 h
at 37°C and 100 pi of each were plated out on L-agar plates containing ampicillin (50
pg/ml final concentration (fc)), X-gal (5-bromo-4-chloro-3-indoyl-P-D-
galactopyranoside; 80 pg/ml fc) and IPTG (isopropyl-l-thio-P-D-galactopyranoside;
0.5 mM fc). X-gal (lactose analogue) and IPTG (inducer of the lac operon) were
added to allow blue-white colour screening of colonies. The multiple cloning site of
pGEM-T is in the a-peptide region of the P-galactosidase gene. Insertional
inactivation of the a-peptide allows recombinant clones to be selected by colour
screening on X-gal/IPTG plates. Non-recombinant colonies (no insert) synthesise P-
galactosidase, which breaks down X-gal to produce a blue product, i.e. resulting in
blue colonies, whereas recombinant colonies (containing insert) synthesise an
inactive form of the enzyme and remain white in colour. Plates were incubated
overnight at 37°C, and white colonies were picked the following day. Colonies were
amplified by inoculation into 10 ml Luria-Bertani (LB) broth containing ampicillin
(50 pg/ml) and incubated overnight in a shaking incubator at 37°C.
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2.11.2.6 IFN-y plasmid DNA preparation
2.11.2.6.1 Determination of insert presence and size
After selecting positive colonies and culturing overnight at 37°C, 8 ml of the
overnight cultures were centrifuged at 1770 xg for 10 min at 4°C to pellet cells
[remaining 2 ml were used for preparing glycerol stocks; see Section 2.11.2.6.4],
Plasmid DNA was prepared using a QIAprep® miniprep kit (Qiagen), according to
manufacturer's guidelines, to verify the presence of an appropriate insert.
QIAprep protocols are based on the modified method of Birnboim and Doly
(Birnboim & Doly, 1979), where bacterial cells were lysed in 0.2 N NaOH, 1% SDS
buffer in the presence of RNase A. Neutralisation of the lysate is followed by
precipitation of chromosomal DNA by the addition of guanidine-hydrochloride. The
precipitate is pelleted by centrifugation at 9000 xg, and the supernatant containing
the plasmid DNA is adsorbed onto a silica-based gel by centrifugation in the
presence of high salt. After washing, plasmid DNA is eluted in 10 mM Tris-HCl,
1 mM EDTA, pH 8.0 (TE elution buffer).
2.11.2.6.2 Restriction enzyme digestion of DNA
Restriction enzymes (all from Roche Diagnostics Ltd, UK) were used with
appropriate incubation buffers, as recommended by the manufacturer. Generally
10 U enzyme/pg DNA was used per reaction. Enzymes were incubated with DNA at
the appropriate temperature for 3-18 hours, depending on the enzyme.
2.11.2.6.3 DNA production of IFNG1
Larger plasmid DNA preparations were also carried out using a QIAprep® midi-prep
kit (Qiagen), in order to obtain at least 10 pg DNA for preparation of probes for in
situ hybridisation. Fifty ml LB-ampicillin cultures were grown overnight at 37°C
from stocks of 10 ml LB cultures and centrifuged at 6000 xg for 15 min at 4°C.
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Plasmid DNA was eluted in 200 pi of elution buffer (10 mM Tris-HCl, pH 8.5) and
stored at -20°C until required.
2.11.2.6.4 Preparation and storage of glycerol stocks
For storage of specific colonies, glycerol stocks were prepared using 2 ml of
overnight 10 ml LB cultures. Eight hundred and fifty pi of each culture was added to
150 pi of glycerol and stored at -70°C until required.
2.11.3 TNF-a mRNA production
2.11.3.1 TNF-a DNA preparation
TNF-a DNA was purchased already cloned into the pORF9 vector (Invitrogen, UK).
The vector was reconstituted and streaked out according to the manufacturer's
instructions. A single colony was picked and cultured in 10 ml of LB broth at 37°C
overnight. QIAprep® miniprep kits (Section 2.11.2.6.1) were utilised to obtain
plasmid DNA. TNF-a DNA was excised from pORF9 by overnight digestion with
BspHl and NheI at 37°C, to produce a fragment of 705 bp in length.
2.11.3.2 Ligation of DNA fragments into pGEM
TNF-a was cloned into pGEM. In this instance, the cloning procedure was slightly
different as the insert was not a PCR product and therefore could not be cloned into
pGEM-T using the T-overhangs, summarised in Figure 2.2. A Ncol and Spel
fragment of pGEM was excised, leaving the pGEM with the SP6 and T7 promoter
sites and this was gel-purified, as described in Section 2.11.2.3.3. The overhangs
generated by Ncol and Spel are compatible with those produced by the BspHl and
NheI enzymes used to excise TNF-a from pORF9. The gel-purified TNF-a fragment
was ligated with the vector fragments at the molar ratios 3:1 and 1:1 overnight at
4°C, using T4 DNA ligase enzyme (Section 2.11.2.4) to produce TNFA1.
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Ligations of TNFA1 were then transformed using XLl-Blue cells, and positive
colonies selected by blue/white screening, as previously described in Section
2.11.2.5, Four white colonies containing the insert were picked and cultured
overnight in 10 ml LB broth at 37°C. TNFA1 plasmid DNA was prepared using
QIAprep miniprep kits and the TNF-a fragment was excised using Apal and EcoRl,
incubated at 37°C overnight. This was analysed on an agarose gel alongside uncut
plasmid DNA.




















Figure 2.2 TNF-a DNA preparation from pORF to pGEM showing an outline of the
steps used to produce the final TNFA2 fragment of 566 bp, used to produce mRNA
probes.
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2.11.3.3 Production of TNF-a-short DNA (TNFA2)
For in situ hybridisation studies, a maximum probe length of approximately 500-600
bp is recommended. Therefore, it was necessary to reduce the length of the 705 bp
insert prior to generating RNA probes, as illustrated in Figure 2.2. This was
achieved by digestion of the TNFA1 with Sacl for which a single site was present in
both the TNF-a insert and the multiple cloning site of the vector, allowing removal
of 139 bp at the 3' end of the insert to produce a truncated version of 566 bp,
TNFA2. After digestion, the plasmid TNFA2 was gel-purified from the cleaved 139
bp fragment and plasmid TNFA2 was re-ligated overnight at 4°C. XLl-Blue cells
were then transformed and positive colonies picked to screen for the insert, as
previously described (Section 2.11.2.5), Ten ml LB overnight cultures, followed by
QIAprep kits were utilised to obtain plasmid DNA to check for the insert by
restriction enzyme digestion (ApaVSad incubated overnight at 35°C). A larger
preparation of plasmid DNA was carried out, using the Qiagen maxiprep kit. Plasmid
DNA was eluted in 150 pi of elution buffer (10 mM Tris-HCl, pH 8.5) and stored at
-20°C until required.
2.11.4 DIG Labelling of IFN-y and TNF-a mRNA probes
Ten pg of plasmid DNA (EFNG1 and TNFA2) was linearised using restriction
enzymes at sites upstream and downstream of the cloned insert (NcoVSall for EFN-y,
and Apal/Sacl for TNF-a, all incubated overnight at 37°C except Apal, which was at
30°C). Both sense and antisense RNA probes were prepared by in vitro transcription
from the T7 and SP6 promoters incorporating DIG UTP (Boehringer Mannheim,
USA). One pg of linearised DNA was transcribed to produce full-length DIG-
labelled RNA with T7 and SP6 polymerases. The efficiency of DIG-labelling and the
concentration of the RNA probes were determined. This was conducted with a spot
assay and direct detection of probes with anti-DIG, Fab fragments conjugated to
alkaline phosphatase (Roche Diagnostics Limited), and colour substrates [0.3 mg/ml
nitroblue tetrazolium (NBT) and 0.16 mg/ml 5-bromo-4-chloro-3-indoyl phosphate
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(BCIP)]. This was compared to DIG-labelled control RNA provided by Boehringer
Mannheim.
2.11.5 In situ hybridisation
In situ hybridisation to detect mRNA expression of IFN-y and TNF-a was carried out
on 4% paraformaldehyde-fixed sections (Anderson et al., 2001). Sections (6 pm) of
fixed, paraffin embedded material were cut onto Superfrost Plus slides and dried at
37°C overnight. Sections were de-waxed in xylene twice and then taken through
graded alcohols (100% to 75%), into dP^O and then PBS for 5 min each. All
subsequent washes were carried out using the Hybaid wash module (Hybaid,
Ashford, England), unless otherwise stated.
Sections were washed at RT for 20 min with 0.2 M HC1 and then for 1 h with 2X
SSC (Saline-sodium citrate buffer; 0.15 M NaCl, 15 mM sodium citrate, pH 7.4),
5 mM EDTA at 50°C. Slides were placed into the Omnislide thermal cycler (Hybaid)
and 200 pi of proteinase K (15 or 20 pg/ml; Roche Diagnostics Limited) solution in
20 mM Tris-HCl, 2 mM CaC^, pH 7.4, was added to each section and incubated at
37°C for 15 min. This increases accessibility to the target sequence by digesting the
surrounding protein. Sections were fixed in 4% paraformaldehyde at RT for 4 min,
and then washed twice for 1 min at RT with PBS. All subsequent washes were
carried out at RT unless otherwise stated. Slides were washed with PBS/5 mM
MgCb for 15 min and then acetylated for 10 min with 100 mM tri-ethanolamine
pH 7.0, 0 .25% acetic anhydride. Slides were then washed 2 x 1 min and 1x15 min
with PBS.
Sections were prehybridised in 65 pi 6X SSC, 45% de-ionised formamide, 5X
Denharts solution and 256 pg/ml bovine liver RNA for 1 h at 52°C. Sections were
then rinsed in 2X SSC and incubated overnight at 52°C in hybridisation solution
comprising 48% deionised formamide, 5X Denharts solution, 1000 U/ml Heparin,
0.1% Triton X-100, 24 mM EDTA, 24 mM Pipes, 720 mM NaCl, 7.2% dextran
sulphate, 512 pg/ml bovine liver RNA and the DIG-labelled RNA probes (0.02-0.2
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ng/ml). Easiseals (Hybaid) were used to prevent evaporation during the overnight
hybridisation.
Unbound probe was removed by washing with 6X SSC containing 45% formamide
for 30 min at 42°C and twice with 2X SSC for 5 min at RT. 200 /zl of RNase solution
(10 mM Tris-HCl, pH 8.0, 500 mM NaCl, 1 mM EDTA containing 0.1 pg/ml RNase
(Dnase-free; Roche) and 100 U/ml RNase T1 (Roche)) was added and incubated for
30 min at 37°C to remove residual unbound and endogenous RNA. Sections were
then washed for 2 x 5 min with 2X SSC and once with 0.2X SSC for 30 min at 50°C.
Slides were immersed in DIG buffer 1 (0.1 M Maleic acid, 0.15 M NaCl) for 1 min,
followed by 200 fi\ blocking solution (IX blocking reagent (Roche), 0.03% Triton X-
100, 0.1 M maleic acid, 0.15 M NaCl) for 30 min and then washed in DIG buffer 1
for 1 min. Two hundred [i\ of conjugate solution (anti-DIG antibody Fab fragments
conjugated to alkaline phosphatase) were added to each section and was incubated
for 2 h. Slides were washed for 2 x 15 min in DIG buffer 1 and then for at least 2 min
with DIG buffer 3 (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2).
Colour reactions were performed overnight at 4°C in the dark with 200 /zl of DIG
buffer 3 containing 0.3 mg/ml NBT, 0.16 mg/ml BCIP and 0.3 mg/ml levamisole.
Sections were washed with DIG buffer 4 (0.01 M Tris-HCl, 1 mM EDTA, pH 8.0)
for 10 min and rinsed twice with dH20. Sections were counterstained with
haematoxylin and mounted with Apathy's mountant. Sections probed with labelled
sense RNA were used as negative controls to check for specificity.
2.12 Preparation ofmouse splenocytes
Mouse spleens were collected into mouse wash medium (MWM; Calcium and
magnesium free-HBSS (Gibco, UK) containing 2% FBS, 100 U/ml Penicillin,
0.1 mg/ml Streptomycin, 25 U/ml Nystatin, 20 pg/ml Gentamycin) under aseptic
conditions and splenocytes were prepared. Spleens were disrupted and repeatedly
aspirated with MWM to release splenocytes. Splenocytes were resuspended into
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10ml MWM and centrifuged at 385 xg for 5 min. Supernatants were discarded, the
pellet was resuspended in 1 ml of lysis buffer (0.02 M Tris-HCl, 0.75% (w/v) NH4CI,
pH 7.2) and incubated at 4°C for 10 min to lyse the red blood cells. Following this,
9ml MWM was added to the lysed cells and centrifuged at 238 xg for 5 min. After
discarding the supernatant, the lymphocytes were resuspended in 2 ml RPMI
Complete medium (5% FBS, 100 U/ml penicllin, 0.1 mg/ml streptomycin, 1 mM
glutamine, 100 pg/ml gentamycin, 50 pm P-mercaptoethanol, 0.08% sodium
bicarbonate and 25 mM Hepes). Viable cells were counted by dye exclusion in 0.1%
nigrosin using a modified Neubauer chamber. Cell concentrations used for each
immunological assay are described in Sections 2.13-2.15.
2.13 Lymphocyte stimulation assays
Lymphocyte stimulation assays (LSAs) were used to determine the ability of defined
antigens to stimulate proliferation of lymphocytes prepared from spleens of control
and infected mice. Splenocytes were prepared as described in Section 2.12 and cells
were diluted to 2 x 106 cells/ml in complete RPMI. One hundred pi of cell
suspension was added to each well of a flat-bottomed 96-well plate containing 100 pi
heat-killed (HK) or triton-X-100 (TX) treated EB suspension, Con A or medium
alone (see Table 2.3 for template and concentrations). Plates were incubated for 48 h
at 37°C prior to assessing cell proliferation. At 48 h, 50 pi complete medium
containing 50 Bq 3H-thymidine (Amersham Pharmacia Biotech) was added to each
well to define activity and plates were incubated for a further 16-18 h. At this point,
cells were harvested to obtain cell proliferation counts/minute (Filtermate Harvester
(Matrix Filter), Packard Bioscience Company, UK).
Table 2.3 LSA template
Mouse A Mouse B Mouse C Mouse D
A Medium
B Con A 1.25 pg
C HK 0.6 pg
D HK 0.3 pg
E TX 0.6 pg
F TX 0.3 pg
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2.14 Cytokine production to mitogen/antigen stimulation
Cytokine responses to C. abortus antigen were also evaluated in splenocytes derived
from control and infected mice. Mouse splenocytes were prepared as previously
described in Section 2.12. One ml of 2 x 106 cells/ml in RPMI complete was added
to each well of a 24-well plate containing 100 pi of RPMI medium, Con A, HK EBs
or TX EBs (Table 2.4) and plates were incubated at 37°C, 5% CO2 for 48 hours. At
this time point, plates were centrifuged for 5 min at 488 xg to collect the
supernatants, which were stored at -70°C until required for analysis by ELISA, as
described in Section 2.10.
Table 2.4 Cytokine stimulation assay template
Mouse A Mouse B Mouse C Mouse D Mouse E Mouse F
A Medium
B Con A 1.25 pg
C TX 0.3 MS
D HK 0.3 gg
2.15 Flow cytometry analysis
Flow cytometry (FLC) was used to characterise lymphocyte subpopulations in
control and infected spleen tissue using specific cell-surface markers. Mouse
splenocytes were prepared as described in Section 2.12. One hundred pi of 1 x 107
cells/ml (1 x 106 cells) in RPMI complete was added to each well of a round-
bottomed 96-well plate. FLC Buffer (100 pi; PBS with 5% FBS, 0.1% sodium azide)
was added to the cells and the plate centrifuged at 488 xg for 3 min. The supernatant
was discarded and 50 pi of the appropriate antibody or control (see Table 2.5 for full
details) was added and incubated at 4°C for 30 min. FLC buffer was added to each
well (100 pl/well) and the plate was centrifuged at 54 xg for 3 min. The supernatant
was then discarded and each pellet resuspended in 200 pi of FC buffer. After an
additional two washes, 50 pi of PE labelled goat anti-rat IgG (1/200) was added to
specific mAbs and or 50 pi of goat anti-hamster IgG (1/15), as appropriate was added
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(Table 2.5), and incubated at 4°C for 30 min. Control wells received only secondary
conjugated reagents. Cells were washed three times in 150 jxl FLC buffer and fixed
in 1% paraformaldehyde, after which plates were sealed and stored at 4°C until
analysed (within one week) (Becton Dickinson FACS Calibur, BD, UK).
Table 2.5 Flow cytometry antibodies
Antibody Type Source Cat No. Dilution Secondary
CD3 Primary Rat MCA500G 1/100 Goat anti-rat
CD4 Primary Rat MCA1767 1/100 IgG (H&L)
CD8 Primary Rat MCA1768 1/100 mouse
CD19 Primary Rat MCA1439 1/50 adsorbed R-
CD45 Primary Rat MCA1031G 1/100 PE* (1/200)




All from primary mAbs are from Serotec, UK




2.16.1 Optimisation of PCR
2.16.1.1. Primer and PCR design
PCR amplification of the C. abortus 16S rRNA gene was conducted using primers
based on those used by Anderson and others (Anderson et al., 1996), to produce a
product of 640 bp. Primer sequences are as follows:
Forward: 16SF1 5' -GTTGAGGGAGAGTCTATGGGATATCA-3'
Reverse: 16SR1 5' -TACGACACGGATAGGGTTGAGACTATCCAC-3'
PCR was carried out in 50 pi reaction mixture volumes containing 300 nM of each
primer, 200 pM of each dNTP, PCR buffer with 1.5 mM MgCh, 2.5 U/lOOpl Taq
DNA polymerase and 5 pi of EBs at various concentrations. The thermocycler
procedure was as follows: 15 min denaturation at 94°C for 1 cycle; followed by 10 s
denaturation at 94°C, 1 min annealing at 59°C, 1 min extension at 72°C for 45 cycles;
and a final extension for 7 min at 72°C. The samples were then cooled to 4°C.
A 10 pi sample of the amplified PCR product plus 2 pi DNA loading buffer was
analysed by agarose gel electrophoresis (Section 2.11.2.3.2) to assess the size of the
amplified products relative to those of the DNA ladder.
2.16.1.2 Titration of EBs to determine sensitivity
The detection limits/sensitivities of the PCR were determined in liver and spleen
tissues. Uninfected mouse tissues were obtained from in-house stocks at MRI.
Twenty-five mg pieces of liver tissue and 10 mg of spleen were prepared as
recommended in the DNeasy Tissue Kit (Qiagen). Following processing of tissues
through the kit, DNA was eluted in 200 pi TE buffer and stored at -20°C until
required for PCR.
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The following was carried out to determine the sensitivity of the PCR: 1. PCRs were
carried out on dilutions of EBs that were not processed through the kit; 2. Dilutions
of EBs were processed through the kit for comparison and the eluate collected for
PCR; 3. Liver and spleen were processed through the kit and the eluate was spiked
with the different dilutions of EBs and PCR was carried out; and 4. Liver and spleen
were spiked with 5 /xl of a dilution of EBs pre-processing in order to determine
whether there were any losses during kit processing, determined by PCR. Five /xl of
dfLO was added as a negative control to each set of samples. PCRs were set up on
the various EB and EB-infected tissues (both liver and spleen) to determine the
sensitivity of each tissue type.
2.16.2 Assessment of mouse tissues for C. abortus by PCR
Liver and spleen tissue from 45 representative animals from infected mouse groups
(Chapter 5) were processed through the Dneasy Kit and PCRs were conducted on
the eluted DNA, as described in Section 2.16.1.1. Five n 1 of eluted DNA from the kit
was added to each PCR reaction. Negative and positive controls were included in
each PCR run to ensure that there were no false positives produced.
2.17 Statistical analysis
Mean + SEM were calculated for different groups each day p.i.. A general linear
model was fitted to the data, which included group, day p.i. and pregnancy status as
main effects and the group x day p.i. interaction. The data were too sparse to
investigate satisfactorily any interactions involving pregnancy status in the complete
data set. The parameters of the model were estimated using the general linear model
(GLM) commands in Minitab 13. GLM was chosen as it allows statistical analysis of
unbalanced data sets (data containing an unequal number of data points in each group
on each day p.i.) GLM is an extension analysis of variance (ANOVA), to test the
hypothesis that the means of several populations are equal. An overall analysis is
advantageous as separating out the data, for example by day p.i., would reduce the
ability to find any significant results. The model used with the complete data set was:
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Response = (overall mean)+(group effect)+(day effect)+(pregnancy effect)+(groupxday effect)+residual
P-values were calculated, showing whether the means for an individual factor are
significantly different from one another. If the effect of an interaction (for example,
group x day p.i.) is significant, then the effects of each factor are not all the same at
different levels of the other factor (s). Where interactions were not significant, they
were removed from the GLM and the model run again. The Tukey Method (Minitab
13) was used to compare confidence intervals to identify any differences between
pairs of means following the GLM. Unless stated, GLM was used to analyse data for
significant effects. One-way ANOVAs were used on some occasions to compare
differences between groups at individual time points.
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CHAPTER 3
PILOT STUDY - INVESTIGATION




C. abortus infection in mice causes abortion and there is a progression of
infection from maternal to foetal areas of placenta.
3.2 Introduction
A combination of hormonal changes, inflammatory responses and pathological
damage endanger survival of the foetus in infected mothers following colonisation of
the ovine placenta with C. abortus (Buxton et al., 2002; Entrican et al., 2001).
Despite extensive studies characterising the pathogenesis and control of C. abortus
infections in ruminants, many questions remain unanswered. Mouse models of
chlamydial abortion have been developed to increase understanding of disease
pathogenesis and immune responses associated with infection (Buendia et al.,
1998;Buendia et al., 1999;de Oca et al., 2000).
There are no pathological signs of infection until day 90 of pregnancy in ovine
infections, although organisms are thought to progress from the maternal to the foetal
side of the placenta from day 60 onwards, at the time of maternal haematoma
development (Longbottom & Coulter, 2003). C. abortus rapidly replicates in the
placentomal hilus, leading to local necrosis and contiguous dissemination of
infection to the cotyledonary and intercotyledonary placenta and opposing
endometrium (Buxton et al., 1990). It is important to fully understand the
progression of infection, particularly what triggers movement of C. abortus across
placental tissue in order to answer questions concerning specific aspects of infection
such as latency.
Buendia et al. (1998) conducted a comprehensive study into the kinetics of infection
with the C. abortus isolate AB7 in an outbred mouse strain (Swiss OF1). The timing
of infection has been shown to be irrelevant to the outcome of infection in both mice
and sheep studies, with abortion being the final result, despite the differences in
placental structure. Buendia et al. (1998) monitored the progression of infection from
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maternal to foetal areas of haemochorial placenta in mice. It varied between early
and mid-challenged groups, although infiltration of C. abortus into the foetal
trophoblast cells occurred at a similar time in both groups (Buendia et al., 1998),
agreeing with what is observed in infected ewes that are infected at different times
during pregnancy (Buxton et al., 1990).
Previously at MRI, non-pregnant mouse models have been used to assess vaccine
efficacy by examining recovery of organisms from liver tissue. However, since C.
abortus targets the placenta and results in abortion, a pregnant mouse model is of
more value, as was first demonstrated by Buzoni-Gatel and Rodolakis (1983). At
MRI, Anderson (1986) compared the virulence of chlamydial isolates, including the
Scottish abortion isolate S26/3, in the mouse strains Porton, Swiss-White and CBA.
These experiments were conducted in non-pregnant mice and therefore did not
determine the suitability of these isolates for use in an abortion model. A pilot study
was carried out in two mouse strains to initiate development of the pregnant mouse
model that could be used for screening protective properties of protein and DNA-
based vaccines using a reduction in abortion as the readout.
3.3 Aim
To investigate the outcome of infection with the S26/3 isolate of C. abortus in two
mouse strains during pregnancy and to examine the kinetics of infection in the
placenta.
3.4 Materials and methods
3.4.1 Mating of mice
Adult (56- to 60-day-old) CBA (H-2K; inbred) and Porton (outbred) virgin females




Groups of mice were infected on day 11 of pregnancy via i.p. injection (Section
2.3.2) and euthanased on the days shown in Table 3.1. Mice were euthanased by
injection of 1 ml of pentobarbitone (Euthatal; Rhone Merieux Limited Harlow, UK).
Table 3.1 Experimental plan of serial kill to monitor kinetics of C. abortus

















1 CBA 4 PBS 2 / 1 / / 1
2 CBA 10 S26/3 2 2 1 1 3 1
3 Porton 4 PBS 2 / / / 2 /
4 Porton 12 S26/3 2 2 / 3 4 1
Note. Day signifies the day p.i. following infection on day 11 of pregnancy. The
pregnancy rate was variable and therefore the PMs were not carried out as
previously planned, explaining the random days that mice were euthanased.
At the necropsy, liver, spleen, and reproductive tract (uterus, placenta, and foetuses,
where possible) were removed. Samples were collected in 10% formal saline for
pathological studies, including H&E staining (Section 2.8.1) and immunolabelling of
chlamydial antigen (Section 2.8.2), Samples of liver and placental were placed in
CTM to assess infection levels through bacterial recovery (Section 2.7).
72
3.5 Results
3.5.1 Mating and pregnancy rate
Despite 30 females having vaginal plugs present, not all 30 mice had been
successfully impregnated. The pregnancy rate varied between the inbred CBA strain
(50%) and the outbred Porton strain (87.5%).
3.5.2 Viability of infection (abortion)
Abortions occurred in all C. abortus-infected mice of both strains in which
pregnancy was allowed to proceed. Abortions in infected mice occurred between 6
and 8 days p.i. (days 17-19 of pregnancy), 2-3 days before normal term, as observed
in uninfected control mice.
3.5.3 Viability of infection (culture of live organisms)
3.5.3.1 Recovery of C. abortus from liver tissue
Duplicate Trac cultures were set up to quantify the number of organisms in liver
tissues from all animals, as described in Section 2.7. The number of chlamydial
organisms recovered from mice at different time points throughout pregnancy was
compared between the two strains (Figure 3.1).
Microbiological analysis revealed slight differences between the mouse strains in the
number of inclusions recovered from the livers during infection of pregnant mice
(Figure 3.1). The number of chlamydial organisms was highest on day 7 p.i. (day 18
of pregnancy), decreasing in both strains after this time. It appeared that there were
more chlamydial inclusions in the cell monolayers infected with material from livers
of the inbred strain than the outbred strain. Although there was no significant
difference in the number of inclusions isolated from the liver between the two strains
(F., 13=1.66, p=0.230), nor were there any significant differences in the number of C.
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abortus inclusions at the different time points of infection/pregnancy in either strain
(F3,13=0.99, p=0.440).
There were noticeable differences in the titres of C. abortus recovered from liver of
pregnant and non-pregnant mice, with inclusions still present in livers of pregnant
mice as late as day 8 p.i., whereas no inclusions were recovered after day 5 p.i. from
livers of non-pregnant mice (data not shown). However, only one non-pregnant
mouse was sampled on day 5 p.i., with no organisms detected in the liver. Non¬
pregnant mice, three of which were sampled on day 8 p.i., and two on day 9 p.i..
were all negative for C. abortus. All uninfected CBA and Porton mice were negative
for chlamydial inclusions.
3 5 7 8
Day post-infection
Figure 3.1 C. abortus isolated from livers of infected pregnant CBA and Porton
mice. Numbers of inclusions (mean + SEM) were counted on McCoy cell
monolayers by light microscopy, expressed as log10IFUs/g of liver.
74
3.5.3.2 Recovery of C. abortus from placental tissue
Numbers of chlamydial organisms present in placental tissue at various time points
during pregnancy were determined by culturing organisms from placental samples
from infected mice on McCoy cell monolayers (Section 2.7). There were no
observable trends in the number of inclusions cultured from placental tissue from
infected animals of both strains over time (Figure 3.2). Titres of C. abortus were
high, which is expected since the placenta is the main target organ. No statistical
differences were determined in the number of IFUs/g of placenta between strains
during infection/pregnancy (Fij0=2.55, p=0.154). Data from one placental sample on
8 day p.i. suggests that the number of inclusions decreased from day 7 p.i. onwards,
as also occurred in liver tissue (Figure 3.1). Comparison of the number of inclusions
detected in placental tissue from CBA and Porton mice during infection also revealed
no significant differences (F3,io=0.46, p=0.647) in either strain. No organisms were
cultured from placenta tissue of uninfected mice of both strains.
Figure 3.2 C. abortus isolated from placental tissue of infected CBA and
Porton mice. Means (+ SEM) log10 IFUs/g of placenta were determined by counting
the number of inclusions on McCoy cell monolayers by light microscopy. Only 1 out
of 4 placentas from Porton mice was obtained on day 8 p.i., with 6.6 x 104 IFUs/g
detected. No placental tissue was recovered from the remaining 3 mice killed on day
8 p.i.
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3.5.3.3 Recovery of C. abortus: liver versus placental tissue
Differences between C. abortus titres cultured from liver and placenta from both
CBA and Porton mice were evaluated, as illustrated in Figures 3.3 and 3.4,
respectively. Consistently higher numbers of organisms were isolated from placenta
than from liver in the inbred strain throughout the course of infection/pregnancy.
Figure 3.3 clearly shows the significantly higher (F],g=76.22, pcO.OOl) number of
IFUs/g of placental tissue compared to the number of inclusions/g of liver tissue.
Similar significant differences were observed in the outbred Porton strain (Figure


















Figure 3.3 Comparison of the titres of C. abortus organisms in liver and
placental tissue of infected CBA mice. Numbers of inclusions were estimated by
counting stained cells by light microscopy and are expressed as means + SEM log10
IFUs/gram of tissue. ** Significant difference p<0.01 (ANOVA). No placental tissue
was recovered from the 2 pregnant mice mice killed on day 8 p.i.
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Days p.i.
Figure 3.4 Comparison of the titres of C. abortus in liver and placental tissue
of infected Porton mice. Numbers of inclusions (means + SEM) were estimated by
counting stained cells under light microscopy, expressed as log10 IFUs/gram of
tissue. ** Significant difference p<0.01. Note: Only 1 out of 4 placentas from Porton
mice was obtained on day 8 p.i.
3.5.3.4 Additional microbiological analysis
Samples of uterus were collected to identify the presence of C. abortus organisms
from mice that had aborted. Although the sample size was small, chlamydial
"5
inclusions were recovered from mice of both strains and ranged from 4.3 x 10' to 2.6
x 10s lhUs/g of uterus, on days 7 and 8 p.i., respectively. No differences were
observed between the mouse strains. The majority of animals born prematurely were
cannibalised by their mothers so were not available for examination. Only one foetus
was assessed for chlamydial infection by culture, and this produced negative results.
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3.5.4 Disease pathogenesis in C. abortus-infected mice
3.5.4.1 Histological analysis
Haematoxylin & eosin staining was carried out on liver, spleen, foetoplacental units
and uterine sections, as described in Section 2.8.1, to determine if any pathological
changes had occurred. Figure 3.5 shows examples of representative liver and
placenta sections. Typically, C. abortus infection in mice caused an influx of
inflammatory cells into tissues, as shown in Figure 3.5a. Inflammatory foci were
scattered throughout the majority of liver sections. Although not observed in liver
tissue, chlamydial inclusions were clearly noticeable in placental sections,
particularly in the foetal labyrinth area (Figure 3.5b,c) and inflammatory cells
frequently surrounded placental inclusions. No major differences were observed in
histological and pathological analysis between CBA and Porton mice.
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Figure 3.5 Tissue sections (H & E) from C. abortus infected mice, (a) Section of
liver tissue from an infected CBA mouse sampled on day 5 p.i. showing an area of
inflammation (arrowhead) among the hepatocytes (x200). (b) Section of placental
tissue collected from an infected Porton mouse on day 5 p.i. with a chlamydial
inclusion (arrowhead) present within the labyrinth area (x200) (c) Foetal side of an
aborted placenta from a Porton mouse on day 7 p.i. showing inclusions (arrowhead)
in the labyrinth area of the placenta (x100).
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3.5.4.2 Immunohistochemical detection of chlamydial antigen
Tissue samples were labelled with polyclonal sera from C. abortus-infected sheep to
determine whether mouse tissues had been colonised with C. abortus and to study
the progression of the infection within these tissues. Figures 3.6a and 3.6b show
sections of uninfected and infected liver tissue, respectively, probed with the
polyclonal sera at a 1/200 dilution.
Differences were observed between control and infected liver sections. Hepatocytes
appeared to lose their organised structure within infected liver sections and had
numerous inflammatory foci, the majority of which were in the same area that
chlamydial antigen was detected. Chlamydial antigen was clearly visible in both
liver (Figure 3.6b) and placental tissues (see Figure 3.7), indicating that there was a
systemic infection and that the target organ was infected. Very few areas of
chlamydial antigen were detected in liver tissue beyond day 5 p.i.. However, in all
liver sections there were many inflammatory cells present throughout the infection
period. It was not possible to examine spleen sections in this experiment because of
the splenomegaly associated with the barbiturate used for euthanasing the mice.
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Figure 3.6 Liver sections from control and C. abortus infected mice following
immunohistochemical detection of chlamydial antigen, (a) A control liver section
from a Porton mouse killed on day 8 p.i. No chlamydial antigen was detected
following incubation with the polyclonal sera (x200). (b) An infected liver section
from a CBA mouse killed on day 5 p.i. Chlamydial antigen (brown staining;
arrowhead) was detected with polyclonal sheep sera within a focus of inflammation
(arrow) (x400).
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3.5.4.3 Progression of infection within the placenta
There were slight differences in the localisation of infection within the placenta
throughout infection/pregnancy. Figure 3.7a shows a placental section from a
uninfected animal labelled with polyclonal sera to show the lack of infection in a
negative control. This agreed with the previous culture experiments, the negative
control animals having no C. abortus antigen present and lacking any pathological
changes.
C. abortus was detected in the placental labyrinth from day 3 p.i. (day 14 of
pregnancy) onwards. Chlamydial antigen was detected at the maternal-foetal
interface on day 3 p.i., specifically in the giant cells and spongiotrophoblast cells.
Chlamydial inclusions were scattered throughout the trophoblastic labyrinth on day 3
p.i., as demonstrated in Figure 3.7b. Chlamydial antigen was identified at the
maternal-foetal interface in placenta samples from infected mice on day 5 p.i. (day
16 of pregnancy), similar to day 3 p.i.. As pregnancy continued and the infection
progressed, inclusions were present within the foetal trophoblast cells of placental
sections, close to the chorionic plate, illustrated in Figure 3.7c. More chlamydial
antigen was stained in the foetal labyrinth than at the maternal-foetal interface at this
time point. By day 7 p.i., the highest number of inclusions were observed in the
labyrinth section of the placenta, with some inclusions being larger in size than
previously observed. Figure 3.7d shows a small, heavily infected area on the foetal
side of an aborted placenta, close to the foetus. Little chlamydial antigen was
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Figure 3.7 Placenta sections from control and C. abortus infected mice at
different time points during infection/pregnancy (a) From a control mouse killed
on day 8 p.i. showing the foetal side of the placenta, with no necrosis or
inflammatory cells present. No chlamydial antigen was detected after
immunohistochemistry (x100). (b) From an infected mouse killed on day 3 p.i.
showing a large inclusion (arrowhead) full of EBs and RBs in the trophoblast cells of
the foetal placenta (FT), detected using polyclonal sera (x400). (c) From an infected
mouse killed on day 5 p.i. with numerous positive immunoreactions for chlamydial
antigen (brown staining) detected throughout the foetal trophoblast cells and at the
foetal side of the placenta (x100). (d) Aborted placenta from an infected mouse on
day 7 p.i. with chlamydial antigen (arrowheads) scattered along the foetal side of the
placenta and close to the chorionic plate at the outer edge of the trophoblast cells
(x100).
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3.5.4.4 Summary of kinetics of C. abortus infection in pregnant mice
In summary, chlamydial inclusions were observed scattered throughout the
trophoblastic labyrinth between days 3 and 7 p.i. (14 and 18 of pregnancy).
Inclusions were small in size and the placental sections were generally not heavily
infected on day 3 p.i.. Inclusions were nevertheless present in the maternal decidua
and there was slight tissue damage at the spongiotrophoblast/giant cell area. As the
pregnancy continued, chlamydial antigen was observed in the maternal decidua and
in the giant cells at the maternal-foetal interface on day 5 p.i.. Many inclusions were
visible in the labyrinth, closer to the chorionic plate and the foetal side of the
placenta on day 5 p.i., more than detected on day 3 p.i.. Immediately preceding
abortion, chlamydial antigen was detected throughout the labyrinth, and scattered
through the giant cell and decidual area. A summary of the kinetics of the infection
in liver and placental samples is shown in Table 3.5.
Table 3.2 Summary of the progression of C. abortus infection in liver and
placental tissues of pregnant mice infected at mid-gestation (day 11)
Day Non¬ Pregnant PLACENTA PLACENTA PLACENTA PLACENTA
p.i. pregnant LIVER Maternal Spongio- Giant cells Foetal




+ + + +
7 - +
_ - + +
8 - +
n/a n/a n/a n/a
+ and - denote the presence or absence of chlamydial antigen by
immunohistochemistry.
n/a = not applicable as all infected mice had been killed or had aborted by this time
except one mouse, in which chlamydial antigen detection was very low.
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3.6 Discussion
To establish the pregnant mouse model, this pilot study compared C. abortus
infection of two mouse strains, examining the histology and immunopathology
associated with chlamydial infection in pregnant animals and the progression of
infection in the placenta.
An inbred strain (CBA; H-2K) and an outbred strain (Porton) were successfully
infected with C. abortus, demonstrated by the culture of live C. abortus organisms
from tissues, by immunoperoxidase staining for chlamydial antigen in tissue
sections, and by abortion. An inbred mouse model would allow a more direct
comparison and assessment of vaccine candidates within an established system. An
outbred model, however, would give a clearer indication of the range of effects of
infection and efficacy of vaccines, as might occur in the natural outbred host of C.
abortus (Aitken et al., 1990). CBA (inbred) and Porton (outbred) strains were chosen
because of previous studies demonstrating their susceptibility to chlamydial infection
(Anderson, 1986), which revealed that Porton mice were the most susceptible to
infection with abortion isolates than Swiss White and CBA mice. The susceptibility
of CBA mice to abortion isolates in comparison to another inbred mouse strain,
C57/BL, has also been demonstrated (Del Rio et al., 2000). In contrast, this current
study revealed no differences in susceptibility between the two mouse strains.
There were no significant differences between the two strains in terms of titres of C.
abortus, distribution of inflammation or in the detection of C. abortus antigen. The
main difference observed between the two strains was the pregnancy rate, which was
37.5% higher in Porton mice than in CBA mice, probably due to their differing
breeding backgrounds. Infection of pregnant mice of both strains resulted in abortion
between days 6 and 8 p.i., 2-3 days earlier than normal term of 21 days, following
challenge at mid-gestation (day 11). This is similar to the pattern observed in
pregnant ewes infected with C. abortus, which results in abortion 3 weeks earlier
than normal term of approximately 145 days. The results of this current mouse
experiment are comparable with those of Buendia et al. (1998), who infected
85
pregnant mice with the AB7 isolate of C. abortus and induced abortions on days 8 to
9 p.i.
C. abortus organisms were cultured from placental and liver tissue collected from
infected CBA and Porton mice. Tissues were sampled at various time points
throughout infection/pregnancy and there were no significant differences between
liver titres or between placental titres of C. abortus during the course of
infection/pregnancy in both inbred and outbred mice. Higher numbers of C. abortus
organisms were recovered from liver and placental tissue from CBA mice on day 7
p.i., which was immediately prior to or at the time of abortion. No chlamydial
organisms could be cultured from liver tissue of non-pregnant mice of either strain
following day 5 p.i. and this is in agreement with work of McCafferty et al. (1994),
who reported a decrease in the number of organisms between days 3 and 5 p.i. in C.
abortus-infected mice. Titres decreased in pregnant animals 3 days later than in non¬
pregnant animals in this experiment, implying that infection is not cleared as
efficiently from the liver of pregnant animals, perhaps due to immunosuppression.
Numbers of chlamydial organisms in infected placentas were high, as might be
predicted for the main target organ. This implies that the organism affects the
placenta in mice as it does in sheep, resulting in abortion of foetuses (Aitken et al.,
1990). Significantly higher numbers of organisms were observed in placental
compared to liver tissue in both mouse strains. Within a placenta, infection was
generally contained to one small area. In contrast, the organism was found
disseminated throughout the larger liver. The same area of liver was not removed
from every animal, thus in subsequent experiments, the same lobe was removed from
each animal to improve comparability between animals. Samples of uterus removed
from aborted animals showed numbers of organisms comparable to those recovered
from liver tissue. This probably reflects the infection passing through the uterus en
route to the placenta, where the highest levels of infection were detected.
In contrast to the results of McCafferty et al. (1994) no necrotic foci were visible by
gross examination in liver or placental tissue. However, in line with their
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observations, histological analysis revealed a massive influx of inflammatory cells
into the liver. More inflammatory foci were observed at day 3 p.i. than at the other
time points of infection/pregnancy, with an even distribution throughout the tissue
sections. Inflammatory foci had decreased slightly by day 5 p.i., as observed by
McCafferty et al. (1994), and on days 7 and 8 p.i foci had declined further.
Within placental sections, infected cells were located at the maternal-foetal interface,
specifically in the giant cells, and in the foetal labyrinth area with less colonisation of
the maternal placenta as infection progressed. Chlamydia was detected in both
maternal and foetal areas of the placenta on day 5 p.i. and C. abortus had colonised
the foetal side of placenta and the chorionic plate towards day 5/7 p.i., implying that
perhaps the organism was progressing towards the foetus, but abortion occurred
before there was time to infect the foetus. Initial studies by Buendia et al., (1998)
investigated the anatomical progression of C. abortus (isolate AB7) within the
placenta in outbred (Swiss OF1) mice. They observed that decidual cells at the
boundary of the maternal-foetal interface were the first cells to be infected and found
no inclusions in the labyrinth until day 7 p.i. onwards. In contrast, we observed
inclusions in the labyrinth trophoblast cells from 3 days p.i., increasing in frequency
towards 7 days p.i., around the time of abortion. Buendia and others (1998) infected
outbred Swiss-White mice with the C. abortus isolate AB7, which may indicate less
susceptibly of that mouse strain compared to CBA or Porton mice, and it may also
highlight differences in virulence between the abortion isolates AB7 and S26/3. As
previously mentioned, Porton mice were demonstrated to be more susceptible to
infection with S26/3 than CBA and Swiss-OFl mouse strains by Anderson (1986).
CBA and Porton mice were infected with S26/3 in this study, with no differences in
susceptibility observed between them.
No direct foetal damage was observed in either study, although this may have been
due to abortion occurring on day 7 p.i. (average), so that there was insufficient time
for the organism to reach the foetus. However, Rodolakis et al. (1989) have isolated
chlamydiae from mouse foetal tissue, although in very low numbers. The present
study did not produce equivalent results, but this could be due to the low foetal
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sample number that were labelled with polyclonal sera or to the poorer sensitivity of
the staining method, picking up whole inclusions more frequently than free EBs.
Only one foetus was used to test for the presence of C. abortus organisms in this
current study and this proved negative. Although chlamydiae reach the ovine foetus
in the final trimester of pregnancy, the time between infection and abortion is greater
in sheep compared to the mouse model. It would be interesting to determine if
lesions and positive immunoreactions are found in surviving offspring, as
demonstrated by Baumgartner and Bachmann (Baumgartner & Bachmann, 1992) in
mice infected with Coxiella burnetii, suggesting that infection of foetuses occurred
immediately prior to or after birth. A plausible explanation of the negativity in foetal
tissue is that GMG cells of the placenta may limit the passage of C. abortus across
the placenta to the foetus, as has been demonstrated by Stewart (Stewart, 1994) in the
prevention of transmission of viruses from mother to foetus. Chlamydial inclusions
have been observed in these GMG cells, both in healthy and degenerating cells (it
should be noted that GMG cells do not multiply post day 15 of gestation) (Sanchez et
al., 1996), therefore, the infection may be prevented from progressing further. GMG
cells are located in the decidua basalis and the metrial gland, and they may remove
abnormal trophoblasts that contain C. abortus.
The liver and spleen have previously been reported as the primary target organs in
systemic chlamydial infection following i.p. injection in mice, with the placenta
being colonised later (Buendia et al., 1998). In this study, C. abortus is present in
both the liver and placenta of both mouse strains by 3 days p.i., but no data were
available prior to this, which was similar to work by Buendia et al. (1998). The main
differences between the two studies was the progression of infection in the placenta,
the foetal labyrinth area being colonised earlier in this study compared with that
identified in work by Buendia et al. (1998) and as previously mentioned this may be
due to the different mouse and chlamydial strains used.
Infection in this experiment was associated with a maternal inflammatory cellular
infiltrate in placental and liver tissue, which is discussed further in Chapter 4.
Buendia et al. (1999) suggest that these are predominantly PMNs. Neutrophil
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infiltration and necrosis at the maternal-foetal interface are characteristic of C.
abortus infection in the ruminant placenta (Buxton et al., 1990) therefore it was not
unexpected that this was observed in mouse infections. PMNs were involved in
resolution of the primary infection, successfully eliminating C. abortus from the liver
of non-pregnant mice by day 5 p.i. (Buendia et al., 1999). Mononuclear leukocytes
may also play a role, although multiplication of chlamydiae in the liver and spleen is
probably controlled by neutrophils (Buendia et al., 1999). However, this clearance of
organisms was not observed in the liver or placental tissues of pregnant mice
compared to non-pregnant mice, suggesting that the activity of these neutrophils may
be less efficient in pregnant mice, perhaps being down regulated in some way. It has
been reported that these polymorphonuclear cells are involved solely in the
resolution of primary infection, but not in the control of secondary infection (de Oca,
2000). Neutrophils however may lead to the recruitment of other cell types, for
example, CD8+ T cells (de Oca et al., 2000b), and influence the production of
cytokines, in particular IFN-y and TNF-a (Ellis & Beaman, 2004), as will be
discussed in Chapter 4.
The larger-scale infection in the labyrinth, in the chorionic plate next to the yolk sac
in the foetal side of the placenta, close to the time of abortion, raises the possibility
that the maternal-foetal junction is disrupted in some way, inducing abortion of the
foetus. Variations in hormone expression during pregnancy both in sheep and mice
are highly likely to play a role in induction of abortion in conjunction with the
inflammatory response. The influx of inflammatory cells to the maternal and other
foetal areas of the ovine placenta may result in necrosis and therefore malfunction of
the maternal placenta, leading to abortion. This is detrimental to both the mother and
the foetus, but allows the ewe to develop immunity following clearance of the
infection. But does this occur in mice? Questions relating to this and other factors
associated with EAE were investigated using this pregnant mouse model and are




ASSOCIATED WITH C. ABORTUS
INFECTION IN AN INBRED MOUSE
STRAIN
4.1 Hypothesis
Infection of pregnant mice with C. abortus results in a Thl immune response,
with CD4+ and CD8+ T cells recruited to sites of infection and increased IFN-y
levels in infected animals.
4.2 Introduction
PMNs and mononuclear cells, such as T cells, are the principal immune cells
recruited to sites of infection in C. abortus-infected sheep and these contribute to the
gross necrotic, inflamed and thickened nature of infected placental membranes
(Buxton et al., 2002). Many cells expressing mRNA encoding for TNF-a, a cytokine
that is characteristic of a Thl immune response, and none expressing IL-4,
characteristic of a Th2 response, were present in infected placental tissues.
Macrophages, MHC class II-expressing cells, CD4 and CD8 T cells and B cells have
all been identified in the mixed inflammatory infiltrate of the intercotyledonary
membranes of infected ovine placentas (Buxton et al., 2002).
Depletion studies in mice have demonstrated the relative importance of some of the
afore-mentioned immune cells in control of C. abortus infections (Buendia et al.,
2002; Buendia et al., 2004; de Oca et al., 2000). PMNs have a crucial role in the first
line of defence against C. abortus, and are a major component of the innate immune
response. Infection of PMN-depleted mice with C. abortus has been shown to result
in an earlier mortality compared to non-depleted animals, and this was associated
with higher levels of TNF-a (Buendia et al., 1999). PMNs are a known source of
TNF-a, and depletion of PMNs prevents the lethal inflammatory cytokine shock
induced by T. gondii in WT mice (Marshall & Denkers, 1998). In contrast, the
association of TNF-a with higher mortality in PMN-depleted mice infected with C.
abortus shows that PMNs may not be the source of this cytokine in C. abortus-
infected mice (Buendia et al., 1999). Widespread necrosis was observed in
uteroplacental units whereas extensive neutrophil infiltration was observed in
infected WT mice in the absence of necrosis. Liver tissue damage was more
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pronounced in infected pregnant WT mice than in non-pregnant mice (Buendia et al.,
1999). Recruitment of immune cells, such as CD8+ T cells and macrophages, to sites
of infection was decreased in the absence of PMNs, allowing further multiplication
of the organism and damage to tissues (de Oca et al., 2000). However, PMN
depletion did not prevent predomination of a Thl immune response characterised by
IFN-y production.
Del Rio et al. (Del Rio et al., 2000) reported that clearance of C. abortus infection
was associated with a prominent neutrophil response and the presence of CD8+ T
cells, agreeing with studies by Buzoni-Gatel et al. (Buzoni-Gatel et al., 1992). There
is controversy as to the relative importance of CD4+ T cells and CD8+ T cells, but it
is widely documented in the literature that Chlamydia infections are controlled by a
Thl response, characterised by CD4+ T cells, NK cells, IL-12, IFN-y and TNF-a
(Buxton et al., 2002; Geng et al., 2000; Morrison et al., 2000). Phenotypic
characterisation of immune cells in snap-frozen tissues revealed the presence of both
CD4+ and CD8+ T cells in non-pregnant C. abortus-infected mice (Buendia et al.,
1999). CD4+ T cells are considered dominant over CD8+ T cells and the latter are
thought not to act in the normal cytolytic manner, but to have a role similar to CD4+
T cells in the recruitment of other cell types and release of IFN-y. B cells are thought
to play only a minimal role in early events of primary immune response to C. abortus
infection, as demonstrated by B cell-deficient mice establishing a specific immune
response leading to protection from secondary challenge (Buendia et al., 2002). NK
cells play a critical role early in the innate immune response, with depleted mice
showing enhanced susceptibility to infection, higher mortality rates and increased
bacterial loads in tissues (Buendia et al., 2004).
Depletion of IFN-y, the major controlling-cytokine in chlamydial infections, in mice
led to increased number and size foci of inflammation within the liver (McCafferty et
al., 1994). Much of the IFN-y research has focused on interactions with NK cells of
the innate immune response, and macrophages and T cells, components of the
secondary, acquired immune response (Ellis & Beaman, 2004). However, IFN-y has
been shown to be a potent and critical modulator of the innate immune response, and
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its interaction with PMNs has been overlooked until recently. Originally thought of
as 'terminal, short-lived cells', PMNs are in fact active, dynamic cells that respond to
immunomodulators such as IFN-y, which can mediate the transition between the
innate and acquired immune response (Ellis & Beaman, 2004). Therefore, PMNs
may play a role in the recruitment of other cell types and also facilitate killing of the
invading organism.
Although numerous studies have examined immune responses to C. abortus
infections in mice, many have utilised non-pregnant mice, and different mouse and
C. abortus strains to those used in this model. In order to define the immune
responses in this model of chlamydial abortion, pregnant mice were infected with C.
abortus and immune responses characterised in mouse tissue samples.
4.3 Aim
To characterise the immune responses associated with C. abortus infection at
different time points during pregnancy, and to carry out a qualitative analysis of the
phenotype and distribution of immune cell subpopulations and in situ analysis of
cytokine expression at the maternal-foetal interface and in maternal tissues.
4.4 Materials and methods
4.4.1 The Whitten effect
Due to the mating problems that occurred in the previous experiment (Section 3.5.1),
the Whitten Effect (Gangrade & Dominic, 1984) was used to synchronise mouse
oestrus cycles for timed matings. All mice used in this experiment were CBA (H-2K)
inbred mice. Female mice are anoestrous in the absence of males. Females were
isolated for 2 weeks before being exposed to male mice for 3 days, with only
olfactory and visual contact possible. Exposure of female mice to pheromones in the
urine of male mice initiated the oestrus cycle and the majority of females were in
oestrus on the third night after exposure. On the third night, male mice were placed
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in cages with female mice (1 male: 2 females), with a total of 25 males to 50 females.
Females were checked for a copulatory plug on the fourth morning, with the
presence of a plug denoting day 0 of gestation (Gangrade & Dominic, 1984).
4.4.2 Experimental procedure
Sixteen female mice that mated successfully were inoculated by i.p. injection with
106 IFUs of C. abortus in 0.2 ml of 0.1 M PBS on day 11 of gestation. A further 6
non-pregnant, but mated mice, were inoculated with C. abortus and 16 pregnant
negative control mice were injected i.p. with 0.2 ml 0.1 M PBS. Mice from each of
the groups were killed on days 3, 5, 6 and 7 p.i. as outlined in Table 4.1.
Table 4.1 Outline of serial kill to examine immune responses in uninfected and































3 0 2 1
Note. Three extra mice in group 2 were abortion controls and left to go to term.
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Mice were euthanased with C02, followed by cardiac puncture (to obtain blood
samples (Section 2.5) and cervical dislocation. The uterus was rapidly removed and
the pups were killed by cervical dislocation. Liver, spleen, placenta and reproductive
tract samples were collected into various fixatives, as described in Sections 2.4 and
2.8, for pathological studies on paraffin sections, and liver and placenta samples were
collected in CTM for culture of chlamydial organisms.
4.5 Results
4.5.1 Pregnancy and abortion rate
In contrast with the poor pregnancy rate (50%) observed in the CBA strain of the
previous study (Section 3.5.1), 64% (32) of mated females became pregnant with
exploitation of the Whitten effect in this study.
Three extra pregnant mice were infected with C. abortus on day 11 of pregnancy and
these mice aborted on day 18 of pregnancy confirming the efficacy of the challenge
inoculum and dose. Mice did not display any clinical signs during infection.
4.5.2 Effect of C. abortus infection on animal weight
Weights of infected and uninfected pregnant mice were compared between days 11
and 14 of pregnancy to determine whether infection with C. abortus had a
detrimental effect on development of the pregnancy. No significant differences
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Figure 4.1 Weights of control and C. abortus-infected pregnant mice following
inoculation on day 11 of pregnancy. Mean (+ SEM) were calculated for control
and infected mice on days 11 and 14 of pregnancy.
4.5.3 Culture of C. abortus organisms from mouse tissues
The differences in titre of organisms isolated from liver and placenta samples on
McCoy cell monolayers (Section 2.7) were evaluated. Liver samples were titrated
from 10~2 to 10"4 and placental samples from 10~2 to 10~5, based on preliminary data
discussed earlier (Section 3.5.3). Levels of infection were significantly higher in
placenta than in liver tissue throughout infection (Figure 4.2) (Fi>24=65.5L p<0.001).
Titres of C. abortus varied significantly dunng infection/pregnancy (F3,24=4.04,
p=0.036) with highest counts on day 5 p.i. in placenta and day 6 p.i. in liver. Results
were comparable with those estimated in the pilot study (Figures 3.3 and 3.4). Only
liver titres from pregnant animals are included in the figure; non-pregnant mice were
still infected on day 6 p.i, but infection levels were much lower (approximately 4
fold). All tissues from uninfected mice were negative for chlamydial organisms.
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Day post-infection
Figure 4.2 Number of C. abortus organisms cultured from liver and placental
tissues from pregnant mice infected on day 11 of pregnancy. The number of
inclusions (means + SEM) was estimated by counting stained cells under light
microscopy, expressed as logi0 IFU/g of tissue. Significant difference between liver
and placenta titres **p<0.01, *p<0.05 (ANOVA).
4.5.4 Histological analysis in pregnant and non-pregnant mouse tissues
H & E staining was carried out on liver, spleen and foetoplacental units after fixation
in 10% formal saline. Examination of slides revealed an influx of inflammatory cells
into areas of both tissue types, with more inflammation in liver than placenta, as
observed in the pilot study (Figures 3.6 and 3.7). No necrosis was visible in infected
livei or spleen tissues or if present, placental tissues, and tissue sections from
uninfected mice had a normal histological appearance.
4.5.5 Immunohistochemistical analysis
4.5.5.1 Detection of chlamydial antigen
To examine the kinetics of infection, immunohistochemical detection of chlamydial
antigen (Section 2.8.2) was carried out at each time point to identify any associations
between the progress of infection and the immune response.
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Chlamydial antigen was detected in liver tissue from day 3 to 7 p.i. in all pregnant
animals that were infected (Figure 4.3). No significant differences in the number of
areas staining for chlamydial antigen were observed over the course of infection
(F3,ii = 1.51, p=0.277), although there was a clear increasing trend as pregnancy
progressed.
Non-pregnant animals had lower infection levels than pregnant mice (Figure 4.3).
Levels of infection in both pregnant and non-pregnant mice were similar on day 3
p.i.. Infection subsequently increased in pregnant animals compared to non-pregnant
animals throughout the infection. Small clusters of chlamydial antigen were present
throughout liver tissue of infected mice, although no whole inclusions were




























Figure 4.3 Chlamydial antigen detection in liver tissue from uninfected and C.
abortus infected mice inoculated on day 11 of pregnancy. Numbers of positive
immunoreactions (means + SEM) of chlamydial antigen were counted in 20 fields
(x20 magnification) in pregnant and non-pregnant mice. Negative control group
represents pooled data from all uninfected mice.
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Chlamydial antigen was detected in placental tissue of C. abortus-infected pregnant
mice, with highest numbers observed on day 7 p.i., around the time of abortion.
Chlamydial inclusions full of EBs and RBs were observed in the foetal trophoblast
cells, some of which were surrounded by inflammatory cells. Other areas of infection
were detected in the giant cell layer and the maternal decidua, with both extracellular
EBs and whole inclusions present. C. abortus progressed from the maternal to the
foetal side as observed previously in the pilot study (Figure 3.7), with no significant
differences between time points (F3,io= 1.33, p=0.331) (Figure 4.4).
Numbers of chlamydial antigen foci counted on day 3 p.i. in infected placental tissue
sections (Figure 4.4) were comparable to the highest number counted in infected
liver tissue sections on day 7 p.i. (Figure 4.3). This demonstrates the higher
susceptibility of placenta than liver tissue to C. abortus organisms and agrees with
previously calculated bacterial burdens (Figure 4.2). Numbers of chlamydial antigen

















Figure 4.4 Chlamydial antigen detection in placental tissue from control and C.
abortus infected mice. The number of positive immunoreactions (means + SEM)
for chlamydial antigen was counted in 20 fields (x20 magnification). Negative control
group represents pooled data from all uninfected mice.
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4.5.5.2 Detection of Ly-6G+ cells in tissue sections
To examine the role of the acute inflammatory response to infection, Ly-6G, as a
marker for PMNs, was immunolabelled in ZSF-paraffin wax sections, as described in
Section 2.8.3.
Ly-6G+cells were observed in infected liver tissues both in inflammatory foci and as
individual cells (illustrated in Figure 4.5a-c). Larger foci were present on days 3 and
5 p.i., but the size and number of foci had decreased by day 7 p.i., with individual
positive cells being more evident. Occasional positive cells were detected in control
liver sections (Figure 4.5d), but no inflammatory foci were present and liver
structure was undisrupted in comparison to infected sections.
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Figure 4.5 Detection of Ly-6G+ cells in control and C. abortus-infected liver
tissues, (a) Inflammatory foci in an infected mouse section (x400) (day 3 p.i.);
(b) Large inflammatory foci in an infected mouse (x200) (day 5 p.i.); (c) One or two
smaller inflammatory foci and circulating Ly-6G+ cells (x200) (infected mouse, day 7
p.i.); (d) One or two circulating Ly-6G+ cells in a control mouse section (x100) (day 6
p.i.).
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Numbers of Ly-6G+ cells were consistently higher in liver sections of pregnant than
non-pregnant mice throughout the period of infection (Fi, 13=5.68, p=0.041) (Figure
4.6). A significant decreasing trend in the number of Ly-6G+ cells was observed in
liver tissue of pregnant mice during the course of infection/pregnancy (F3,n=3.95,
p=0.047). No significant differences between time points were detected in non¬
pregnant mice during the infection (F2,4=0.61, p=0.598), although a similar
decreasing trend was observed from day 3 to 7 p.i.. Highest numbers of Ly-6G+ cells
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Figure 4.6 Number of Ly-6G+ cells detected in liver sections from C. abortus
infected pregnant and non-pregnant mice. Mean (+ SEM) numbers of Ly-6G+
cells in 20 fields of view (x20 magnification) were calculated in liver tissue collected
from infected pregnant and non-pregnant mice at each time point. *Significant
difference p<0.05 (ANOVA). Control group represents pooled data from all
uninfected mice.
Ly-6G+ inflammatory foci were more frequently observed than individual positive
cells in placental tissue. Distribution of Ly-6G+ cells in defined areas of placental
sections are illustrated in Figure 4.7. As pregnancy and infection progressed,
occasional inflammatory foci containing Ly-6G+ positive cells were present in the
labyrinth trophoblast cells (Figure 4.7), with inflammatory cells being detected in
large numbers in all areas of placental tissue by day 7 p.i. (Figure 4.7a,c). A more
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diffuse inflammatory infiltrate was detected in the maternal decidual cells, with only
a few inflammatory foci being present (Figure 4.7b). Only small numbers of Ly-6Gf

















Figure 4.7 Detection of Ly-6G+ cells in C. abortus-infected placental sections
(from mice killed on day 7 p.i.). (a) Cross-section through placenta showing areas
of Ly-6G labelling in the maternal decidua, giant cell layer and trophoblast cells
(x100); (b) Ly-6G+ cells in the maternal decidual area (x400); (c) Inflammatory foci in
the labyrinth area at the foetal placental side (x200); (d) Inflammatory cells
surrounding a chlamydial inclusion in trophoblast cells (x400).
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Differences in Ly-6G+ infiltrate in specific areas of the placenta over time are
presented in Figure 4.8 and are consistent with the kinetics of the appearance of
chlamydial antigen during pregnancy (Figure 4.4). A slight increasing trend in
numbers of Ly-6G+ cells in the maternal decidua was observed as infection
progressed, with the highest infiltrate detected on day 6 p.i. A similar trend was
observed in the giant cell layer, with highest numbers of Ly-6G+ cells detected on
day 5 p.i. (Figure 4.8).
Highest numbers of Ly-6G+ cells were observed in the foetal labyrinth area on day 6
p.i. No cells were detected in the uterine epithelium until day 7 p.i. with the
exception of one on day 3 p.i. A clear increasing trend of Ly-6G+ cell numbers in the
maternal decidua was observed from day 3 to day 6 p.i., after which counts
decreased. This is in contrast to liver tissue (Figure 4.6), where the inflammatory
response decreased from day 3 p.i. in line with the decrease in the number of















Figure 4.8 Numbers of Ly-6G+ceils/mm2 in specific areas of uninfected and C.
abortus-infected placental tissue during infection/pregnancy. MG= Metrial
gland, MD= Maternal decidua, GC= Giant cell layer, FT= Foetal trophoblast cells,
UT = Uterine epithelium. Control group represents pooled data from all negative
control mice. NB. No metrial gland was present on day 5 p.i., so that no conclusions
could be drawn regarding PMN infiltration into this area.
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4.5.5.3 B cell detection in tissue sections
B cells, as revealed by expression of B220, were frequently seen both in
inflammatory foci and individually, though more often in the latter state in liver
tissue. Fewer B cells than PMNs were stained within inflammatory foci, as the
majority of cells within these foci were Ly-6G+, as described in the previous section
(Section 4.5.5.2) and corroborated by other authors (Buendia et al., 1998). Figure
4.9 illustrates individual cells and small inflammatory foci of B220+ cells, detected
from days 3 to 7 p.i. Only occasional B cells were detected in liver sections from
control mice (Figure 4.9d).
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Figure 4.9 Detection of B220* cells in uninfected and C. abortus-infected liver
sections, (a) Inflammatory focus and individual B220+ cells in infected liver tissue
day 3 p.i. (x400); (b) B220+ cells in infected liver (day 5 p.i.) (x200); (c) Numerous B
cells in an inflammatory focus in an infected liver section (day 7 p.i.) (x400); (d)
Control liver section (day 6 p.i.) with very occasional B cells detected (x100).
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Numbers of B cells counted in liver tissue sections are shown in Figure 4.10. B cell
infiltration was clearly higher in infected than control mice during infection.
Comparison of B cell numbers in liver sections from C. abortus infected pregnant
and non-pregnant mice revealed significantly higher numbers in pregnant mice on
day 6 p.i. only (ANOVA, Fi,3=11.14, p=0.044) (Figure 4.10), which was similar to
the PMN response. There were no apparent differences in B cell numbers in liver
sections from infected pregnant mice between time points during
infection/pregnancy, with between 60-80 positive cells consistently detected in 20
fields of view (F3,n=0.35, p=0.787). Similarly, there were no significant differences
(F2,4=0.12, p=0.894) in B cell numbers in liver sections from infected non-pregnant



































Figure 4.10 Numbers of B cells (B220+cells) detected in liver tissue from C.
abortus-infected mice. Mean (+ SEM) B220+ cells in 20 fields of view (x20
magnification) were counted from pregnant and non-pregnant mouse liver sections
on each day p.i. *Significant difference p<0.05 (ANOVA). Control group represents
pooled data from all uninfected mice. Note. No non-pregnant mice were sampled on
day 5 p.i.
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In placental tissue, the majority of B cells were observed in the maternal decidua
area, with infrequent B220+ cells observed in the labyrinth area, as illustrated in
Figure 4.11. By day 7 p.i., B cells were rarely detected in the giant cell layer (Figure
4.11b) and B220+ cells were only occasionally present in the labyrinth. In one
infected mouse, B220f expression was absent even within the metrial gland and
maternal decidua (Figure 4.1 Id).
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Figure 4.11 B cell detection in C. abortus-infected placenta sections. Detection
of B220+ cells in the maternal decidua at days 3 (c) (x400) and 7 p.i. (a) (x200) and
(b) in the giant cell layer at day 7 p.i.(x400); (d) Maternal decidua from an infected
mouse without B cells (day 5 p.i.) (x400).
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Highest numbers of placental B220+ cells were observed on day 3 p.i, in the metrial
gland at the maternal side of the placenta (Figure 4.12). Counts were also noticeably
high in the uterine epithelium on days 6 and 7 p.i. In general, B220+ cell counts were
lower than those of Ly-6G+ cells throughout infection (Figures 4.12 and 4.8).
Overall numbers of B cells increased in the placenta as infection progressed, being
higher on days 6 and 7 p.i than days 3 and 5 p.i. Placentas of control animals were
negative for B cells (Figures 4.12) despite the presence of low numbers of Ly-6G+
cells within the same placental sections (Figure 4.8).
Figure 4.12 B220+ cell counts in placenta tissue from control and C. abortus-
infected mice. B220+ cells were counted (x40 magnification) in each specific area
of placenta on each day p.i. (cells/mm2). MG= Metrial gland, MD= Maternal decidua,
GC= Giant cell layer, FT= Foetal trophoblast cells, UT = Uterine epithelium. All
placental tissue from control mice was negative for B220. NB. No metrial gland was
present on day 5 p.i., so that no conclusions could be drawn regarding B cell
infiltration into this area.
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4.5.5.4 Comparison of PMN and B cell counts in C. abortus-infected liver
sections
Numbers of Ly-6G+ and B220+ cells were counted in individual liver sections of
pregnant mice to compare infiltration of the two cells types (Figure 4.13). Figure
4.13 clearly shows that greater numbers of PMNs than B cells were recruited to sites
of infection in liver tissue of pregnant mice (F|.24=81.26, pcO.OOl) at all sample
times during infection/pregnancy (F3i24=3.29, p=0.045). Inflammatory foci were
composed mainly of PMNs. with occasional B cells, which is consistent with a
primary role for PMNs in controlling C. abortus infections. There were no
significant differences between PMN and B cell counts in non-pregnant animals





Figure 4.13 Comparison of B cell and PMN numbers in liver tissue of pregnant
mice following infection with C. abortus on day 11 of pregnancy. Numbers of
positive cells (mean + SEM) were determined in 20 fields of view by light
microscopy (x20 magnification) for each day p.i. Significant difference (ANOVA)
**p<0.01, *p<0.05.
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4.5.5.5 T cell immunohistochemistry
CD3+, CD4+ and CD8+ T cell immunohistochemistry was attempted extensively
without success in ZSF paraffin wax sections, as described in Section 2.8.3, Initial
studies were conducted on C. abortus-infected spleen sections, as the spleen is rich in
CD4+ and CD8+ T cells. Various antibodies from a range of companies were tested at
different concentrations and varying conditions such as incubation times and
temperatures. Despite extensive efforts, no positive cells were detected, even in
spleen tissue. Chronically infected Toxoplasma gondii mouse tissues were also




Isotypes of antibodies to C. abortus EBs were characterised in serum samples by
ELISA (Section 2.9.1) to determine the nature of the immune response to infection
in mice. ELISA results for IgGl, IgG2a and IgM isotypes are shown in Figures 4.14,
4.15 and 4.16, respectively.
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Titres of IgGl, which is a dominant feature of Th2 immune response, were low
throughout infection, with a significantly higher response (FUg=17.86, p<0.001) in
serum from infected pregnant mice than in serum from control mice (Figure 4.14).
The IgGl response was highest on day 6 p.i., although there was no evidence of
significant variations over the course of infection/pregnancy (F3,i9=1.69, p=0.218) in
either control or infected pregnant mice. No significant differences were determined
in IgGl titres in non-pregnant mice on days 3, 6 or 7 p.i. (F2,4=0.13, p=0.881). IgGl










Figure 4.14 Serum lgG1 response to C. abortus infection in pregnant and non¬
pregnant mice. Mean ODs (+ SEM) of lgG1 levels were determined on each day
p.i. in sera from infected pregnant and non-pregnant and uninfected mice.
**
Significant difference between control and infected mice p<0.01 (ANOVA). NB.
No non-pregnant were sampled on day 5 p.i. and only one non-pregnant mouse was
sampled on day 7 p.i.c
in
IgG2a responses in uninfected and C. abortus-infected mice were comparable on day
3 p.i. (Figure 4.15). However. lgG2a levels were higher in infected than control
mice from day 5 p.i. onwards, and titres were highest on day 7 p.i. in serum from
infected pregnant mice. Titres of IgG2a, which is indicative of a Thl immune
response in mice, increased significantly over the course of infection (F3,n=l 1.75,
p=0.002), with levels being higher on days 6 and 7 p.i. than on days 3 and 5 p.i.. In
addition a significantly higher IgG2a response was detected in infected pregnant than
control mice throughout infection/pregnancy (F|,2o= 12.61, p=0.004). No significant
differences were determined between IgG2a titres at different time points in C.
abortus-infected non-pregnant mice (F2,4= 1.11, p=0.437), although highest titres
were observed on day 6 p.i.. IgG2a titres in sera from infected pregnant mice were























Figure 4.15 Serum lgG2a response to C. abortus infection in pregnant and
non-pregnant mice. Mean ODs (+ SEM) of lgG2a levels were determined in sera
from uninfected and infected mice at different time points. *Significant difference
between control and infected pregnant groups p<0.05 (ANOVA). NB. No non¬
pregnant were sampled on day 5 p.i. and only one non-pregnant mouse was
sampled on day 7 p.i.
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IgM titres were significantly higher in infected pregnant mice compared to control
mice (F|,19=81.32, p<0.001) throughout pregnancy/infection (Figure 4.16). IgM
levels were significantly different during infection in pregnant mice sera (F3,u=4.83,
p=0.029), having increased on day 5 p.i. compared to day 3 p.i. and being highest on
day 7 p.i.. In contrast, IgM responses did not significantly differ during infection in
non-pregnant infected mice (F2.4=0.28, p=0.773). No significant differences were
determined between pregnant and non-pregnant C. abortus-infected mice (Fij3=3.59,
p=0.091).
Figure 4.16 Serum IgM response to C. abortus infection in pregnant and non¬
pregnant mice. Mean ODs (+ SEM) of IgM levels were determined in sera from
uninfected and infected mice on at each time point. ** Significant difference
between control and infected pregnant mice p<0.01 (ANOVA). NB. No non-pregnant




To determine the specificity of the antibody response, Western blotting analysis of
whole EBs was conducted (Section 2.9.2), Figure 4.17 shows IgGl and IgG2a
specificities of a range of sera from mice infected with C. abortus that were assessed
using a multiscreen assay. In agreement with the ELISA data, an IgGl response was
undetectable in all mice except one, which was killed on day 7 p.i. (Figure 4.17a,
lane 10). However, because the hyperimmune sera failed to show IgGl reactivity it
was difficult to conclude whether this was a true effect. It was not possible to repeat
the analysis due to exhaustion of sera. Nonetheless, since ELISA titres also failed to
increase in infected animals (Figure 4.14), it can be assumed that this was a genuine
result.
In contrast, IgG2a antibodies revealed high specificity for EBs, with the positive
control serum reacting to MOMP (approximately 38 kD) and to a range of proteins
from 90 kDa to 55-60 kDa. Serum samples in lanes 4, 5, 6, 7 and 8 had strong
reactivity to a range of proteins at approximately 55 kDa, and weaker reactivity at 21
kDa. Serum samples 4, 5, 6 and 7 were from mice killed on day 7 p.i., samples 8 and
9 from mice killed on day 6 p.i. and sera samples 10 and 11 were from mice killed on
days 3 and 5 p.i., respectively. Serum samples in lanes 4 and 6 (day 7 p.i.) also
produced a specific albeit weak MOMP response (38 kDa).
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Figure 4.17 Western blots of control and C. abortus-infected mouse serum
against whole EBs. Membranes were probed with sera from various mice, followed
by either biotin conjugated goat anti-mouse lgG1 (a) or lgG2a (b) antibody and
avidin peroxidase, and detected with DAB (Section 2.9.2.3). Samples 1 and 2 are
positive controls of pooled convalescent sera from C. abortus-infected mice; 12 and




4.5.7.1 IFN-y response to C. abortus infection in mice
A commercial ELISA was used to determine IFN-y concentrations in serum samples
collected at necropsy over the course of infection/pregnancy. Figure 4.18 shows that
IFN-y concentrations in serum samples from infected mice were consistently higher
than those in serum samples from control mice throughout infection. Serum IFN-y
concentrations showed an increasing trend as infection progressed, peaking at day 6
p.iwhich was immediately prior to abortion. However this increase in cytokine
levels over the course of infection/pregnancy was not significant (Fij i=0.82,
p=0.515). In contrast, cytokine levels in non-pregnant mice were significantly higher
on day 3 than days 6 and 7 p.i. (F2,3=98.71, p=0.002), coinciding with the reduction
in bacterial burden in these non-pregnant animals. Concentrations of IFN-y in sera of
non-pregnant animals were less than those observed in pregnant animals (no





















Figure 4.18 IFN-y concentrations in sera from control and C. abortus-infected
mice. Mean concentrations (+ SEM) were determined for each group by
extrapolation from a standard curve provided with the kit. The negative control bar
represents pooled samples from control mice.
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4.5.7.2 TNF-a response to C. abortus infection in mice
Serum concentrations of another important pro-inflammatory cytokine, TNF-a,
during C. abortus infection of mice was estimated using a commercial ELISA.
Serum TNF-a levels were considerably higher in infected pregnant mice than in
infected non-pregnant and control mice, which with the exception of one animal,
were negative (Figure 4.19). Levels of TNF-a expression showed an increasing
trend from day 3 to day 7 p.i., with significant variations between the time points
(F3.i i = 17.45, pcO.OOl) (Figure 4.19). Cytokine levels in non-pregnant mouse sera
were low with no significant differences observed throughout infection (F2,2=0.14,
p=0.881). Concentrations of TNF-a in C. abortus-infected non-pregnant mice were
significantly lower than those in C. abortus-infected pregnant mice (Fui=39.0,
p<0.001), although there was little difference between the groups on day 3 p.i., as
demonstrated for the IFN-y response. Both TNF-a and IFN-y serum concentrations
























Figure 4.19 TNF-a concentrations in sera from control and C. abortus-infected
mice. Mean concentrations (+ SEM) were determined for each group by
extrapolation from a standard curve provided with the kit. NB. No non-pregnant mice
were sampled on day 5 p.i.
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4.5.8 In situ hybridisation
4.5.8.1 Detection of IFN-y mRNA+ cells
Expression of IFN-y in tissues was determined by in situ hybridisation using specific
DIG-labelled probes (Section 2.11). Positive cells, detected using a DIG-labelled
anti-sense IFN-y probe, in liver and placenta are shown in Figure 4.20, alongside a
section probed with a DIG-labelled sense IFN-y probe (Section 2.11.5). IFN-y
mRNA+ cells were generally associated with sites of inflammatory cell foci in liver
sections (Figure 4.20b), where C. abortus antigen was routinely detected (Chapter
3, Figure 3.6b). Isolated individual mRNA+ cells were also present, although these
were less common. In contrast, positive cells were far fewer in number and
distribution in placenta and were generally observed as single positive cells in the
uterine epithelium, with only occasional IFN-y mRNA+ cells present within the





Figure 4.20 IFN-y mRNA+ cells in C. abortus-infected tissue sections. Liver
tissue (x200) labelled with (a) control sense (T7) probe (b) anti-sense (SP6) probe;
Uteroplacental tissue labelled with (c) control sense (T7) probe (x200) and (d) anti-
sense (SP6) probe (x100).
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To evaluate the influence of pregnancy on expression of IFN-y in liver during the
course of infection numbers of positive cells were counted (Figure 4.21). There were
significant differences in IFN-y mRNA expression during infection in pregnant
(F3.11=4.54, p=0.039) but not in non-pregnant mice (F2,4=0.24, p=0.798). In a similar
manner to serum IFN-y concentration, there was an increasing trend as infection
progressed, with a peak on day 6 p.i. IFN-y mRNA response was significantly
(Fi,13=50.78, p<0.001) lower in infected non-pregnant than infected pregnant mice















Figure 4.21 Numbers of IFN-y mRNA* cells in C. abortus- infected liver tissue.
Numbers of positive cells were counted (x40 magnification), expressed as the mean
(+ SEM) number of positive cells/mm2 for each day p.i. *Significant difference p<0.05
(ANOVA) between pregnant and non-pregnant mice. The negative control bar
represents pooled samples from control mice. NB. No non-pregnant mice were
sampled on day 5 p.i. and only one non-pregnant mouse was sampled on day 7 p.i.
IFN-y mRNA+ cells were fewer in placental than liver tissue and were generally
restricted to the maternal areas, although occasional positive cells were detected in
the foetal labyrinth (Figure 4.22). Positive cells were also detected in the uterus,
although in smaller numbers than in liver tissue (Figure 4.22). Numbers of IFN-y
mRNA+ cells detected in uteri on day 6 p.i. were clearly higher than those detected
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on day 3 p.i.. However, in placenta tissue, huge variation was observed in mice
sampled on day 5 p.i., ranging from approximately 1.45 cells/mm2 to 7.5 cells/mm2.
Not all infected placental tissues sections that were analysed contained positive cells
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Figure 4.22 IFN-y+ cell counts in control and C. abortus-infected uterine and
placental tissue. Numbers of positive cells counted per mm2 (x40 magnification)
are shown for each pregnant animal. Control groups represent pooled data from all
negative control mice.
4.5.8.2 Detection of TNF-a mRNA+ cells
In general, numbers of TNF-a mRNA+ cells were low throughout infection in
comparison to those expressing IFN-y mRNA (Figure 4.20). Representative images
of positive cells in liver tissue are shown in Figure 4.23. TNF-a mRNA+ cells were
occasionally present in inflammatory infiltrates (Figure 4.23b) but were routinely
identified as single positive cells scattered throughout the tissue sections (Figure
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Figure 4.23 TNF-a mRNA detection in C. abortus-infected liver tissue from
mice killed on day 6 p.i. (a) & (c) Labelled with control sense (T7) probe (x400);
(b) (x600) & (d) (x400) Labelled with anti-sense (SP6) probe.
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Numbers of TNF-a mRNA expressing cells in both liver (Figure 4.24) and placenta
were lower than those observed for IFN-y (10-20 fold less, except on day 6 p.i.), in
contrast with ELISA results (Section 4.5.7.2), Highest numbers of TNF-a cells were
detected in pregnant and non-pregnant mice livers on day 6 p.i., and the number of
TNF-a+ cells was significantly higher in pregnant than non-pregnant mice throughout
the infection (Fi.|3=1 1.66, p=0.008). Significantly fewer positive cells were present
in liver tissue from the infected pregnant mouse group on days 3, 5 and 7 p.i than the
on day 6 p.i. (F3,i] = 13.16, p=0.001), which is immediately prior to or at the time
when abortions occurred.
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Figure 4.24 TNF-a cell counts in liver tissue from C. abortus-infected pregnant
and non-pregnant mice. Numbers of positive cells were counted, expressed as the
number of positive cells/mm2 for each group. Control group represents pooled data
from all negative control mice.
In contrast to IFN-y mRNA+ cell counts, TNF-a mRNA+ cells were detected in
placentas of only two mice, one of which was killed on day 6 p.i. with 1.45
2 2cells/mm , and the other on day 7 p.i. with 4.35 cells/mm . Numbers of TNF-a
mRNA+ cells were higher in liver than placental tissue on day 6 p.i., whereas on day
7 p.i. counts in placenta were clearly higher than those in liver tissue. Very
occasional TNF-a mRNA+ cells were identified within the foetal labyrinth, with the
remainder being localised in maternal tissue.
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4.6 Discussion
Characterisation of the immune response to C. abortus in this CBA mouse model
was necessary to validate its use in future studies and this study complemented
previous analyses carried out in C. abortus-infected mice (Buendia et al., 1998),
1999), where several features of a Thl response were identified (Buxton et al.,
2002).
The inbred CBA mouse strain was chosen over the outbred Porton strain to allow
comparison and statistical analysis of immune responses between genetically
identical mice. As was clearly demonstrated in the pilot study, C. abortus gave rise to
a systemic infection that targeted the liver and placenta and resulted in abortion. The
pregnancy rate was notably better in this study than in the pilot experiment, as a
result of the synchronising Whitten effect, which was then adopted in subsequent
matings.
In terms of the recovery of C. abortus, numbers of organisms were significantly
higher in placenta than those in liver throughout infection/pregnancy. This was
consistent with the placenta being the target organ for C. abortus in infected pregnant
mice (Buendia et al., 1998; Buzoni-Gatel et al., 1992) (Chapter 3) and sheep
(Buxton et al., 1990; Stamp et al., 1950). In accordance with the pilot study, no
significant differences were detected over the course of infection/pregnancy in the
titres of C. abortus in liver or placenta. However, chlamydial antigen counts showed
an increasing trend in both tissue types as infection and pregnancy progressed. In
agreement with recovery data, numbers of chlamydial organisms detected by
immunohistochemistry were significantly higher in placenta than liver tissue,
reflecting progression of C. abortus from peripheral tissues to the target organ. Non¬
pregnant mice showed extremely low levels of antigen, illustrating the difference in
susceptibility between pregnant and non-pregnant animals, which may reflect the
immunosuppressed nature of pregnant mice, as previously discussed in Chapter 3.
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Ly-6G+ and B cell numbers were higher in liver tissue of pregnant than non-pregnant
mice, possibly due to the overall higher levels of infection in the former, as
demonstrated by the greater number of detectable organisms. The influx of Ly-6G+
in liver was highest on day 3 p.i. and gradually decreased thereafter in both pregnant
and non-pregnant mice. This was perhaps due to movement of the organisms to the
placenta in pregnant mice and to the earlier clearance of C. abortus from livers of
non-pregnant mice. As observed by Buendia et al. (1999) greater hepatic damage
was observed in pregnant than non-pregnant mice, with numerous foci of PMN and
mononuclear cells. In contrast, B cell numbers did not vary significantly during
infection and differences between pregnant and non-pregnant animals were not as
pronounced as those observed for PMNs. Comparison of PMN and B cell infiltrates
into the liver tissue of pregnant mice showed significantly higher numbers of PMNs
than B cells throughout infection. This concurs with other mouse model experiments,
in which the essential role of PMN in primary infections and the minimal role of B
cells in early infections have been demonstrated (Buendia et al., 1999, 2002). The
decrease in PMN infiltration with progression of infection is likely to be associated
with their ability to recruit other cell types to the sites of infection, thus diminishing
their role as specific immunity starts to develop (Romani et al., 1997).
Although PMN and occasional B cells were identified in inflammatory foci in liver
and maternal placental areas, it is probable that monocytes and T cells, which are
present in the inflammatory exudates in infected ovine organs, (Navarro et al., 2004)
were also present. Circulating (individual) PMNs and B cells were frequently
observed within liver sections and were also present in large numbers in spleen
sections. No areas of necrosis, which are common in mice that have been depleted of
PMNs (Buendia et al., 1999), were observed in liver or spleen. In placenta, PMN and
B cell infiltration was more extensive in maternal than foetal areas, despite the high
numbers of infectious organisms present in the foetal labyrinth. Although occasional
large inflammatory foci consisting of granulocytes were detected in the foetal
labyrinth, often surrounding chlamydial inclusions as infection progressed.
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Antibody alone is not correlated with protection, but in the mouse, it has been
suggested that IgGl is associated with a Th2 immune response and IgG2a with a Thl
immune response (Snapper & Paul, 1987; Stevens et al., 1988) and it is well
documented that a Thl response is necessary to control Chlamydia infections
(Buzoni-Gatel et al., 1992; Igietseme et al., 1993). Therefore, by identifying
antibody isotypes and cytokines produced in response to C. abortus infection, the
nature of the immune response can be determined. A low IgGl response to C.
abortus EBs was detected throughout infection in CBA mice, whereas a marked
increase in the IgG2a response occurred towards the latter stage of infection. This is
consistent with a Thl type immune response in this model, and is comparable to
responses detected post-C. trachomatis infection in mice (Igietseme et al., 1998).
IgG2a levels were similar to those of uninfected mice on day 3 p.i., whereas by days
5, 6 and 7 p.i., infected pregnant mice had a higher IgG2a response than control
mice. IgM levels were higher in sera of infected mice than that of control mice,
showing that the primary antibody response had developed in response to C. abortus
infection. It would be interesting to monitor the IgG2a response post-abortion to
determine if it is long-lived as in sheep, where seroconversion occurs immediately
prior to abortion (Longbottom & Coulter, 2003). This was beyond the scope of the
present study. Western blotting further verified the specificity of the IgG2a antibody
response to C. abortus EBs, with reactivity against a range of proteins.
The role of inflammatory cytokines, IFN-y and TNF-a, is well documented in all
Chlamydia infections and both are highly characteristic of the controlling Thl type
immune response. Levels of these cytokines in sera were determined to investigate
whether C. abortus infection in this mouse model would induce similar responses to
those observed in sheep and to other species of Chlamydia. No IFN-y was detected in
sera from non-intected mice, whereas 2b-bU pg/ml of IFN-y was found in sera from
infected pregnant mice over the course of pregnancy/infection, indicating that the
cytokine was produced in response to C. abortus infection. Highest concentrations
were observed on day 6 p.i., immediately prior to abortion, suggesting that IFN-y
may contribute to the induction of abortion. The release of IFN-y by inflammatory
126
cells (such as macrophages and T cells) leads to further recruitment of inflammatory
cells to sites of infection. This could induce pathological damage, resulting in
impaired placental function and abortion, rather than control of the infection.
However, since IFN-y primarily controls C. abortus and other Chlamydia infections
in vitro (Brown & Entrican, 1996; Graham et ai, 1995; Summersgill et al., 1995) its
precise role in vivo is unclear. The observation of highest IFN-y concentrations
around the time of abortion is consistent with a role for IFN-y in control of the
infection at this time, as its production was increased when high numbers C. abortus
organisms were detected.
Other C. abortus models have yielded much higher levels of IFN-y in serum,
averaging 6000 pg/ml from day 2 p.i. onwards (Buendia et al., 2004) than those
observed in this study. These differences could be related to the more resistant
C57BL/6 mouse strain infected with C. abortus by Buendia et al. (2004) in their
study. Infection of C57BL/6 mice has previously been shown to result in faster
clearance of C. abortus infection from these mice than that seen with CBA mice (Del
Rio et al., 2000). These differences may also have arisen from the use of different
ELISA kits with distinct sensitivities.
Kinetics of the appearance of IFN-y mRNA+ cells in the tissues were similar to those
observed in serum, with a peak in the number of cells on day 6 p.i.. Considerably
more IFN-y mRNA+ cells were present in liver sections than in placenta of infected
mice and the cytokine was detected within cytoplasm of inflammatory cells in the
liver, suggesting production by macrophages, T cells or granulocytes (Ellis &
Beaman, 2004; Rothfuchs et al., 2004; Rottenberg et al., 2002). It also appeared that
IFN-y mRNA production was localised to sites where chlamydial antigen was
detected in serial liver and placental sections. Double staining of IFN-y mRNA by in
situ hybridisation followed by immunohistochemistry to detect chlamydial antigen
was attempted unsuccessfully on single sections. However, by conducting in situ
hybridisation and immunohistochemistry on serial sections, IFN-y mRNA+ cells
were observed to colocalise with Chlamydia antigen and inflammatory foci,
suggesting release of IFN-y by PMNs and a role for IFN-y in controlling C. abortus
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infections in this mouse model. IFN-y mRNA+ cells were few in number in placental
tissues and distribution was generally within the uterine epithelium, where the
majority of the inflammatory infiltrate was detected, although occasional IFN-y
mRNA+ cells were detected among maternal decidual and foetal trophoblast cells.
This is in agreement with the few IFN-y mRNA encoding cells identified in sheep
studies, which were associated with or adjacent to areas of arteritis (Buxton et al.,
2002), but contradicts the theory of a role for IFN-y in control in infected placenta
(Brown & Entrican, 1996).
NK cells have been associated with IFN-y production and control of infection for
species such as Plasmodium (De Souza et al., 1997) and Listeria (Dunn & North,
1991). IFN-y can also be produced by macrophages, as reported for a related species
C. pneumoniae (Rottenberg et al., 2000). Although NK cell and macrophages were
not examined in this experiment, it would be extremely interesting to evaluate these
cell populations in future experiments to identify the cells that produce IFN-y in C.
abortus infections. Buendia and others (2004) reported that depletion of NK cells led
to uncontrolled multiplication of C. abortus, suggesting that IFN-y production was
diminished in the absence of NK cells. They observed an association between IFN-y
and NK cells on day 4 p.i., although the cytokine was detected in the absence of NK
cells on day 2 p.i. IFN-y treatment of PMNs has been shown to enhance killing of
bacteria such as Brucella abortus and Mycobacterium tuberculosis (Ellis and
Beaman, 2004) by various mechanisms. It would be useful to examine this in C.
abortus infections given the association between IFN-y expression and PMN
infiltration observed in this and other studies.
Although TNF-a mRNA expression was readily detected in the cytoplasm of
mononuclear cells in infected ovine placentas (Buxton et al., 2002), few cells
expressing TNF-a mRNA were detected in the liver or placenta of mice in this study,
despite the high concentration of this cytokine in sera from infected mice (80 - 600
pg/ml from days 3 to 7 p.i., respectively). In this study, serum TNF-a concentrations
in infected mice were remarkably higher than IFN-y concentrations detected. TNF-a
may play either a role in either the control of the infection as an increasing trend in
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TNF-a concentrations was observed as infection progressed, or alternatively, this
cytokine may play a role in abortion as it has been linked to abortion and miscarriage
(Arslan et al., 2004; Erlebacher et al., 2004; Soto et al., 2003). The higher TNF-a
concentrations on day 6-7 p.i. at the time of abortion may therefore be of
significance, even though the cytokine was not expressed at localised sites of
infection in the placenta. TNF-a, which is produced in response to T. gondii
infections, can have deleterious effects on oocyte maturation that compromises the
development of the resultant embryo in cattle (Soto et al., 2003), suggesting a role
for TNF-a in induction of abortion in C. abortus-infected sheep (Buxton et al., 2002)
but not mice. Differences such as the length of pregnancy and immune responses in
sheep and mice will ultimately lead to differences in control of C. abortus infections
and in the induction of abortion. Although inflammatory responses are observed both
in mice and sheep, the longer pregnancy in sheep allows more extensive pathological
damage and necrosis to develop compared to that in mice and this may be related to
the higher expression of TNF-a in sheep placenta than in mice placenta and
contribute to abortion.
Like IFN-y, TNF-a mRNA was expressed in cells associated with inflammatory foci
and it is known that TNF-a can be released by PMN (Schaller et al., 2004). In
contrast, Buendia et al. (1999) described high TNF-a expression in C. abortus-
infected PMN-depleted mice. In this study the numbers of TNF-a mRNA+ cells in
the cytoplasm of cells in liver and placenta were substantially lower than numbers of
IFN-y mRNA+ cells. Highest numbers of TNF-a+ cells were detected on day 6 p.i. in
the liver, which coincides with the pre-abortion and the high serum concentration of
TNF-a on day 6 p.i.. TNF-a mRNA expressing cells were detected in only two of the
placentas tested, in marked contrast to what is observed in infected ovine placentas
(Buxton et al., 2002), which may bring into question the role of TNF-a in inducing
abortion in C. abortus-infected mice.
Due to the unsuccessful T cell immunohistochemistry, the distribution of CD4+ T
cells in infected mouse tissues could not be determined. Resolution of this problem
would have allowed identification of T cell populations with sites of infection and
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cytokine expression. However, despite the lack of information on the T cell
distribution, it can be concluded a Thl type immune response was present in the C.
abortus infected mice. The predominance of IgG2a antibodies and detection of
TNF-a and IFN-y mRNA+ cells are all indicative of a strong Thl immune response
(Birkelund et al., 2004; Igietseme et al, 1998; Snapper & Paul, 1987), and suggest
that the infection induced the putative protective immune response in the mouse
model. However although the afore-mentioned cells and responses are characteristic
of protective Thl immunity, some of the factors may actually play a role in abortion.
Infiltration of inflammatory cells and release of cytokines by these cells results in the
recruitment of other cell types to the infection sites within the placenta, and this may
cause severe pathological damage as well as controlling the infection. This occurs in
ovine infections, where substantial levels of necrosis, probably as a result of the
influx of inflammatory and other cells, in the interplacental areas and cotyledons are
reported (Buxton et al., 2002). Infiltration of infected cells during pregnancy is likely
to compromise placenta function, and therefore interfere with foetal development,
thereby resulting in abortion. Pregnancy failure in a mouse model has been linked to
presence of the proinflammatory cytokine TNF-a, which was associated with
impaired synthesis of progesterone by the corpus luteum and the induction of the
prolactin receptor signaling suppressors of cytokine signaling 1 (SOCS1) and SOC3
(Erlbacher et al., 2004). Progesterone, the hormone of pregnancy, decreases in
infected sheep placenta and this may contribute to abortion and as previously
mentioned, TNF-a levels increase during C. abortus infection of mice and sheep
(Buxton et al., 2002), further supporting its possible role in abortion. Immune
activation and associated reproductive endocrine dysfunction are also likely to play a
role in the induction of abortion in infected animals.
This study of immune responses to C. abortus in the pregnant mouse model has
revealed similarities to the immune responses identified in the ovine host. An influx
of inflammatory cells to sites of infection was observed in mice, which is similar to
ovine infections, and a Thl response appears to be dominant in both species,
characterised by the expression of IFN-y and TNF-a at both molecular and protein
levels. Despite the obvious differences between mouse and sheep in placentation, the
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similarities between C. abortus infection in the two species, in terms of abortion and
immune responses, provides further evidence of the suitability of this pregnant






C. ABORTUS INFECTIONS IN MICE
5.1 Hypothesis
Infection of non-pregnant mice with C. abortus will lead to the development of a
latent infection and pregnancy will cause the organisms to recrudesce, resulting
in abortion.
5.2 Introduction
The stage of pregnancy at which pregnant ewes are infected with C. abortus
determines the outcome of infection. As previously mentioned, ewes that are infected
during early pregnancy abort in the final trimester (Buxton et al., 1990). In contrast,
infection of non-pregnant sheep leads to development of a latent infection and the
localisation of the organism during this phase remains unknown (Huang et al., 1990;
McEwen et al., 1951; Wilsmore et al., 1990). If sheep are infected late in pregnancy
they similarly develop this latent infection (McEwen et al., 1951). No matter when
infection occurs, C. abortus organisms cannot be detected until the ewes become
pregnant, and is first detected on day 90 of pregnancy when the infection recrudesces
to cause abortion (Buxton et al., 1990).
The location of C. abortus during the latent phase prior to recrudescence, has not
been determined, though it is thought to be in lymphoid organs, with multiplication
under the control of IFN-y (Brown & Entrican, 1996). Hormonal shifts and changes
in immune responses as a result of pregnancy are thought to alter the controlled
latent state of the organisms, allowing them to become reactivated and infect the
placenta, although the precise mechanisms remain unidentified (Section 1.7).
Despite the extensive use of mouse models to study immune responses to Chlamydia
and to assess efficacy of vaccine candidates, no comparisons of the model with
aspects of the ovine disease have been carried out to validate the mouse as a model
for EAE. This experiment therefore investigated the development of latent infections




To determine whether latent infections develop in non-pregnant mice by evaluating
the incidence of abortion in the subsequent pregnancy, as occurs in the ovine host.
5.4 Materials and methods
5.4.1 Infection and mating of mice
Non-pregnant CBA (H-2K) mice were infected by i.p. injection on day 0 with 106
IFUs of S26/3. Uninfected (negative control) animals were administered with 0.2 ml
PBS via i.p. injection.
5.4.2 Initial investigation into latency in mice - experiment A
Twenty non-pregnant female mice were infected with S26/3 and ten non-pregnant
female mice were inoculated with PBS, as described in Section 5.4.1. Two
uninfected and four infected non-pregnant mice were euthanased on days 3 and 5 p.i.
to confirm that mice were infected pre-mating (Table 5.1). The remaining mice were
mated on day 7 p.i., (synchronised using the Whitten Effect, as described in Section
4.4.1) with males overnight (1 female: 1 male) and the presence of a vaginal plug
denoted as day 0 of pregnancy. Two uninfected and four infected pregnant/mated
mice were euthanased on days 22 and 24 p.i. and at the end of pregnancy (day 30
p.i.), i.e. post-littering or abortion depending on the outcome of disease, as shown in
Table 5.1.
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Table 5.1 Experiment A - plan of inoculations and serial kills in the initial
investigation into latent C. abortus infections in mice









20 C. abortus day 0; mated day 7
p.i.
3, 5, 22, 24,
30
4
From each mouse, liver and uterus/foetal-placental units were collected into CTM to
assess the recovery of live C. abortus organisms. Liver, spleen and foetal-placental
units were also collected into 10% formal saline for histology and chlamydial
detection studies.
The pregnancy rate was exceptionally low in this study, at approximately 18%,
despite 100% vaginal plugs being present on day 0. It was decided that information
on the recrudescence of latent infections was imperative to validate the mouse model
of chlamydial abortion. Hence the experiment was repeated with a larger sample size
in order to achieve a higher pregnancy rate so that the final outcome of pregnancy
could be evaluated (Experiment B, Section 5.4.3),
5.4.3 Repeated study into the development of latency in mice - experiment B
Eighty-three non-pregnant female mice were infected with either S26/3 or PBS on
day 0 (Table 5.2). In this study, 5 (3 from group 1 and 2 from group 2) non-pregnant
infected mice were killed on each of days 3, 7 and 14 p.i. to verify that mice were
successfully infected (day 3 p.i.) and to determine if C. abortus organisms had been
cleared from the mice (days 7 and 14 p.i.). Two non-pregnant uninfected mice (group
3) were also euthanased on day 28 post-inoculation to obtain negative control tissues.
As shown in Table 5.2, 42 infected mice and 4 non-infected mice from groups 2 and
3, respectively, were mated on day 21 p.i.. Mice had been synchronised with the
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Whitten Effect and were mated at a ratio of 1 female: 1 male. Group 1 mice were
non-pregnant infected controls. Five infected non-pregnant mice (group 1), and 6
infected pregnant mice (group 2) were euthanased on days 28, 35 and 38 p.i. to
establish any differences in infection between pregnant and non-pregnant mice. Two
uninfected pregnant mice (group 3) were euthanased on day 38 p.i. to obtain
chlamydial-negative liver, spleen, foetuses and placentae. Autopsies were carried out
on the remaining 5 infected non-pregnant mice (group 2) on day 49 p.i.. Both
infected (24 mice; group 2) and uninfected (2 mice; group 3) pregnant mice were
allowed to abort or litter and post-mortems were conducted on days 49 and 50 p.i.
Pups from infected animals were euthanased 7 days post-littering to determine the
rate of survival during this period.
Table 5.2 Experiment B - plan of inoculations and serial kills in the repeated
investigation into latent C. abortus infections in mice
Group n Inoculum/pregnancy status Day p.i. of No. of mice
necropsies killed/day
1 29 C. abortus, non-pregnant 3, 7, 14 3
mice 28, 35, 38, 49 5
2 48 C. abortus pre-mating, mated 3, 7, 14 2
day 21 p.i. 28, 35, 38 6
49 24
3 6 Uninfected group, 4 mated 28 (non-pregnant) 2
day 21 p.i. 38 2
49 2
Liver, spleen, mesenteric and hepatic lymph nodes and uteri were collected from
non-pregnant animals for PCR detection of C. abortus. Liver, spleen and uterus
samples were stored in CTM to be assessed for the culture of infectious organisms.
From pregnant animals, the above tissues were removed as well as foetuses/pups




5.5.1 Experiment A - initial investigation into latency in mice
5.5.1.1 Outcome of experiment A
Since no infected pregnant mice were present at the end of the experiment, it was not
possible to conclude whether mice had developed a latent infection by virtue of
abortion. As previously mentioned, the pregnancy rate was only 18%, which was
considerably lower than in previous studies.
5.5.1.2 Recovery of chlamydial organisms
Tissue samples were collected into CTM to assess the recovery of live C. abortus
organisms to monitor infection levels in infected mice, as described in Section 2.7.
Figure 5.1 shows the number of organisms cultured on cell monolayers from tissue
samples collected over the course of infection.
Recoveries of C. abortus from pregnant and non-pregnant mice were analysed
separately and results are presented for individual animals to demonstrate the wide
variation in titres in each group. Figure 5.1 shows the successful infection of mice
pre-mating, with liver titres of 2500-30000 IFUs/g. In non-pregnant mice (that were
mated but unsuccessfully impregnated), liver tissue from one mouse was infected on
day 22 p.i., and C. abortus organisms were cultured from uteri sampled on days 24
and 30 p.i. C. abortus was not identified in both uterus and liver of any mouse. Of
the two infected pregnant mice killed on day 22 p.i., organisms were cultured from
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Figure 5.1 C. abortus recovery from infected pregnant and non-pregnant mice.
Numbers of inclusions (log IFUs/g tissue) cultured from liver, uterus and placenta
tissue from each mouse were counted under light microscopy and the IFUs/g
calculated. Mice were mated on day 7 p.i. All uninfected mice were negative for C.
abortus organisms.
5.5.1.3 Histological analysis
Histological analysis of sections stained with H & E revealed typical characteristics
of C. abortus-infection in mice on days 3 and 5 p.i, with inflammatory infiltration
present in livei tissues. By day 22 p.i., liver, uterine and placental tissues generally
appeared uninfected although occasional small clusters of inflammatory foci were
observed. All uninfected mice appeared normal.
5.5.2 Experiment B - repeated study into the development of latency in mice
5.5.2.1 Outcome of infection in experiment B
The pregnancy rate for mice mated in experiment B was 32%, almost double that of
experiment A, although this was still lower than had been achieved previously
(Chapters 3 and 4). Abortions did not occur in mice that were infected pre-mating
and live, healthy pups were delivered as normal at term.
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5.5.2.2 Culture of chlamydial organisms
To establish levels of infection in mice, live organisms were cultured (Section 2.7)
from liver, spleen and uteroplacental units, where possible. Recovery of live C.
abortus organisms was assessed for all 83 liver and spleen tissues samples (Figure
5.2), as well as for pregnant uteri and foetuses from pregnant mice and live pups at
the end of the experiment. It is clear that mice were successfully infected (Figure
5.2), indicated by the culture of live organisms on day 3 p.i in liver and spleen tissue.
Fewer inclusions were cultured on day 7 p.i. than on day 3 p.i. and this was in only 3
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Figure 5.2 Recovery of organisms from infected mice. Log IFUs/g of tissue are
presented for individual animals on days 3 and 7 p.i. for infected, non-pregnant
mice. No inclusions were cultured from uninfected tissues or from infected non¬
pregnant liver or spleen tissues on days 14, 28, 35, 38, or 49 p.i. Mice were mated
on day 21 p.i. Similarly no organisms could be recovered from liver or spleen
samples or from foetuses or placental tissues collected from pregnant mice on days
28, 35, 38, 49 or 50 p.i..
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5.5.3 Diagnostic PCR
5.5.3.1 Optimisation of diagnostic PCR
PCR is a highly sensitive tool for diagnosing Chlamydia infections, and could
therefore increase the possibility of detecting low numbers of organisms compared
with the previously used culture methods (Sections 5.5.1.2 and 5.5.2.2),
The PCR was optimised and sensitivity levels determined in both liver and spleen
tissues (Section 2.16.1), PCRs were carried out on the following templates: 1.
Dilutions of EBs only (Figure 5.3a); 2. EB-only eluate (eluate from dilutions of EBs
processed by the Dneasy kit) (Figure 5.3b); 3. Eluate from liver or spleen tissues
spiked with dilutions of EBs then processed by the Dneasy kit (first 7 lanes in Figure
5.3c,d); and 4. Eluate from liver or spleen tissues processed by the Dneasy kit, then
spiked with dilutions of EBs (second 7 lanes in Figure 5.3c,d). Sensitivity of the
PCR and loss of sensitivity due to sample processing through the Dneasy kit are
summarised in Table 5.3,
Highest sensitivity was detected when PCR was conducted on dilutions of EBs that
had been neither processed by the Dneasy kit nor mixed with tissue samples (Table
5.3), A loss in PCR sensitivity was apparent when reactions were conducted on EB
dilutions alone compared with PCRs on tissues processed by the Dneasy kit and
subsequently spiked with EBs. The spiking of EBs prior to tissue processing
decreased the sensitivity of detection in liver tissue, however, increased the
sensitivity of detection in spleen tissue.
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Figure 5.3 Sensitivities of PCR in spiked liver and spleen tissue with positive
results shown at 640 bp on an agarose gel. (a) on EBs alone (control); (b) on
EBs processed through kit; (c) on liver and (d) spleen tissues: the first 7 lanes
represent tissue plus EBs processed through the kit, and second 7 represent tissue
processed through the kit and EBs were then added to eluate. Numbers of IFUs are
labelled.
Table 5.3 Sensitivity levels (IFUs) of PCRs using dilutions of EBs, and spiked
liver and spleen tissues
Sample EBs processed EBs non-processed Loss of sensitivity
EBs alone 60 2.4 25 X
Liver 60 6 10X
Spleen 6 60 0
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5.5.3.2 Sample assessment
In order to establish which mice were positive for C. abortus by PCR, 45
representative mouse liver and spleen samples from the different groups were
processed through the Dneasy Kit, and the 16SF PCR was carried out (Section
2.16.1.1). Results from a range of samples that were assessed for the presence of C.
abortus by PCR and were analysed on an agarose gel are shown in Figure 5.4.
Positive results were detected by PCR up to and inclusive of day 14 p.i. All samples
were negative after this time point (Table 5.4) with no positive results detected in
infected mice following mating on day 21 p.i. PCR appears to be a more sensitive
tool for diagnosis as positive results were identified in mice that were identified as
negative by culture (summarised in Table 5.5). PCR results were more sensitive and
consistently positive on days 3, 7 and 14 p.i. although one negative result was
recorded on day 7 p.i.
lkb
marker




Figure 5.4 Representative PCR results in uninfected and infected liver and
spleen tissues. PCR reactions were run on a 1% agarose gel, with a 1 kb marker, a
negative control, dH20 (lane 1) and a positive control (25 ng genomic DNA) (lane 2).
Other samples were as follows: 3-uninfected liver (day 28 p.i.), 4-uninfected spleen
(day 28 p.i.), 5-infected liver (day 3 p.i.), 6-infected spleen (day 3 p.i.), 7-infected
liver (day 7 p.i.), 8-infected spleen (day 7 p.i.), 9-infected liver (day 14 p.i.), 10-
infected spleen (day 14 p.i.), 11-infected liver (day 14 p.i.), 12-infected spleen (day
14 p.i.), 13-infected liver (day 35 p.i.), 14-infected spleen (day 35 p.i.).
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Table 5.4 Summary of PCR results
Group 1 Infected mice
(non-pregnant)
Group 2 Infected mice
mated on day 21 p.i.
Group 3 PBS controls
mated on day 21 p.i.
Day
P-i-
Mouse Liver Spleen Mouse Liver Spleen Mouse Liver Spleen
3 1-4 +ve +ve 4-3 +ve +ve
2-0 -i-ve +ve 5-6 +ve +ve
3-4 -i-ve +ve
7 1-7 +ve +ve 7-9 +ve +ve
2-2 +ve +ve 8-8 +ve -ve
6-6 +ve +ve
14 3-5 +ve -i-ve 6-5 +ve +ve
4-8 +ve +ve
5-2 -t-ve +ve
28 1-8 -ve -ve 3-1 -ve -ve 9-2* -ve -ve
1-3 -ve -ve 5-7 -ve -ve 9-6* -ve -ve
2-1 -ve -ve 5-0* -ve -ve
35 3-3 -ve -ve 5-9 -ve -ve




38 1-1 -ve -ve 4-1* -ve -ve 9-9 -ve -ve
*
iCD -ve -ve
49 1-5 -ve -ve 7-7 -ve -ve








* Signifies pregnant animal
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5.5.3.3 Culture and PCR as diagnostic techniques
Table 5.5 shows a comparison between the similarities of PCR amplification of
chlamydial DNA and culture of C. abortus from infected liver and spleen tissues.
Uninfected mice were negative by both PCR and culture.
Of 9 infected mice that were positive by PCR, only 4 were positive by culture (44%)
from liver and 5 by culture (55%) from spleen. Overall, 12 liver samples were
positive by PCR, with only 2 negative samples. In contrast only 6 samples were
positive by culture. Similar results were obtained for spleen, with 12 positive and 2
negative results determined by PCR and 8 positive and 6 negative results by culture.
PCR detected positive samples after day 7 p.i. while culture did not.
Table 5.5 PCR versus culture results in C. abortus infected mice
Group 1 Group 2
Day
p.i.
Mouse Liver Spleen Mouse Liver Spleen
PCR Culture PCR Culture PCR Culture PCR Culture
3 1-4 +ve +ve +ve +ve 4-3 -i-ve -i-ve -i-ve +ve
2-0 +ve +ve +ve +ve 5-6 -i-ve -i-ve -i-ve +ve
3-4 +ve +ve -i-ve +ve
7 1-7 +ve +ve -t-ve +ve 7-9 -i-ve -ve -t-ve -i-ve
2-2 +ve -ve +ve -i-ve 8-8 -i-ve -ve -ve -ve
6-6 +ve -ve +ve -ve
14 3-5 +ve -ve +ve -ve 6-5 +ve -ve +ve -ve
4-8 -t-ve -ve -i-ve -ve
5-2 +ve -ve +ve -ve
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5.6 Discussion
Non-pregnant mice were infected to establish whether a latent infection would
develop and recrudesce to cause abortion once mice were pregnant, as is observed in
latently infected non-pregnant sheep that are subsequently impregnated. The study
was conducted twice as a result of a low pregnancy rate in the initial study. No
organisms were detected at any point in pregnant mice and these did not abort in the
second experiment. This suggests that the model is not identical to the ovine disease,
as latent infections did not develop to cause abortion in mice. Sufficient organisms
may not have been present to cause abortion. In addition, the protective immune
response may have efficiently controlled the infection before it reached the placenta.
Pregnancy rates were significantly lower in both experiments A and B than those
achieved in previous studies. Non-infected mice were mated, and subsequently
infected at mid-pregnancy in Chapters 3 and 4, whereas in this experiment, mice
were infected and subsequently mated. Only 7 days separated inoculation and mating
in experiment A and this may have affected the fertility of the mice. However, no
signs of infection were detected prior to this time point (day 5 p.i.) in liver, spleen or
uterine tissues as revealed by detection of live organisms by culture. The time
between infection and mating in the repeated (and amended) experiment B was
increased three-fold to ensure the infection had cleared in the hope that this would
not impair fertility. Despite this, the pregnancy rate remained relatively low,
although it was higher than in experiment A. 'Footprints' and enlarged, reddened
uteri in mated, but non-pregnant mice in experiment B were frequently observed.
Footprints are raised areas of the uterus with an almost bulbous appearance, where
there were previously foetuses. Some uteri were enlarged in terms of the overall
diameter compared to non-pregnant uteri, which were characteristically very thin,
and there also appeared to be an increased blood flow to the uterus, suggesting that
foetuses may have been present but had been resorbed.
Generally, mice had cleared the infection between days 5 and 22 p.i. in experiment
A. However, the recovery of C. abortus organisms from 3 non-pregnant mice implies
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that mating or even early loss of pregnancy, hindered clearance of a few organisms at
least. More importantly, organisms were recovered from the uterus and placenta from
the two infected pregnant mice at day 22 p.i., suggesting either a slight recrudescence
or the infection had not been effectively controlled. Although, infection levels were
markedly lower than in tissues assessed on days 3 and 5 p.i., particularly in the
placenta. Although it failed to establish whether infection pre-mating influences the
outcome of pregnancy, this study provided further evidence that mice are extremely
efficient in the clearance of organisms from tissues.
Inflammatory foci denominated by PMNs were observed on days 3 and 5 p.i. in liver
tissue, corroborating with results obtained in Chapter 4, those of the mouse model
developed by Buendia et al. (Buendia et al., 1999), and sheep studies (Buxton et al.,
2002). Infiltration had dramatically decreased by day 22 p.i. and remained at a low
level on days 24 and 30 p.i. This provides further evidence that PMNs are involved
in preliminary control of C. abortus infection, and concurs with the studies of
Buendia et al. (1999) in which the role of PMN was identified in primary but not
secondary infections.
Abortion was not observed in experiment B and pregnant mice delivered live,
healthy pups at term. C. abortus was not detected in either non-pregnant or pregnant
mouse liver, spleen, uteri or placentae despite the increased time between infection
and mating to allow a latent infection to develop, and the use of a more sensitive
diagnostic tool. A persistent rather than a latent infection may have developed,
defined as a long term association between Chlamydia and the host, in which the
organism remains viable but in a culture-negative state (Rottenberg et al., 2002). In
terms of C. abortus, persistent infections are thought to occur post-abortion, as
demonstrated by Papp and Shewen (Papp & Shewen, 1996), rather than in non¬
pregnant sheep where the infection is latent/dormant.
C. abortus was cultured from liver and spleen on day 3 p.i., but by day 7 p.i. mice
were almost free from infection and by day 14 p.i., no organisms were detected using
the culture method. PCR was more sensitive than culture and chlamydial DNA was
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detected in all liver and spleen tissues collected on day 3 p.i. and in the majority of
tissues collected on days 7 and 14 p.i.. This is in agreement with studies by Amin
(Amin, 2003a) where PCR was more sensitive than culture for C. abortus diagnosis
in tissue samples collected from aborted ewes. However, it is possible that the failure
to culture Chlamydiae was due to the presence of intermediate forms that were non¬
infectious (Buxton et ai, 1996) and this is consistent with in vitro experiments in
which persistent forms are detected following the addition of EFN-y (Beatty et al.,
1994; Brown et al., 2001; Entrican et al., 2001; Rottenberg et al., 2002). Following
mating and sampling after day 14 p.i. in this mouse experiment, there were no signs
of C. abortus recrudescence by culture, PCR or abortion. In contrast to mice, non¬
pregnant sheep show no signs of infection following initial infection, and as in
routinely-infected (from contaminated tissues, aerosols etc.) pregnant sheep, there
are no pathological symptoms until day 90 of pregnancy, with abortion as the first
sign of infection (Buxton et al., 1990). Several studies conducted (Amin, 2003a;
Buxton et al., 1996; Papp et al., 1993) have shown that immunohistochemical
detection of chlamydial antigen is more sensitive than culture. Buxton et al. (1996)
showed PCR to the most sensitive method and suggested that it should the method of
choice for detection of sites of latent infections.
Although no signs of infection were identified post-mating, it is possible that the
infection recrudesced during pregnancy but the methods of diagnosis were not
sensitive enough to detect it. PCR could detect C. abortus in tissues that were
negative by culture, although the sensitivity was 60 IFUs and 6 EBs in liver and
spleen, respectively, compared with 2.4 IFUs when the PCR was carried out on IFUs
that had not been processed or added to tissues. Fortunately new PCR techniques are
constantly being developed with higher specificity and sensitivities, and this may
enhance diagnosis of infection in sheep. PCRs have been shown to have sensitivities
from 0.25 IFUs down to 0.063 IFUs (Amin, 2003b; Madico et al., 2000), with no
differences between tissue culture inoculum and mouse liver spiked with inoculum
(Amin, 2003b), in contrast to results in this study. These higher sensitivities were
based on a touchdown enzyme time release-PCR rather than the conventional PCR
used in this study. Only small pieces of tissues were processed for PCR analyses
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(25 mg liver, 10 mg spleen), so one must bear in mind that there is a possibility if
negative results are obtained, organisms could be in another area of the tissue. Ideally
screening multiple areas of an organ would provide a more representative analysis,
however there disadvantages of time and expense associated with this.
It is also possible that C. abortus organisms could have been residing in lymph nodes
as is suggested to occur in ovine infections (Papp et al., 1994). It would therefore be
useful to assess the lymph nodes in mice for the presence of C. abortus by both
culture and PCR methods in future studies. A systemic infection was established in
the mice and the reticuloendothelial organs infected by this route were assessed,
providing appropriate information on the infection, or lack of, in pregnant mice. A
latent or persistent state of infection results from deprivation of host tryptophan, for
which C. abortus is auxotrophic for its growth and multiplication (Entrican, 2002).
IFN-y is released in response to C. abortus infections and the cytokine induces
expression of IDO, which in turn degrades the host tryptophan to kynurenine. In
human and mouse placentae, tryptophan is degraded through constitutive expression
of IDO in trophoblast cells (Entrican, 2002). Currently, there is no information of the
expression of IDO in the ruminant placenta. C. abortus lacks the trp operon and
therefore cannot synthesise its own tryptophan, yet the organism requires it for
growth and can succeed in growing in the placenta. This is probably possible due to
temporal differences in IDO expression and the intricate immunological and
physiological interactions during pregnancy, although exact details are unknown
(Entrican et al., 2004). Thus IFN-y does not necessarily programme the host cell to
kill the organisms as first thought and can be involved in the maintenance of
persistence in the host (Entrican et al., 2004).
These two studies conducted on latent infections in non-pregnant mice illustrate that
the mouse is not a perfect model for the ovine disease in terms of similarity with all
aspects of the disease. This is also the situation with other Chlamydia infections such
as the C. trachomatis (MoPn) mouse model for human infections, whereby mice
develop immunity to reinfection unlike humans, which can be repeatedly reinfected
(Morrison & Caldwell, 2002). However, one must remember that rodent models are
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used widely for the reasons of cost, time and ability to manipulate the immune
responses and the greater availability of reagents for mice than larger mammals.
Organisms are undetectable in non-pregnant sheep, and are believed to remain in a
latent or dormant state until favourable conditions in pregnancy lead to reactivation
and multiplication of C. abortus in the placenta. Even if mice in these experiments
did not clear the infection or a latent infection developed, the onset of pregnancy did
not trigger the reactivation of the infection. This may be attributed to differences in
placental structures of mice and sheep.
To date, there are no reports in the literature of experimental models of latency in
sheep. Information on the exact location of C. abortus organisms during subclinical
persistent infections would prove exceptionally useful in terms of diagnosis and
control. Close examination of changes in immune responses and hormonal changes
would also reveal vital information regarding control and reasons for recrudescence.
Research into latent infections of C. abortus and persistent infections of other
Chlamydia species is continually progressing and will help in elucidating the reasons
behind persistence, revealing new possible targets of control. Despite its differences
regarding latency, this mouse model of chlamydial abortion will be of great benefit
in terms of screening vaccine candidates that can then be assessed in the natural host,




ANALYSIS OF IMMUNITY TO
ABORTION
6.1 Hypothesis
Re-challenging post-abortion results in a reduction in the number of abortions,
indicating immunity to disease, as occurs in the ovine host.
6.2 Introduction
The immune response to C. abortus infection has yet to be fully defined and studies
to identify the prevalent immune responses are ongoing. C. abortus-infected ewes
that abort in one pregnancy are immune to abortion in the subsequent pregnancy and
this immunity to abortion has also been demonstrated to experimental secondary
infection (Papp et al., 1994). Further investigation of this 'natural' immunity to
abortion will provide insight into mechanisms of the protective immune response.
That ewes seroconvert following abortion has been previously demonstrated (Aitken,
2000), however, as with the other Chlamydiales, the cell mediated immune response
against C. abortus is more important than the humoral response in terms of control
(Guagliardi et al., 1989; Igietseme et al., 2002).
Some sheep develop sterile immunity, other animals continue to shed C. abortus
organisms for up to 3 years post-abortion (Papp et al., 1994), however the
differences in immunity/sterility between the animals is not understood, knowledge
of which is essential for vaccine development. Organisms were identified in
placental tissue and post-partum fluids of immune sheep (that had previously
aborted) in the subsequent pregnancy post-abortion yet abortion did not occur in
these sheep, although infection levels were significantly lower than in primary-
infected sheep (Papp et al., 1994; Papp & Shewen, 1997).
Experiments in the mouse model have examined immune responses to C. abortus,
showing similarities to those responses observed in infected ewes (Buendia et al.,
1999; Del Rio et al., 2000) and vaccines have been tested in pregnant mouse models
(Caro et al., 2003; Hechard et al., 2003a; Hechard et al., 2003b) proving the
usefulness of animal models. However, no studies have been conducted to determine
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how suitable the pregnant mouse model is as a model for ovine chlamydial infections
in terms of immunity post-abortion. Such studies will provide valuable information
on immune responses and also show further similarities and/or differences between
the model and the natural ovine host.
6.3 Aim
To further validate the mouse model by investigating immunity to abortion in the
subsequent pregnancy post-abortion to progress understanding of immunity and to
allow comparison with the ovine disease.
6.4 Materials and methods
6.4.1 Experimental plan - mating and infection of mice
CBA (H-2k) mice were mated (synchronised using the Whitten Effect, Section
4.4.1), allowed to go to term, and mated again 3 weeks post-term (Table 6.1). Mice
were inoculated by i.p. injection with 0.2 ml 106 IFUs of S26/3 or with PBS on day
11 of pregnancy, details shown in Table 6.1.
Mice were killed by CO2 and cardiac puncture. Following removal of the uterus,
foetuses were killed immediately by cervical dislocation. Samples of foetoplacental
units were collected into CTM to examine recovery of infectious organisms (Section
2.7), and into various fixatives for immunopathological studies (Section 2.8). In
situations where mice were not successfully impregnated, the uterus was sampled.
Serum was collected from blood samples to identify Chlamydia-specific antibody
isotypes (Section 2.9) and liver tissues were fixed for various immunopathological
and in situ hybridisation studies (Section 2.11.5). Liver and placenta samples were
snap-frozen for T cell immunodetection studies and liver tissue was also stored in
CTM for culture of infectious organisms. Spleen tissue was collected into MWM for
the following immunological assays: lymphocyte stimulation assays, flow cytometry
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analysis and stimulation of splenocytes for cytokine analysis (Sections 2.13, 2.14
and 2.15, respectively).
Table 6.1 Experimental plan of investigation into immunity to C. abortus
infection in mice
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6 PBS C. abortus
(S26/3)
2 mice killed on days 3 and
5 p.i.; 2 mice killed post-
abortion/littering
NB. Final PMs were carried out 1 week post-littering/abortion (day 22 p.i. secondary
inoculation).
6.5 Results
6.5.1 Outcome of each pregnancy
68% of mice were successfully pregnant in the first pregnancy compared to only
43% in the second pregnancy. Figure 6.1 shows the decrease in pregnancy rate


















Figure 6.1 Pregnancy rates of uninfected and C. abortus-infected mice. The
percentage of pregnant mice in each group of mice is presented, alongside the
overall percentage for pregnancies 1 and 2.
Uninfected mice littered live, healthy pups in both pregnancies (Table 6.2). Infection
of mice (groups 2 and 3) with C. abortus in the first pregnancy resulted in abortion
on day 6-8 p.i. (days 17-19 of pregnancy), as expected. Group 2 mice did not abort in
the second pregnancy after inoculation with PBS; live, healthy pups were littered and
the offspring survived for at least 7 days. Secondary infection in the second
pregnancy of group 3 mice also resulted in the littering of live, healthy pups,
indicating immunity to abortion following re-infection. Mice littered following
inoculation with PBS in the first pregnancy and aborted in the second pregnancy
after infection with C. abortus (group 4), verifying the infectivity of the inoculum.
The number of mice killed at each time point after the second inoculation is shown in
Table 6.3 and, unless otherwise stated, results throughout this chapter refer to these
animals killed post-second inoculation in the second pregnancy.
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Table 6.2 Pregnancy outcome in mice infected with C. abortus in two
pregnancies
Group Pregnancy 1 Pregnancy 2
1 - Uninfected mice
[PBS in P1 and P2]
Littered Littered
2 - Experimental group
[S26/3 in P1, PBS in P2]
Aborted Littered
3 - Experimental group
[S26/3 in P1 and P2]
Aborted Littered




Table 6.3 Number of uninfected and C. abortus infected mice killed at each
time point
Group 1 Group 2 Group 3 Group 4
3 5 22 3 5 22 3 5 22 3 5 22
Pregnant 2 1 1 1 1 3 2 1 3 1 0 1
Non¬
pregnant
0 1 1 3 4 1 3 4 1 1 2 1
Numbers 3, 5 and 22 represent the days p.i. that mice were killed post-secondary
inoculation.
6.5.2 Culture of C. abortus organisms
Chlamydial inclusions were detected by culturing samples of homogenised tissues,
collected from control and infected mice, on McCoy cell monolayers (Section 2.7).
C. abortus was recovered from aborted placental samples from group 2 and 3
animals following infection in pregnancy one and from group 4 mice following
infection in pregnancy two, varying from 6.98 x 102 to 4.77 xlO5 IFUs/g of placenta.
All samples from uninfected mice (group 1) were negative for C. abortus organisms.
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Tissues from mice that were infected in the first pregnancy but were inoculated with
PBS only (group 2) or EBs (group 3) in the second pregnancy were negative
following secondary inoculation. Only samples collected from group 4 after the
second pregnancy were positive for C. abortus organisms (Table 6.4).




pregnancy Day p.i. Liver Uterus Placenta
4A1 14 3 9.84x103 n/a 4.48x104
Pregnant 4A2 Post 22 0 0 2.69x104
4A3 14 3 5.21 x103 0 n/a
Non¬
pregnant 4A6 16 5 1.44x104 1.09x104 n/a
Numbers equate to IFUs/g of tissue. Placenta from 4A1 was collected from the
uterus. 4A2 was killed on day 22 p.i., but the mouse aborted and the placenta was
collected on day 7 p.i.
6.5.3 Histology and chlamydial antigen detection
Histopathological investigation (Section 2.8.1) revealed differences between groups
of mice. All sections from uninfected mice (group 1) appeared normal with no
necrosis or inflammatory cell infiltration. The majority of tissue sections sampled
from group 2 (post-second pregnancy) had inflammatory foci present, although these
were smaller in size and less frequent than those observed in tissues from the
inoculum control (group 4) mice and some appeared similar to uninfected sections.
Inflammatory foci were generally observed in tissues collected from secondary-
infected mice (group 3), although foci were smaller in size compared to those
observed in inoculum control mice (group 4). Slightly more inflammatory foci were
observed in tissue sections of group 3 than those of group 2 mice. Necrosis was not
observed in liver or placental tissues, agreeing with previous studies (Chapters 3 and
4). All uninfected mice (group 1) and mice from groups 2 and 3 were negative for
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chlamydial antigen following the second pregnancy, as determined by
immunohistochemistry (Section 2.8.2). Chlamydial antigen was detected only on
days 3 and 5 p.i. in tissues sampled from group 4 mice, which were infected with C.
abortus in the second pregnancy.
6.5.4 Identification of immune cell phenotypes
6.5.4.1 Detection of PMNs in liver
Focal inflammation was present in liver sections from all groups of infected mice
(pregnant and non-pregnant mice) (Figure 6.2), with significantly higher numbers of
PMNs in group 4, which had a primary infection of C. abortus in the second
pregnancy, than within other groups (F3!36=28.62, p<0.001). Despite group 3 mice
being infected with C. abortus for a second time in the second pregnancy, a similar
infiltration of PMNs was observed during the course of infection to that of group 2
mice, which were not given secondary infection in the second pregnancy. To assess
similarities between pregnant and non-pregnant mice, PMN infiltration was
compared, with similar numbers detected on day 3 p.i. in both groups of mice and
significantly more cells present in liver tissues from all groups of pregnant mice on
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Figure 6.2 Ly-6G+ cell detection in liver tissue from control and infected
pregnant and non-pregnant mice after the second inoculation. Mean (+ SEM)
numbers of positive cells/mm2 were calculated for pregnant and non-pregnant mice
of each group on each day p.i. NB. No non-pregnant mice were present in group 1
on day 3 p.i. and no pregnant mice were present in group 4 on day 5 p.i. Where
there are no error bars, there was only one mouse killed at that time point (Table
6.3).
6.5.4.2 Detection of B cells in liver
Similar to PMN infiltration, higher numbers of B cells were detected in group 4
(primary infection in the second pregnancy) than within other groups of mice
(pregnant and non-pregnant) (F3,36=8.74, p<0.001) (Figure 6.3), although fewer B
cells were present in all groups of mice than PMNs. Similar numbers of B cells were
observed in sections of group 2 and 3 mice, which were immune to abortion in the
second pregnancy. The presence of B cells in inflammatory foci were compared
between pregnant and non-pregnant mice but this revealed no significant differences
(F|,36=0.35, p=0.562). No significant differences were detected at the different
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Figure 6.3 B220+ cell detection in liver tissue from control and infected
pregnant and non-pregnant mice after the second inoculation. Mean (+ SEM)
numbers of positive cells/mm2 were calculated for pregnant and non-pregnant mice
of each group on each day p.i. NB. No non-pregnant mice were present in group 1
on day 3 p.i. and no pregnant mice were present in group 4 on day 5 p.i. Where
there are no error bars, there was only one mouse killed at this time point (Table
6.3).
6.5.4.3 Detection of PMN and B cells in placental tissue
Few placental samples from mice were collected into ZSF due to the low number of
foetuses present in the uteri of some mice and because generally when mice litter, the
mother eats the placental tissue. Lower numbers of PMNs were detected in the foetal
labyrinth and chorionic plate areas than in maternal areas of the placenta in all of the
placental sections that were analysed (Figure 6.4). Despite mice being immune
(groups 2 and 3) and the lack of recovery of live organisms from placenta of these
mice, an inflammatory response was present as was observed in liver tissues (Figure
6.2). Ly-6G+ cells were detected in different areas of the placenta in samples from
group 3 mice with highest numbers present in placental tissue from a group 3 mouse
(3A2), which was killed on day 3 p.i.. This mouse had higher numbers of positive
cells than those detected in placenta from the other mouse that was killed on day 3
p.i. (3A8) and the mouse killed on day 5 p.i. (3B5) in this group 3. B220+ cells were
restricted to the maternal areas of placental tissue in all mice, and overall the number
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of B cells in each area was less than that of PMNs, agreeing with previous results





















Figure 6.4 Ly-6G+ and B220+ cell detection in uteroplacental units in control
and infected mice after the second inoculation. Numbers of positive cells/mm2
were determined in different areas of uteroplacental units for individual mice. All
mice were sampled on day 3 p.i. except 3B5 which was collected on day 5 p.i. Prefix
1, 2, 3 or 4 signifies the group (Table 6.1). UT=uterine epithelium, MG=metrial
gland, MD=maternal decidua, GC=giant cells, LEMabyrinth, CP=chorionic plate.
6.5.4.4 T cell detection in liver and placental tissues
To determine the cellular response, T cells were detected by immunohistochemistry
on representative samples of frozen tissue sections. This was carried out at the
University of Murcia, as described in Section 2.8.4.2, CD4+ and CD8+ T cells were
detected in all tissue sections that were analysed (Figures 6.5 and 6.6).
Immunophenotypical analysis of the lymphocyte infiltrate showed that CD4+ T cells
were the predominant population in the inflammatory foci of mice (Figure 6.5). A
significantly greater number of CD4+ than CD8+ T cells were present in all of the
liver sections that were analysed (F|,28=8.23, p=0.009). Numbers of CD4+ cells were
comparable between secondary infected mice (group 3) on day 5 p.i. and inoculum
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control (group 4) mice on days 5 and 22 p.i. in liver tissue. CD4+ T cells were
variable between mice within the same groups, whether pregnant or not, with the
highest number of these cells present on day 5 p.i. in immune (group 3) mice. CD4+
T cells were also numerous on day 3 p.i. (2A2) and on day 22 p.i. (4A2). In contrast,
the number and distribution of CD8+ T cells varied less between individual mice,
although there were slightly more cells present in two mice from group 4 (Figure
6.5). No significant differences were determined between the number of CD4+ or
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Figure 6.5 CD4+ and CD8+ T cell counts in liver tissues from individual mice
after the second inoculation in the second pregnancy. Total numbers of positive
T cells were counted in 20 fields of view by light microscopy (x20 magnification) on
immunolabelled liver sections.
In all liver sections positive cells were scattered throughout the parenchyma, with





Figure 6.6 T cell staining in liver sections from pregnant mice infected with C.
abortus, (a) CD4+ and (b) CD8+T cells in liver tissue from an immune mouse (group
3) killed on day 5 p.i.
Four uteroplacental tissue samples were analysed for the presence of T cells at the
University of Murcia. The majority of CD4^ and CD8+ T cells were expressed in the
uterine epithelium, although T cells were also detected in the foetal labyrinth area
(Figure 6.7). T cells were detected in uteroplacental tissues from immune (group 3)
mice only but were not detected in the aborted placental sample (4A1) from the
inoculum control group 4. As in liver sections, a higher number of CD4+ than CD8 +
T cells were detected in placental sections (Figure 6.7). Images of representative


























Cell type/area of placenta
Figure 6.7 T cell distribution within infected placental tissue after the second
inoculation. Total numbers of CD4+ or CD8+ T cells were counted in 20 fields of
view by light microscopy (x20 magnification). UT=uterine epithelial cells,
LT=labyrinth trophoblast cells, GC=giant cells. Prefix 2, 3 or 4 denotes group. Mice
3A2 and 3A8 were killed on day 3 p i., 3B5 on day 5 p i., and 4A1 represents an
aborted placenta on day 7 p.i.
Figure 6.8 T cell staining in C. abortus-infected placenta sections, (a) CD4T
cells at the edge of the trophoblast labyrinth area, (b) CD8+ cells within the uterine
epithelium. Distribution of CD8+ cells was very similar to CD4+ T cell distribution in
the uterus of infected mice.
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6.5.4.5 NK cell detection in liver and placenta tissues
To determine if NK cells were expressed in response to C. abortus infection in mice,
immunohistochemical labelling of frozen sections with an anti-Ly49G was
conducted at the University of Murcia (Section 2.8.4.2), NK cell detection was
successful in the positive control section kindly provided by Assistant Professor
Antonio Buendia, however all of the sections from this study that were analysed
were negative for NK cells.
6.5.5 Antibody responses
6.5.5.1 ELISA results
C. abortus-specific antibody responses in mice were determined by analysis of sera
by EB-specific ELISA, as described in Section 2.9.1, Figures 6.9, 6.10 and 6.11
show IgGl, IgG2a and IgM responses, respectively. Blood samples were collected at
3 different time points: 1. Pre-infection by tail snips (before pregnancy 1; day 0)
(data not shown as all results were negligible); 2. Between pregnancies 1 and 2 by
tail snips (equates to day 40 after the primary inoculation); and 3. At the final PM by
cardiac puncture on 3, 5 or 22 days post-secondary inoculation.
IgGl, which is indicative of a Th2 immune response, had significantly higher
responses in group 2 (F3,32=3.35, p=0.031) after the first pregnancy as shown in
Figure 6.9a, despite mice in groups 2 and 3 being infected with exactly the same
EBs. IgGl levels remained high within group 2 following the second pregnancy,
except on day 5 p.i. (Figure 6.9b). IgGl responses were low in all mice after the
second pregnancy, except those from group 2, which were significantly higher than
in the other groups (F3,36=4.14, p=0.016). Responses were similar at all other time
points throughout infection/pregnancy (F2.36=0.84, p=0.446) in all groups. Similar
responses were also detected in pregnant and non-pregnant mice (Ft,36=0.01,



























Figure 6.9 lgG1 antibody response in control and infected mice (a) post¬
primary inoculation/pregnancy. Mean (+ SEM) ODs were determined by ELISA
for all mice (pregnant and non-pregnant) in each group on day 40 post-primary
inoculation, (b) post-secondary inoculation/pregnancy. Mean (+ SEM) ODs were
determined by ELISA for each group of pregnant and non-pregnant mice on each
day p.i. (the final PM day post-second infection). NB. No non-pregnant mice were
present in group 1 on day 3 p.i, and no pregnant mice in group 4 on day 5 p.i.
Where there are no error bars present, one mouse only was killed at that time point
(Table 6.3).
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The IgG2a antibody response to C. abortus was significantly higher in the infected
groups (2 and 3) compared to the control groups (1 and 4) after the first pregnancy
(F3,36=7.77, p<0.001) (Figure 6.10a). IgG2a responses, which are indicative of a Thl
immune response, continued to increase after the second pregnancy in groups 2 and
3, following inoculation with PBS (group 2) or secondary infection (group 3)
(Figure 6.10b). Higher IgG2a levels were detected in sera from group 2 than group 3
mice, despite the lack of secondary challenge in this group 2. Comparison of IgG2a
responses in pregnant and non-pregnant mice revealed no significant differences
(Fi,36=0-49, p=0.491), although higher IgG2a responses were observed in non¬
pregnant mice of all groups, except on day 5 p.i. (group 2) and day 22 p.i. (group 3).
IgG2a responses remained low in sera from the inoculum control mice (group 4),
although the titres had started to increase by day 22 p.i.. Significantly higher
responses were determined in groups 2 and 3 than in groups 4 and 1 (F3i36=4.99,























—1n m Hi r rfl
□ Pregnant
■ Non-pregnant
3 | 5 | 22 3 5 22 3 : 5 j 22 j 3 | 5
GP 1 GP 2 GP 3 GP 4
Day post-infection
22
Figure 6.10 lgG2a antibody response in control and infected mice (a) post¬
primary inoculation/pregnancy. Mean (+ SEM) ODs were determined by ELISA
for all (pregnant and non-pregnant) mice in each group on day 40 post-primary
inoculation (between the first and second pregnancies), (b) post-secondary
inoculation/pregnancy. Mean (+ SEM) ODs were determined by ELISA for each
group of pregnant and non-pregnant mice on each day p.i. (the final PM day post-
second infection). NB. No non-pregnant mice were present in group 1 on day 3 p.i,
and no pregnant mice in group 4 on day 5 p.i. Where there are no error bars
present, one mouse only was killed at that time point (Table 6.3).
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IgM titres were significantly higher in the infected groups (2 and 3) compared with
the control groups (1 and 4) after the first pregnancy/inoculation (F3,36=5.50,
p=0.004) (Figure 6.11a), similar to the IgG2a titres. IgM titres varied significantly
throughout infection in the groups after the second pregnancy being higher in all
infected (groups 2-4) than in the uninfected (group 1) mice (F336=4.05, p=0.021)
(Figure 6.11b). Few differences were observed between IgM responses in sera from
group 2 and 3 mice, and these responses were similar to those in sera from group 4
mice. IgM responses varied significantly during infection, with a higher titre detected
on days 5 and 22 p.i. than on day 3 p.i. in infected groups 2, 3 and 4 (F2,36=4.18,
p=0.030). As with IgGl and IgG2a responses, the IgM titre was not significantly
different in pregnant compared to non-pregnant mice (Fi,36=0.18, p=0.675), although
the majority of non-pregnant mice had higher responses, with the exception of
groups 2 and 4 on day 22 p.i. and group 3 on day 5 p.i..
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Figure 6.11 IgM antibody response in control and infected mice (a) post¬
primary inoculation/pregnancy. Mean (+ SEM) ODs were determined by ELISA
for all (pregnant and non-pregnant) mice in each group on day 40 post-primary
inoculation (between the first and second pregnancies), (b) post-secondary
inoculation/pregnancy. Mean (+ SEM) ODs were determined by ELISA for each
group of pregnant and non-pregnant mice on each day p.i. (the final PM day post-
second infection). NB. No non-pregnant mice were present in group 1 on day 3 p.i,
and no pregnant mice in group 4 on day 5 p.i. Where there are no error bars
present, one mouse only was killed at that time point.
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6.5.5.2 Western blotting
To identify the specificities of the antibody responses, IgGl and IgG2a responses to
C. abortus EBs were assessed by Western blot analysis, as described in Section
2.9.2, Figure 6.12a shows representative results of the almost undetectable IgGl
response against whole EBs. This contrasts with the high IgGl response of group 2
detected by ELISA in response to whole EBs. There are only faint bands when
hyperimmune sera from C. abortus-infected mice was used, at approximately 90
kDa.
Anti-IgG2a reactivity to whole EBs (Figure 6.12b and c) was notably higher than
the IgGl reactivity when mouse hyperimmune sera was used. Serum samples in
lanes 3 and 4 in Figure 6.12b represent sera from uninfected mice (group 1),
showing that there was no response in comparison to infected mice. Serum samples
in lanes 5, 7-12 and 14, representing group 2 mice, showed a strong IgG2a response
to a number of proteins (Figure 6.12b). Similarly sera from group 3 (lanes 2-12;
Figure 6.12c) reacted to a wide range of proteins, whereas this reactivity is reduced
in group 4 sera (lanes 13 and 14, Figure 6.12c). Although MOMP is the major
immunodominant antigen, sera did not appear to react specifically to MOMP but to a


























Figure 6.12 lgG1 and lgG2a responses in sera from control and infected mice
post-secondary inoculation to EBs by Western blots analysis, (a) lgG1
response : 1 negative control, 2 mouse hyperimmune sera, 3-4 negative control
mice, 5-9 group 2 sera, 10-14 group 3 sera, 15-18 group 4 sera, (b) lgG2a
response: 1 negative control, 2 mouse hyperimmune sera, 3-4 negative control
mice, 5-14 group 2 sera, (c) lgG2a response: 1 group 2 serum, 2-12 group 3 sera,
13-14 group 4 sera, 15 mouse hyperimmune sera, 16 negative control.
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6.5.6 Cytokine production during C. abortus infections
6.5.6.1 IFN-y protein expression
IFN-y concentrations in supernatants from splenocytes stimulated with specific
C. abortus antigens were determined, as described in Sections 2.10 and 2.14.
Although no statistically significant different results were observed between pregnant
and non-pregnant mice (p>0.1 for all antigens), IFN-y concentrations appeared
consistently higher in non-pregnant mice (Figure 6.13b).
IFN-y was produced specifically in response to C. abortus HK and TX EBs by in
vitro stimulation of splenocytes from mice that had been infected with C. abortus
(groups 2, 3 and 4) (Figure 6.13). Generally, HK EBs induced greater IFN-y
production than TX EBs, although overall there were little differences. Very low
concentrations of IFN-y were detected in response to medium alone, although this
was slightly elevated in splenocytes of infected groups 2 and 3. IFN-y responses
were significantly higher in HK (F3,36=9.46, p<0.001) and TX (F3.36=8.39, p<0.001)
EB-stimulated splenocytes from groups 2 and 3 than in those of group 4. An
increasing trend in IFN-y concentration was observed from day 3 to 5 p.i. in pregnant
mice of groups 2 and 3 in response to HK and TX EBs (Figure 6.13a).
Concentrations remained high on day 22 p.i. in pregnant mice of groups 2 and 3 and
a slight increase was also detected from day 3 to 22 p.i. in group 4 (Figure 6.13a). A
similar increasing trend was observed over the course of infection in non-pregnant
mice of groups 2 and 4, whereas in non-pregnant mice of group 3, similar responses
were detected on all of days 3, 5 and 22 p.i. (Figure 6.13b). These slight differences
in cytokine production over the course of infection (in pregnant and non-pregnant
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Figure 6.13 Splenic IFN-y concentrations as a result of in vitro stimulation with
specific C. abortus-antigens in control and infected mice after secondary
inoculation (a) pregnant mice and (b) non-pregnant mice. Data are presented as
means (+ SEM) for each group of mice on days 3, 5 and 22 p.i, determined by
commercial ELISA using known standards (Section 2.10). Medium=RPMI
Complete, Con A= 1.25 pg, HK EBs= 0.6 pg and TX EBs= 0.6 pg.
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6.5.6.2 TNF-a protein expression
TNF-a, another proinflammatory Thl cytokine, expression was also monitored in
response to specific chlamydial antigen stimulation (Figure 6.14), as described in
Sections 2.10 and 2.14. Representative samples were analysed to give an indication
of the levels of TNF-a production in uninfected and infected mice.
Similar to the IFN-y response (Figure 6.13), there was little cytokine production to
medium alone compared to the positive control (Con A) and to specific chlamydial
antigens (Figure 6.14). No obvious differences were observed in the TNF-a response
between pregnant and non-pregnant mice, however this could not be analysed for
statistical significance due to the low sample number. TNF-a production was highest
in infected mice (groups 2, 3 and 4) in response to C. abortus-specific antigens and
FIK EB-induced TNF-a responses were almost consistently higher than those
induced by TX EBs. Between 500-1000 pg/ml (866.9 + 120) TNF-a was produced
by stimulated cells in group 4 (in response to EBs) and higher levels of
600-1500 pg/ml (1037.3 ± 202) and 500-2000 pg/ml (1161.9 ± 165) were produced
by stimulated cells in groups 2 and 3, respectively, showing that there was little
difference between the two latter immune groups. TNF-a concentrations were lower
than IFN-y (Figure 6.14) in the positive control and EB-specific supernatants, with
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Figure 6.14 TNF-a concentrations as a result of in vitro stimulation of
splenocytes with specific C. abortus-antigens from pregnant and non¬
pregnant control and infected mice. Data are presented as means (+ SD),
determined by commercial ELISA for representative mice from each group. Prefix
1,2, 3 or 4 signifies the group.
Representative serum samples (collected at the PM) were also analysed for TNF-a
production by commercial ELISA, as shown in Table 6.5. Despite some of the mice
mentioned in Table 6.5 inducing TNF-a expression in response to specific
chlamydial antigens in supernatants collected from stimulated splenocytes and
having a detectable background response to medium alone (Figure 6.14), no TNF-a
was detected in these serum samples. TNF-a was identified in sera from group 4
mice, although concentrations were extremely low in comparison to those detected in
cell supernatants in response to specific chlamydial antigens. These differences in
cytokine concentrations in supematants and sera may be due to some inhibitory
substances in sera preventing identification of TNF-a. It also suggests that cytokine
concentrations in sera are unrepresentative of the local immune responses within
infected tissues.
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Table 6.5 TNF-a concentrations in serum samples after the second pregnancy
Cone










Prefix 2,3 or 4 denotes the group (Table 6.1).
6.5.7 In situ hybridisation
Having determined the protein expression of the proinflammatory cytokines, IFN-y
and TNF-a, mRNA expression in tissues was examined by in situ hybridisation, as
described in Section 2.11.5, IFN-y and TNF-a mRNA+ cell counts are shown in
Tables 6.6 and 6.7, respectively.
A lower number of IFN-y mRNA+ cells were detected in this experiment (Table 6.6)
than in primary-infected pregnant mice in Chapter 4. All sections from uninfected
mice (group 1) were negative. One aborted placenta collected after the first
pregnancy from group 2 had IFN-y+ cells present but no mRNA expression of IFN-y
was detected in any liver or placental tissues from this group following the second
pregnancy. IFN-y mRNA+ cells were also observed in aborted placenta tissue
collected after the first infection/pregnancy in group 3, whereas no positive cells
were present in placental tissue following secondary infection. Low numbers of cells
expressing IFN-y mRNA were detected on days 3 and 5 p.i. in liver sections of
immune mice (group 3), and one mouse (3B6) in particular had very high numbers of
positive cells compared to liver sections from mice of the same group (Table 6.6).
Numerous IFN-y+ cells were present in liver tissue from inoculum control mice
(group 4), following their primary infection with C. abortus in the second pregnancy.
176
Interestingly, positive cells were detected in the placenta of one mouse from this
group (4A1), but not in the liver of the same mouse on day 3 p.i., suggesting IFN-y
may be localised to sites of infection. This is supported by culture (Section 6.5.2)
and immunohistochemistry data (Section 6.5.3). IFN-y mRNA+ expression had
decreased in group 4 by day 22 p.i., coinciding with the lack of detectable infection
by culture and immunohistochemistry.
Table 6.6 IFN-y counts in tissue samples from control and infected mice after
the first and second pregnancies
Mouse Tissue Day p.i. Cells/mm2
Pregnancy 1 2A2 Aborted 3 6.5
3A2 Placenta 3 1.45
3B6 5 2.9
Pregnancy 2 3B6 Liver 5 11.6
Pregnant mice 4A1 Placenta 3 4.35
4A2 Liver 22 1.45
Pregnancy 2 3A5 Liver 3 2.9
Non-pregnant mice 3A3 Liver 3 1.45
3A4 Liver 5 1.45
3B3 Liver 5 4.35
4A3 Liver 3 5.8
4A5 Liver 5 4.8
4A5 Liver b 6.1
Numbers of positive cells/mm2 is shown for each mouse for each of liver and
placenta tissue at each time point post-secondary inoculation. Prefix 2, 3 or 4
denotes the group (Table 6.1).
TNF-a mRNA+ cells were detected in only 5 of 38 liver sections examined, 4 of
which were from the inoculum control (group 4) mice, the fifth infected in the first
pregnancy only (group 2) (Table 6.7). TNF-a+ cells were observed only in infected
liver tissue sections, and were fewer in number than IFN-y+cells.
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Table 6.7 TNF-a mRNA+ cells in liver tissue after the second pregnancy






Prefix 2 or 4 denotes the group (Table 6.1).
6.5.8 LSAs
To investigate stimulation of mouse splenocytes in response to specific chlamydial-
antigens, HK and TX EBs, LSAs were carried out, as described in Section 2.13. In
order to demonstrate the wide variation associated with this assay, absolute
counts/min (Figure 6.15) and stimulation indices (Sis; Figure 6.16) are presented for
both pregnant and non-pregnant mice although there were no significant differences
between the two groups of mice (p>0.1 for all antigens).
C. abortus-specific responses were detected in all infected mice (Figure 6.15 and
6.16). An increased proliferation (counts/min; cpm) to both HK and TX EBs was
observed from day 3 to 5 p.i., with a slight decrease in proliferation on day 22 p.i. in
pregnant mice that were immune to abortion (groups 2 and 3), with similar responses
obtained in these two groups (Figure 6.15a). Examination of Sis of the same data
from pregnant mice revealed a less pronounced increase from day 3 to 5 p.i. in group
2, and the Sis appeared similar at all time points in group 3 (Figure 6.16a).
Similar proliferative responses (cpm) were observed throughout infection in non¬
pregnant mice, with a decrease to both HK and TX EBs on day 22 p.i. in groups 2
and 3 (Figure 6.15b). In contrast, Sis imply that proliferation increased rather than
decreased in response to both HK and TX EBs on day 22 p.i. in group 3 mice
(Figure 6.16b). Responses varied slightly in group 4 and were lower than those of
groups 2 and 3 throughout the infection (Figure 6.15b).
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There were significant differences in proliferative responses to both HK (F3,36=12.34,
p<0.001) and TX EBs (F3.3<-,= 12.54, p<0.001) between the groups of mice (pregnant
and non-pregnant), being higher in groups 2 and 3 than 1 and 4, in a similar trend to
IFN-y production. HK EB-induced stimulation was significantly (F2,36=4.22,
p=0.024) higher on day 5 p.i. in all groups of mice, whereas stimulation induced by
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Figure 6.15 Proliferation induced by specific chlamydial antigens of
splenocytes from control and C. abortus-infected (a) pregnant and (b) non¬
pregnant mice, detected by incorporation of 3H-thymidine. Results are shown
as absolute cpm values calculated from the arithmetic means of triplicate
measurements for each group on each day p.i.. The stimulating antigens were:
Medium (background control; RPMI Complete), Con A (1.25 pg), HK EBs (0.6 pg)
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Figure 6.16 Stimulation indices of proliferation induced by specific chlamydial
antigens of splenocytes from control and C. abortus-infected (a) pregnant and
(b) non-pregnant mice, detected by incorporation of 3H-thymidine. Results are
shown as mean (+ SEM) Sis calculated from the arithmetic means of triplicate
measurements in relation to the background cpm for each group on each day p.i..
The stimulating antigens were: Con A (1.25 pg), HK EBs (0.6 pg) and TX EBs
(0.6 pg).
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6.5.9 Flow cytometry analysis
Flow cytometry analysis was used (Section 2.15) to identify cell subpopulations
expressed in the different control and infected groups of mice (Table 6.1). Gates for
flow cytometry analysis were set to CD45+cells (Figure 6.17).
No clear observable trends were observed in any of the cell populations determined
between the groups of mice (Figure 6.17). The percentage of CD3+ cells was
significantly higher on days 5 and 22 p.i. in pregnant mice than non-pregnant mice,
with little difference between the two groups of mice on day 3 p.i. (F2,34=3.75,
p=0.043). Percentages of CD3+ cells were similar in all groups of mice. As with
CD3+ cells, more CD4+cells were present in pregnant mice than non-pregnant mice
(F|,34=T8.05, p<0.001) and percentages of CD4+ T cells were also similar in all
groups of mice. Pregnant mice had a higher percentage of CD8+ T cells than non¬
pregnant mice and this varied significantly between the groups of mice ^3,34=3.20,
p=0.048), with slightly more CD8+ T cells detected in group 4 pregnant mice. Very
low numbers of y8 T cells were detected in all mice and this population was also
significantly higher in pregnant than non-pregnant mice (F3,32=3.20, p=0.048). In
contrast to the T cells, significantly more CD19+ cells (B cells) were identified in
non-pregnant than pregnant mice (F1,34= 12.87, p=0.002). CD19+ cells were the
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Figure 6.17 Phenotypic variation in splenocyte subpopulations of (a) pregnant
and (b) non-pregnant control and infected mice. Analysis was performed on
CD45 gated cells. Mean (+ SEM) percentages for each cell type for each group on
the different days p.i. are presented, gd = y5 TCR.
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6.6 Discussion
This pregnant mouse model of chlamydial abortion has similarities with ovine
chlamydial infections, including abortion and induction of a Thl type immune
response. Although these similarities verify the use of the pregnant mouse model for
assessing vaccines against EAE, it was important to compare other aspects of ovine
chlamydial infections to the disease in mouse to fully validate the model system. The
purpose of the study described in this chapter was to examine immunity to abortion
in mice, for comparison with immunity to abortion in sheep, in the following
pregnancy post-abortion. The model was used to determine if, following primary
infection and abortion, mice would be immune to abortion in the subsequent
pregnancy with (group 3) and without (group 2) experimental secondary infection.
For the remainder of this chapter, the groups shall be referred to as the following,
with 'P' defining pregnancy: Group 1 (P/P) mice were inoculated with PBS only in
both the first and second pregnancies, i.e. uninfected; Group 2 (1°P/P) mice were
infected with C. abortus in the first pregnancy and PBS in the second; Group 3
(l°p/2°p) mjce were inocu]ated with C. abortus in both pregnancies i.e. primary and
secondary infections; and group 4 (P/1°P) mice were inoculated with PBS in the first
pregnancy and a primary infection of C. abortus in the second pregnancy.
Group 2 (1°P/P) and 3 (1°P/2°P) mice that were infected with C. abortus at mid-
gestation aborted as expected in the first pregnancy and groups 1 (P/P) and 4 (P/1°P)
littered live healthy pups. The pregnancy rate decreased in the second pregnancy,
which may have been due to the previous infection affecting the successful
impregnation of the mice, as possibly occurred in a previous study (Chapter 5).
Although this could have been a result of the primary infection with C. abortus
affecting the fertility of the mice, it is unlikely, as a similar pattern would not have
occurred in groups 1 (P/P) and 4 (P/1°P), which were infected only with PBS in the
first pregnancy. It would also contrast to what occurs in sheep, where those ewes
that have aborted can continue to lamb successfully in subsequent breeding seasons.
Regardless of the lower pregnancy rate, outcomes of infection for each group were
determined in the second pregnancy. Uninfected mice (group 1; (P/P)) also littered in
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the second pregnancy, and mice in the inoculum control group 4 (P/1°P) were
successfully infected with C. abortus, demonstrated by the recovery of live
organisms from tissues and abortion.
Mice that aborted in the first pregnancy but were mated again without secondary
experimental infection (group 2; 1°P/P), produced live, healthy pups mimicking the
immunity that occurs in sheep following natural and experimental primary infections
(Papp et al., 1994; Aitken & Longbottom, 2004). It can be concluded that disease in
the mouse model is analogous to that in sheep in terms of immunity to abortion in a
subsequent pregnancy, and this is further supported by group 3 (1°P/2°P) animals
that aborted in the first pregnancy and were mated again. These mice were
subsequently inoculated with a secondary infection of C. abortus and this resulted in
littering of live, healthy pups demonstrating immunity to secondary infection, which
has also been shown in sheep (Papp et al., 1994). It is probable that sheep may be
infected again around the time of lambing, particularly if it is in the second breeding
season after C. abortus entered the flock. One problem associated with routinely
using sheep that are immune to abortion for breeding is the likelihood that a chronic
reproductive tract infection has developed, as has been demonstrated by Papp et al.
(Papp et al., 1994, 1998). Ewes that had previously aborted were found to excrete C.
abortus organisms at the time of oestrus although this was in a very small sample
number (Papp et al., 1994, 1998). This implies that other ewes could be infected at
this time, showing that it is important to segregate previously aborted ewes at oestrus
and lambing to prevent other flock members becoming infected. It would have been
useful to take vaginal swabs after the first and second pregnancies in mice to
determine if shedding occurs, as this may have provided further information on
sterility, of which little is known in the ovine field.
Having identified that immunity to abortion occurred in groups 2 (1°P/P) and 3
(l°P/2°), the incidence of C. abortus and the nature of the immune responses were
examined. Chlamydial organisms were recovered and chlamydial antigen was
detected only in mice that were infected in the second pregnancy (group 4; P/1°P)
until day 5 p.i.. C. abortus was not detected in any tissues from either of the group 2
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(1°P/P) or 3 (1°P/2°P) animals that were immune to abortion. This indicates that the
animals had cleared the infection or the level of infection was too low to be detected
in pregnant mice of group 2 and there was no recrudesce to cause abortion. No
organisms were detected in non-pregnant mice of groups 2 or 3. Adaptive immunity
was present in group 3 mice, shown by control of the secondary infection, as denoted
by the lack of detection of antigen and organisms from day 3 p.i. and also by the lack
of abortion. Therefore immunity appears to be sterile although this was only
determined by culture and immunohistochemistry. PCRs (Chapter 5) could be
adopted in future studies in both mice and sheep to monitor C. abortus infection
post-abortion.
The inflammatory response agreed with the recovery and antigen data, being
significantly higher in tissues from inoculum control mice (group 4; P/1°P) than from
tissues of group 2 (1°P/P) and 3 (1°P/2°P) mice, suggesting that there were either no
or very few organisms present. The lack of organisms is likely to be a result of
control by the acquired immune response in group 3 rather than that of innate
immunity in group 4, therefore there was less inflammation in groups 2 and 3 than in
group 4 mice. It should be noted that PMN infiltration had also decreased by day 22
p.i. (approximately 14 days post-abortion) in tissues from group 4 (P/1°P) mice,
coinciding with a reduction/clearance of organisms and a change from innate to cell
mediated immunity. Papp and Shewen (1996) reported that there was no evidence of
pathology associated with persistent infections in the uterus of sheep that were
immune to abortion, but plasma cells and intraepithelial lymphocytes were increased
in number and distribution. Uteri from some mice across all infected groups were
macroscopically enlarged and reddened. This could have been as a result of increased
inflammation, as demonstrated by detection of PMNs, B cells, CD4+ and CD8+ T
cells in the uterine epithelium or purely related to the impact of pregnancy. However
both PMNs and B cells are suggested to have limited roles in immunity to secondary
infections of C. abortus (Buendia et al., 2002; de Oca et al., 2000).
NK cells were not detected in any of the tissues analysed at the University of Murcia.
In contrast, Buendia et al. (Buendia et al., 2004) have shown that NK cells increase
186
in liver and spleen of non-pregnant mice in response to early C. abortus infection,
where NK-depleted mice were shown to be more susceptible to infection, as
demonstrated by higher mortality and infection levels. Differences between this
study and that by Buendia include the pregnancy status of the mice and the period of
time between infection and assessment for NK cell presence. Since NK cells may
only have a role in the early innate response, this explains their absence in immune
mice (groups 2 (1°P/P) and 3 (1°P/2°P)) but not in mice from group 4 (P/1°P),
although the time scales were different.
A Thl cell mediated response controls C. abortus infections (de Oca et al., 2000; Del
Rio et al., 2000). Characterisation of the T cell response in the present study
identified both CD4+ and CD8+ T cells in infected liver and placenta tissues in mice
across all groups. Higher numbers of CD4+ T cells, which are characteristic of a Thl
immune response, were identified than CD8+ T cells in all mice throughout infection,
a finding similar to that observed in ovine infections (Buxton et al., 2002). No
distinct differences were detected between infected groups or pregnant and non¬
pregnant mice, and a CD4+ T cell response was elicited in all infected mice (groups 2
(1°P/P), 3 (1°P/2°P) and 4 (P/1°P)). It may have been expected that T cell numbers
would be higher in group 3 mice compared to group 4, due to the acquired immune
response. CD4+ and CD8+ T cell numbers were widely variable in T cell number and
distribution within liver sections in all groups and placental tissue from immune mice
(groups 2 (1°P/P), 3 (1°P/2°P)), which may indicate individual differences in
immunity. CD4+ and CD8+ T cells have been identified in infected liver sections in
other mouse models of C. abortus (de Oca et al., 2000; Del Rio et al., 2001),
showing that similar immune responses are mounted despite differences in mouse
strains and C. abortus isolates. Immunity to secondary infection with C. trachomatis
depends on CD4+T cells (Williams et al., 1997), and as demonstrated in this study,
higher numbers of CD4+ cells were detected than CD8+ cells. It has been claimed
that CD8+ cells may be more important in the resolution of C. abortus infections (Del
Rio et al., 2001; de Oca et al., 2000), which does not agree with this study.
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Very few differences were identified in cell subpopulations by flow cytometry in
infected mice compared to uninfected mice. No differences were even detected
between cell subpopulations in infected and uninfected mice by searching for
blasting cells, based on size. B cells were more numerous in all mice than T cells,
and CD19 cells were higher in uninfected mice (group 1; P/P) than all infected mice
(groups 2-4), although these differences were not significant. T cell numbers may
have been expected to increase in immune mice (group 3) but this was not observed.
Differences may have been observed in lymph nodes more localised to sites of
infection, such as the uterine lymph node, as unless the infection remains in the
spleen, it is difficult to detect differing cell subpopulations in response to a
circulating infection. Due to their small size, uterine lymph nodes would need to be
pulled for each group in order to obtain sufficient cells for flow cytometry analysis.
Slightly more CD4+ than CD8+ T cells were detected in the spleen and numbers of y5
T cells was particularly low in all groups of mice, as expected (REF). It is suggested
that ap T cells are the major T cell population in acquired immunity to chlamydial
infection and that y8 T cells play an ancillary role in regulating the aP T cell response
(Yang et al., 1998). These y8 T cells may be important early in infection, as observed
in models of Salmonella and trypanosome infections (Williams et al., 1996).
Unexpectedly, IgGl titres were extremely high in sera from group 2 (1°P/P) mice
compared to the other groups of infected mice and previous studies (Chapter 4).
IgGl is indicative of a Th2 response therefore it was not expected to increase in C.
abortus-infected mice (group 2; 1°P/P), as C. abortus infections are controlled by a
Thl type immune response (Chapter 4; Buendia et al., 2004). However, a similar
effect was not observed after the primary infection in group 3 and these two groups
of mice were infected with exactly the same inoculum. Wide variation exists in
group 2 (1°P/P) animals, as demonstrated by the large error bars, therefore the high
IgGl response was not observed in all mice of this group, in 5 out of 12 mice. The
majority, but not all, of the mice that had a high IgGl response were pregnant,
therefore it could have been related to the more dominant Th2 response that is
thought to be prevalent during pregnancy (Kidd, 2003), however, the low IgGl
response of pregnant and non-pregnant mice in group 3 would contradict this. A high
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IgG2a response was observed in both groups 2 (1°P/P) and 3 (1°P/2°P) after the first
pregnancy and primary C. abortus infection, supporting the presence of a Thl
response in infected mice. Following the second pregnancy, the IgG2a response
increased further in groups 2 (1°P/P), 3 (1°P/2°P) and 4 (P/1°P) in pregnant and non¬
pregnant mice, agreeing with previous studies (Chapter 4). Antibody has been
suggested to be important for resistance to re-infection (Moore et al., 2002; Moore et
al., 2003) and to enhance the immune response, and this agrees with the increased
IgG2a response to C. abortus in group 3 mice, which were immune to secondary
infection in this study. Western blotting results further supported the specificity of
the IgG2a response to C. abortus infections and the lack of an IgGl response in these
immune mice. IgM responses were similarly higher in infected mice after the first
pregnancy, and continued to increase in groups 2, 3 and 4 following the second
pregnancy/inoculation. Similarly, whole IgG and IgM systemic responses have been
identified in post-abortion sheep (Papp et al., 1994).
One must note that the longevity of the antibody response is unknown in sheep,
although it is thought to persist for at least two years in immune sheep, as they are
immune to abortion in the following breeding seasons (Papp et al., 1998). In contrast
there is no indication of the length of the antibody response following primary
infection in mice. It may be that they were immune to abortion and/or secondary
experimental infection in the second pregnancy due to the shorter time between
abortion after the primary infection and experimental secondary infection and the
presence of antibody. Perhaps if mice had been re-infected and /or remated 1 year
post-abortion as occurs in sheep, they would not be immune to abortion. This was
beyond the scope of the present study.
Protein and molecular expression of LFN-y and TNF-a were also determined,
providing further evidence that a Thl cellular immune response was present and
controlled both primary and secondary C. abortus infection in this mouse model.
Both IFN-y and TNF-a protein responses in supernatants were higher in groups 2
(1°P/P) and 3 (1°P/2°P) than in uninfected mice (group 1; P/P) after the second
pregnancy. There was a clearer distinction between higher IFN-y responses in mice
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that did not abort in the subsequent pregnancy (groups 2 and 3) to the lower IFN-y
responses of group 4 (P/1°P) mice than between TNF-a responses in the different
groups, but only a proportion of samples were assessed for the latter cytokine.
Increased production of cytokines in groups 2 and 3 could be linked to the presence
of acquired immunity, which had not yet developed in group 4 until after day 5 p.i.,
These increased responses in infected than uninfected mice are similar to those found
in Chapter 4 in sera samples. Other mouse models of C. abortus have also found
elevated IFN-y and TNF-a responses in infected mice compared to uninfected mice
(Bouakane et al., 2003; Buendia et al., 2004; de Oca et al., 2000) as well as in other
models of Chlamydia infections (Geng et al., 1998; Qiu et al., 2004; Rothfuchs et al.,
2004).
A reduction in mRNA expression of both proinflammatory cytokines within infected
tissue sections was observed. Although an increase in mRNA expression may be
expected, the lack of organisms within the tissues of groups 2 and 3 would perhaps
negate the need for specific cytokine production at previous sites of infection. IFN-y
and TNF-a mRNA expression were barely detectable in tissues from group 2 (1°P/P)
mice that appeared to have cleared the infection, however a specific memory
response was still present in these mice, demonstrated by in vitro chlamydial antigen
stimulation that increased cell proliferation and simultaneous cytokine production.
Similarly in group 3 (1°P/2°P), where no chlamydial organisms were detected,
mRNA expression of the cytokines was infrequent and reduced in comparison to
previous studies (Chapter 4) and to the inoculum control group 4 (P/1°P) tissues,
from which organisms were recovered and detected. This suggests that IFN-y and
TNF-a act locally at sites of infection in primary-infected mice (group 4) as well as
specifically to C. abortus antigens (groups 2, 3 and 4). A memory response had
developed in these immune groups, where no C. abortus was detected, as shown by
in vitro stimulation with specific antigens, although this was less pronounced in
primary-infected mice, where innate immunity was prevalent.
As a result of the decreased pregnancy rate, both pregnant and non-pregnant mice
were examined in this study. This allowed investigation into the potential use of both
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pregnant and non-pregnant mice for vaccine experiments, although a pregnant model
obviously offers the advantage of using a reduction in abortion as the readout. In
terms of immune responses, however, few differences were observed between them,
with inflammatory cells and proinflammatory cytokines present in all infected mice.
Chlamydial-specific antibody responses were also detected in both groups of mice
and memory responses were detected in all infected mice, irrespective of their
pregnancy status. This study therefore validates the use of both pregnant and non¬
pregnant mice to examine immune responses to C. abortus infections, although
pregnant mice are ultimately better as immunity to abortion can be demonstrated,
which is the outcome that is desired from successful vaccination.
Examination of immunity post-abortion revealed similarities with the ovine disease,
in terms of both mice and sheep being immune to abortion in subsequent pregnancies
post-abortion. This was observed in animals that were and were not administered
with a secondary experimental infection. A systemic antibody response specifically
to C. abortus was detected and a protective Thl response was characterised. The
development of other reagents for in situ hybridisation and detection of other
immune cells by immunohistochemistry may provide further information regarding





C. abortus infection of ewes results in abortion, leading to large economic losses to
agricultural industries worldwide. Research has focused on the characterisation of
pathology and immune responses associated with infection in the natural ovine host.
The aim of this project was to develop a pregnant mouse model to assess the efficacy
of vaccines, using a reduction in abortion as the readout. This will reduce costs and
time and increase the scope of information that can be obtained over that arising
from experiments conducted in the natural ovine host.
Initial studies involved establishment of the model by comparison of C. abortus
infection of two mouse strains - inbred CBAs and outbred Portons - in terms of
susceptibility to infection. Culture of C. abortus organisms from infected tissues and
progression of infection were examined over the course of infection. This revealed
few differences in susceptibility between the two strains. Of primary importance was
the final outcome of abortion in C. abortus-infected pregnant mice, which is similar
to that occurring in infected ewes (Buxton et al., 1990; Buxton et al., 2002), despite
the differences in placental structure between the two species. Although sheep give
birth to both dead lambs and weak live offspring that frequently die following
infection with C. abortus, mice produced dead foetuses only. C. abortus progressed
from the maternal to foetal side of the mouse placenta over the course of infection,
which is similar to disease progression in sheep, whereby organisms migrate towards
the foetus; infection established in the foetal trophoblast cells of both species. This
progression was also similar to that in the pregnant mouse model developed by
Buendia et al. (1998).
Subsequent studies of the immune response in C. abortus-infected mice identified
characteristics of a type 1 (Thl) immune response, which is known to control
chlamydial infections (Buendia et al., 2002; Igietseme, 2002; Morrison & Caldwell,
2002). The inflammatory infiltrate present in infected mouse reticuloendothelial
organs and placenta comprised PMNs, B cells, and CD4+ and CD8+ T cells, which is
analogous to that seen in sheep (Buxton et al., 2001). Macrophages have been
described in inflammatory exudates in C. abortus-infected ovine placental tissue
(Buxton et al., 2002; Navarro et al., 2004) and it is likely that these cells were
193
prevalent also in inflammatory infiltrates in mice. In addition, initial inflammatory
responses following genital tract infection of mice with C. trachomatis (MoPn) are
composed predominantly of PMNs, and lymphocytes and macrophages infiltrate the
submucosae as the infection resolves (Morrison et al., 1995; Morrison & Morrison,
2000). Chlamydia-specific antibodies, specifically IgM and IgG2a, were produced in
response to C. abortus infections in mice and the latter isotype is characteristic of a
Thl immune response.
An increase in the expression of LFN-y and TNF-a cytokines was detected in sera and
by in situ hybridisation in liver and placental tissues in response to C. abortus
infections. The exact mechanisms of tissue damage and abortion in C. abortus-
infected sheep are unclear, but are probably linked to the induction of these
proinflammatory cytokines in that they are not seen in normal placenta. IFN-y
expression increased around the time of abortion in mice, suggesting that it was
produced to resolve the infection, as the growth of organisms is restricted by IFN-y
in vitro (Brown & Entrican, 1996; Byrne & Faubion, 1982). However, IFN-y may
also have contributed to abortion as Thl cytokines are down-regulated in uninfected
pregnant animals (Ragusa et al., 2004) because of their potential detrimental effect
on pregnancy. TNF-a levels were higher around the time of abortion in mice and
TNF-a expressing cells are found in large numbers in infected ovine placentas
(Buxton et al., 2002). This cytokine has potential, albeit contrasting, roles in both
control of the infection and the induction of abortion (Entrican et al., 2004).
Immunological and physiological changes, as well as the presence of the organisms
during pregnancy in infected mice or sheep are likely to contribute to the final
outcome of abortion.
Both non-pregnant and pregnant mice are immune to experimental secondary
infection with C. abortus demonstrated by failure to detect the organism irrespective
of pregnancy status, and the delivery of live, healthy pups by pregnant animals. This
is similar to what occurs following ovine infections, where ewes have been
demonstrated to be immune to experimental secondary infection (Papp et al., 1994).
No organisms were detected after day 3 post-secondary infection in re-infected mice
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in contrast to primary infections. In future studies, tissues could be sampled on the
day following secondary infection to determine whether the mice were actually
susceptible to re-infection by C. abortus. Re-infected mice displayed a milder
inflammatory response, comprised mainly of small clusters of CD4+ T cells, as is
observed in mice re-infected with C. trachomatis (Morrison & Morrison, 2000). CD4
or CD8 depleted or KO mice could be infected with C. abortus, as has similarly been
conducted in C. trachomatis genital tract infections (Magee et al., 1995; Morrison et
al., 1995) and in C. pneumoniae mouse infections (Rothfuchs et al., 2004) to
progress further understanding of the immune response. These studies would provide
additional information on the relative roles of the T cell populations in immunity to
the organism, to allow comparison with other mouse models (de Oca et al., 2000)
and other Chlamydia species. Neither mice nor sheep abort in the pregnancy
subsequent to abortion (without secondary infection), although there appear to be
differences in immunity between these species. Mice appear to have cleared the
infection in this study, whereas ewes have been shown to develop chronic infections
that leads to the further spread of infection in subsequent breeding seasons (Papp &
Shewen, 1996).
A latent infection did not appear to develop in non-pregnant mice as occurs in sheep,
highlighting possible differences in the control of C. abortus infection in mice and
sheep. Although non-pregnant mice appeared to have either cleared or controlled the
infection so that abortion did not occur, an undetectable persistent infection may
have developed. In contrast, a latent infection develops in non-pregnant sheep that
recrudesces to cause abortion in the following pregnancy. This re-emergence of C.
abortus during pregnancy in sheep is likely to be the result of favourable conditions
arising in the placenta, such as changes in hormonal expression and immune
responses (Entrican et al., 2004). A similar scenario is present in the C. trachomatis
murine genital tract model, whereby mice naturally resolve the infection within 4
weeks without treatment and develop long-lived immunity (Barron et al., 1981;
Morrison et al., 1995), in contrast to the multiple infections that can occur in humans
that can only be controlled by antibiotic treatment. Therefore, although there are
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many advantages to using chlamydial mouse models, there are clear differences in
the diseases when compared to the natural hosts.
Concluding remarks and future work
Despite the increasing knowledge on the immunopathogenesis of C. abortus
infections, the underlying mechanisms for abortion remain unresolved. Available
evidence suggests that a combination of hormonal changes, inflammatory responses
and pathological damage compromise survival of the foetus in infected mothers. In
infected sheep, progesterone levels decrease and this is considered to play a role in
abortion, as this hormone is required for the maintenance of normal pregnancy
(Buxton and Henderson, 1999). It would be interesting to monitor the changes in
hormonal levels during C. abortus infection in pregnant mice in future studies to
determine if there are any clear patterns associated with abortion, as occurs in sheep.
Although both sheep and mice abort following infection with C. abortus the
mechanisms of abortion may not necessarily be the same. Owing to their different
lengths of gestation, placental structures and immune responses, the extent of
pathological damage and therefore the presence of immune cells, may differ between
the species. Extended inflammation and necrosis in infected placentas in sheep may
explain greater expression of TNF-a mRNA expression in sheep. An increased
inflammatory response to this pathological damage is likely to result in more
pathological changes and this may actually contribute to abortion rather than control
the infection. To provide further information on the role of TNF-a, this cytokine or
its receptors could be knocked out in mice (TNFR1 KOs) (Riehl et al., 2004). This
would reveal whether TNF-a is involved primarily in the control of chlamydial
infections or in the induction of abortion, or in both, which is the more likely
scenario. Similar studies could be conducted with IFN-y gene KO or depleted mice,
although many IFN-y depletion and gene KO experiments in mice that have been
infected with C. trachomatis have been carried out, showing its essential role in
controlling infections (Cotter et al., 1997; Dalton et al., 1993; Wang et al., 1999).
McCafferty et al. (1994) demonstrated exacerbated pathology and increased
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infection associated with C. abortus infections, following neutralisation of IFN-y in
mice. It would be interesting to investigate this further by knocking out IFN-y genes
(Wang et al., 1999) in mice to determine the precise role of this cytokine in in vivo
infections and to compare results with in vitro studies.
Development of more probes to examine the localised expression of other Thl
cytokines such as IL-12, and even Th2 cytokines, such as IL-4 and IL-10, by in situ
hybridisation would provide further information on the balance of Thl/Th2 immune
responses at sites of infection during pregnancy. Identification of such cytokines is
also important in animals that are immune to abortion to provide further information
on the protective immune response to C. abortus. Further examination of immunity
to abortion and the anatomical location of C. abortus as well as the mechanisms
responsible for control of infection during latency are also required as it may allow
an earlier detection and therefore treatment of infected sheep. However, such studies
would be more beneficial in the natural host as further studies are required to
determine if latent infections developed in the mouse model.
Obviously there are differences in chlamydial disease in the mouse and in the natural
ovine host, however primary infections in pregnant mice closely mimic those in
sheep. Similarities in pathogenesis and the strong adaptive immune response
generated in this pregnant mouse model following resolution of infection establishes
the usefulness of the model for the further studies of protective immunity. Future
studies should thus not only focus on assessment of vaccines, but on more in depth
characterisation of immunity and the role of particular cell types in C. abortus
infected mice that can then be transferred to sheep studies. This model will be of
great benefit to MRI and to the chlamydial research field.
This model could be used to assess the efficacy of the two commercial vaccines
available in the UK (Mydiavac and Enzovax) in addition to assessing novel vaccine
candidates, to determine whether the vaccines have a similar efficacy in both sheep
and mice in terms of reducing the incidence of abortion. In conclusion, the major
contribution of this pregnant mouse model will allow assessment of current and
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future vaccines in a quick and effective manner, reducing time and money that would
be otherwise required for sheep vaccine trials.
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Abstract
Chlamydophila abortus targets the placenta, causing tissue damage, inflammation and abortion (enzootic abortion of ewes). It is
one of the main infectious causes of abortion in ewes, resulting in major economic losses to agricultural industries worldwide.
Although ruminants and pigs are the principal hosts, humans are also susceptible to infection. Control of disease requires a host
inflammatory response, which is likely to contribute to pathology and abortion. Mouse models have been widely used to provide
insight into the role of specific immune cells in controlling infection and disease. The use of such model systems for investigating the
mechanisms of abortion, latency, persistence, and immunity to reinfection will result in the identification of novel vaccine control
strategies for sheep.
© 2004 Elsevier Ltd. All rights reserved.
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1. Introduction
Chlamydiae are obligate intracellular bacteria that in¬
fect epithelial cells and monocyte/macrophages of a wide
host range, resulting in a broad spectrum of diseases
(Table 1) (Longbottom and Coulter, 2003; Schachter,
1999; Storz, 1988). Following reclassification in 1999,
the order Chlamydiales now comprises four distinct fam¬
ilies, namely the Simkaniaceae, Waddliaceae, Para-
chlamydiaceae and Chlamydiaceae (Everett et al.,
1999). The Chlamydiaceae are divided into two genera,
Chlamydia and Chlamydophila, and nine species
(Table 1). This classification is based on limited pheno-
typic, morphological and genetic criteria (Corsaro et al.,
2003; Everett et al., 1999).
Corresponding author. Tel.: +44 1 31 4456 136; fax: +44 1 31 4456
235.
E-mail address: david.longbottom@mri.sari.ac.uk (D.
Longbottom).
Chlamydiae undergo a biphasic developmental cycle
that consists of two distinct morphological forms, the
elementary body (EB) and the reticulate body (RB),
which are specifically adapted to extracellular and intra¬
cellular environments, respectively (Longbottom and
Coulter, 2003). The EB, which is the infectious form
of the bacterium, is small in size (200-300 nm in diame¬
ter) and metabolically inactive. EBs give rise to primary
infection of susceptible hosts by attaching to the surface
of mucosal epithelial cells. Upon entry, the EB. which
resides within an intracytoplasmic inclusion, transforms
into the larger (500-1000 nm) RB, which is non-infec¬
tious and metabolically active. The RB multiplies by
binary fission, rapidly filling the inclusion, which in¬
creases in size. Towards the end of the developmental
cycle, the RBs transform back into EBs, which are then
released by lysis or exocytosis and go on to infect neigh¬
bouring cells (Beatty et al., 1994).
Chlamydiae comprise an exceptionally diverse group
of organisms, infecting a wide variety of hosts and caus¬
ing a broad range of diseases. This paper reviews the
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Humans Chronic conjunctivitis (trachoma)
Sexually transmitted disease; pelvic inflammatory disease; infertility
Mice, hamsters Respiratory and genital tract infection (model for C. trachomatis infection in humans)
Pigs Intestinal, respiratory and reproductive disease
Humans Pneumonia, bronchitis, pharyngitis; also associated with atherosclerosis,
reactive arthritis and asthma
Birds, poultry Respiratory disease (zoonotic pathogen)
Ruminants, pigs Abortion (zoonotic pathogen)
Ruminants, pigs Enteric disease; pneumonia; conjunctivitis; polyarthritis; metritis; and encephalomyelitis
Cats Conjunctivitis (probable zoonotic pathogen)
Guinea pigs Ocular and genital tract infection (model for C. trachomatis infection in humans)
immunopathology of Chlamydophila abortus in sheep
and mice.
2. Ovine enzootic abortion and transmission of infection
C. abortus (formerly Chlamydia psittaci serotype 1)
infects the placenta, causing a disease in sheep known
as enzootic abortion of ewes (EAE) or ovine enzootic
abortion (OEA) (Aitken, 2000; Longbottom and Coul¬
ter, 2003). It is the most common infectious cause of
abortion in lowland flocks intensively managed at lamb¬
ing time, and has a major economic impact on agricul¬
tural industries worldwide. Although there are no
recent figures on the economic impact of EAE in the
UK, losses have previously been estimated at £15-20
million per annum (Wood, 1992). The organism causes
a similar disease in goats, but infections of cattle, pigs
and horses are thought to be less common. Infection
can also be transmitted to humans, where it is of partic¬
ular concern to pregnant women (Longbottom and
Coulter, 2003).
The main routes of transmission of C. abortus are
through ingestion of organisms shed in vaginal fluids
and placental membranes at the time of abortion or
lambing, or through inhalation of aerosols from the
environment. EBs can remain viable in the environment
for several days, depending on environmental conditions
(Aitken et al., 1990). This is due to the rigidity of the cell
envelope, which is both osmotically stable and poorly
permeable. There is some evidence of venereal transmis¬
sion (Papp and Shewen, 1996), but this route is unlikely
to contribute much to the epidemiology of EAE in the
UK, because there is little contact between ewes and
rams during the lambing season (Appleyard et al.,
1985). Another potential route of transmission is
through direct infection of the foetus via the placenta,
although again it is unclear what contribution this might
make to the epidemiology of EAE (Buxton et al., 1990,
2002).
An initial outbreak within a flock that may give rise
to only a few abortions can lead to over 30% of the ewes
aborting or giving birth to stillborn or weak offspring in
the following year (Aitken, 2000). In subsequent lamb¬
ing seasons the incidence of abortion is likely to remain
at 5-10% if affected animals are left untreated.
3. Clinical symptoms
Infection of pregnant ewes with C. abortus up to 5-6
weeks prior to parturition leads to clinical disease, and
results in either abortion in the final 2-3 weeks of gesta¬
tion, or the birth of stillborn or weak lambs that fre¬
quently die in the first few days of their life (Aitken
et al., 1990). Infection of ewes within the last 5-6 weeks
of pregnancy often leads to the development of a latent
infection, where ewes appear to be uninfected until the
next lambing season (Aitken et al., 1990). Surviving
lambs born to infected mothers may be affected by
EAE in their first pregnancy (Wilsmore et al., 1990).
Persistent, subclinical or latent states can be
maintained for several months following infection of
non-pregnant ewes, probably under control of the pro¬
inflammatory cytokine interferon-gamma (IFN-y)
(Brown and Entrican, 1996), before the onset of preg¬
nancy triggers bacterial multiplication (McCafferty,
1990). C. abortus is undetectable by any means in la¬
tently infected ewes (Jones et al., 1995), and it is not un¬
til around day 90 of gestation that the organisms are
reactivated in some way, resulting in clinical expression
in the placenta, and ultimately abortion.
Although, there are generally no premonitory indica¬
tions of the impending abortions, vaginal discharges can
be observed for up to 48 h prior to lamb loss. These
discharges can continue for 2-3 weeks, adding to the
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environmental spread of infection (Nietfeld, 2001). Fol¬
lowing abortion, ewes develop protective immunity that
prevents C. abortus-induced abortions in subsequent
pregnancies. However, immunity is not necessarily ster¬
ile, as some ewes are reported to continue to shed infec¬
tious organisms seasonally for up to three years,
increasing the spread of disease (Papp et al., 1994). Most
ewes remain reproductively sound and can continue in
subsequent breeding programmes.
4. Immunopathogenesis
One of the most fascinating aspects of C. abortus
infection is the lack of any pathological changes until
after day 90 of gestation (normal gestation is approxi¬
mately 143 days), irrespective of the timing of infection
(Buxton et al., 1990). Following an initial infection, it is
thought that the organism resides first in the tonsil, from
where it is disseminated by blood and lymph to other or¬
gans (Jones and Anderson, 1988). It has been suggested
that C. abortus may reside in lymphoid organs during
the latent phase of infection (Papp et al., 1993).
4.1. Placental infection
Ruminant placentation is cotyledonary, non-decidu-
ate and synepitheliochorial (Entrican, 2002; Benirschke.
2002a). The association between maternal and foetal tis¬
sues of the ovine placenta is less intimate in comparison
with other types of placentation such as the single layer
of contact between maternal and foetal vascular systems
that occurs in the discoid hemochorial placenta of
mice and humans (Engelhardt and King, 1996). The
cotyledons on the foetal side of the ovine placenta are
associated with rounded elevations of the uterine
endometrium called caruncles (maternal side), and this
whole unit is called a placentome (Longbottom and
Coulter, 2003; Studdert, 1968). Contact between the foe¬
tal chorion and maternal epithelium is maintained by
microvillous interdigitation in the placentome, through
penetration of chorionic villi into maternal crypts. In
contrast, murine placentas are mainly composed of
folded villous tissues with very thin foetal capillaries
covered by the trophoblast cell layer, termed the placen¬
tal labyrinth, and these are immersed in the maternal
sinusoidal blood. This region constitutes the major site
of maternal/foetal exchange, enhanced by maternal
blood no longer being enclosed within proper arteries,
so that maternal blood directly bathes the surface of
the trophoblast cells i.e. hemochorial (Benirschke,
2002b; Cross et al., 2002). Despite these obvious differ¬
ences between ovine and murine placentation, pregnant
mouse models have been developed to investigate the
role of immune cells and to assess candidate chlamydial
vaccines (Buzoni-Gatel and Rodolakis, 1983; Caro
et al., 2003). One of the main advantages of using mouse
models is the length of the gestation period, being only
21 days in mice compared with approximately 143 days
in sheep, offering a faster and cheaper means of analys¬
ing vaccine candidates.
Maternal haematomas develop in ovine placentas at
around day 60 of gestation at the maternal-foetal inter¬
face in the hilus of the placentome (Longbottom and
Coulter, 2003; Studdert, 1968). This results from leakage
of blood at the septal tips of the maternal caruncle, and
probably corresponds to the time that infectious organ¬
isms pass from mother to foetus. Following establish¬
ment of infection in the foetal trophoblastic epithelial
cells, infection spreads out into the intercotyledonary
regions of the chorion, resulting in epithelial damage,
oedema and inflammation. This inflammation is a result
of infiltration by neutrophils, macrophages, lympho¬
cytes and plasma cells. Not all of the placentomes be¬
come infected, and the level of inflammation and
necrosis in the cotyledons and membranes is variable
(Buxton et al., 2002). Ultimately, the damage caused
by infection in the placentomes compromises the mater¬
nal-foetal exchange of nutrients and oxygen, which con¬
tributes to foetal death and abortion (Buxton et al.,
2002). Foetal infection is also possible, characterised
by focal necrosis in the liver, and small foci of necrosis
may be found in the lung, spleen, brain and lymph nodes
(Buxton et al., 1990).
4.2. Inflammatory response
Chlamydial infection stimulates a strong inflamma¬
tory response, which is necessary to control infection,
but could also lead to the pathology associated with
the infection. This raises the intriguing question of
whether abortion is due to the damage caused by the
organisms themselves or to damage caused by the
inflammatory host response.
Two inflammatory cytokines, IFN-y and tumour nec¬
rosis factor-alpha (TNF-oc), which are produced in re¬
sponse to infection, are thought to contribute to the
pathology and also to threaten the maintenance of preg¬
nancy (Entrican, 2002). Mononuclear cells expressing
mRNA encoding TNF-oc are abundant in infected arter¬
ies and arterioles, and also in the inflammatory exudates
associated with the chorionic epithelium, whereas very
few cells express mRNA encoding IFN-y (Buxton
et al., 2002). TNF-oc is thought to play a crucial role in
immunity to C. abortus, through the activation of phag¬
ocytic cells that rapidly degrade infected cells or extra¬
cellular EBs (Igietseme et al., 2002). A high
concentration of TNF-oc at the materno-foetal interface
is incompatible with pregnancy (Dealtry et al., 2000)
and TNF-oc has also been linked to spontaneous embryo
loss in pregnant mice (Yui et al., 1994). Therefore, TNF-
oc released in response to chlamydial infection (possibly
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to the lipopolysaccharide component) may be contribut¬
ing to the placental damage that leads to abortion (Bux¬
ton et al., 2002).
IFN-y is crucially involved in controlling chlamydial
infections (Brown and Entrican, 1996). It can activate
the microbicidal activity of host macrophages and cause
destruction of infected cells in vitro, indicating its impor¬
tance in host resistance (Igietseme, 2002; McCafferty
et al., 1994). It has been demonstrated that C. abortus
multiplication can be restricted by IFN-y in vitro in ovine
cells (Graham et al., 1995). IFN-y is expressed in placen¬
tal tissue during normal pregnancy, but it can also be
cytotoxic for human trophoblast cells at high concentra¬
tions (Yui et al., 1994). Therefore, an increase in IFN-y
expression in response to chlamydial infection within
the placenta may be detrimental to the host tissue as well
as to the invading organisms. It seems highly likely that
the presence of IFN-y in the placenta controls the growth
of C. abortus but simultaneously impairs foetal survival
by damaging the functional activities of placental tropho¬
blast cells, which in turn contributes to abortion.
IFN-y-gene knockout mouse models have been devel¬
oped, and alongside in vitro studies, have proved to be
extremely useful in demonstrating the essential role of
IFN-y in controlling all chlamydial infections (Dalton
et ah, 1993; Rottenberg et ah, 2000; Lampe et ah,
1998). Severe disease sequelae develop in mice that fail
to develop an adequate T helper 1 (Thl) immune re¬
sponse, of which IFN-y is the key effector (Yang et ah,
1996). Cotter et ah (1997) demonstrated the importance
of IFN-y in resolving C. trachomatis infection in mice
in which the gene for IFN-y had been disrupted
(IFN-y ), and in the mouse pneumonitis (MoPn)
model system. Wild type mice infected with C. tracho¬
matis MoPn resulted in the systemic dissemination of
a small number of organisms to major organs from
day 7-14 post-infection and the infection resolved with¬
in 3 weeks. In IFN-y knockout mice, a prolonged and
more pronounced systemic dissemination of Chlamydia
was observed, as demonstrated by significantly higher
numbers of organisms cultured from spleen tissue.
IFN-y (and other cytokines) appears to be pivotal in
the establishment of a persistent or latent infection in
the host, suggesting that the latent phase is mediated
by host cytokine production in non-pregnant ewes
(Brown and Entrican, 1996; Entrican et ah, 2001). A
CD4 Thl immune response is thought to primarily
mediate the protective response to chlamydial infection,
with IFN-y being a major cytokine involved in the re¬
sponse. The anti-inflammatory cytokines, IL-4 and IL-
10, down-regulate IFN-y during pregnancy (Krishnan
et ah, 1996). This has yet to be proven in sheep but if this
is the case, down-regulation of IFN-y may lead to chla-
mydiae being reactivated from their 'latent' state, allow¬
ing colonisation of the placenta and disruption of the
maternal-foetal junction, resulting in abortion.
4.3. Hormonal Influences
Hormones involved in pregnancy are likely to play a
crucial role in inducing abortion and progesterone, 17P-
oestradiol and prostaglandin E2 (PGE2) are all central
to pregnancy (Entrican et ah, 2001; Longbottom and
Coulter, 2003). Progesterone is necessary for the mainte¬
nance of normal pregnancy and is produced in chorionic
epithelial cells in the latter part of pregnancy. It then
interacts with oestradiol and PGE2 to control the onset
of parturition. Progesterone levels decrease in infected
placentas, whereas the concentrations of oestradiol
and PGE2 increase in the amniotic and peripheral
plasma, and amniotic and allantoic fluids, respectively
(Leaver et ah, 1987, 1989). The changes in hormonal lev¬
els during pregnancy may increase susceptibility to
infection, and promote placental infection at about
day 90 of gestation (Buxton et ah. 1990). Indeed, a study
of C. trachomatis infection in rats demonstrated that
progesterone enhances susceptibility to disease, whereas
oestradiol decreases susceptibility (Kaushic et ah, 2000).
Chlamydial infection also affects the levels of all of the
above hormones, and it has been suggested that this hor¬
mone imbalance is an underlying cause of abortion
(Buxton and Henderson, 1999). Since multiplication of
chlamydial organisms takes place in the foetal chorionic
epithelial cells, the main source of progesterone in the
latter stages of pregnancy, damage to this area is likely
to play a role in altering the hormonal balance, which
is necessary for the maintenance of normal pregnancy,
resulting in premature labour.
Hormones also affect T-cell reactivity and cytokine
production. For example, progesterone is involved in
the development of Th2 cells that produce IL-4 and
IL-5, 17p-oestradiol enhances IL-10 and IFN-y secre¬
tion by antigen-stimulated clones and PGE2 biases the
cytokine production of dendritic cells towards IL-10,
reducing IL-12 production (reviewed by Entrican,
2002). Thus, in pregnant animals, the inflammatory re¬
sponse due to the invading organisms in association
with changes in hormone levels alters the placental envi¬
ronment and endangers the developing foetus (Buxton
et al., 2002; Entrican et al., 2001).
5. Pregnant mouse models
Pregnant mouse models have been widely used to
investigate the immunopathogenesis of C. abortus-
induced abortion. The first C. abortus murine model
was developed by Buzoni-Gatel and Rodolakis (1983),
who demonstrated that infection of pregnant mice with
C. abortus resulted in abortion. This showed similarities
to abortion cases in small ruminants and indicated
the value of mouse models for comparison of strain
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virulence (Anderson, 1986; Rodolakis et al., 1989) and
evaluation of vaccine candidates (Caro et al., 2001,
2003; de Sa et al., 1995; Hechard et al., 2003a,b).
Polymorphonuclear neutrophil (PMN) infiltration
and necrosis of the maternal-foetal junctions are char¬
acteristic features of chlamydial infection of the ovine
placenta (Buxton et ah, 1990). Pregnant mouse models
have been used to expand our knowledge regarding
the role of these cells in the control of infection (Buendia
et ah, 1999). Larger numbers of chlamydiae were iso¬
lated from spleens of PMN-depleted mice than those
of non-depleted mice suggesting they play an important
role in controlling chlamydial infection in mice as well as
in sheep. Additionally, non-depleted uteroplacental
units showed massive neutrophil infiltration at the sites
of infection (Buendia et ah, 1998). It appears that PMNs
play a role in controlling C. abortus multiplication in in¬
fected organs in the early stages of infection and may be
an important component of the innate immune re¬
sponse. It is worth noting that such a massive inflamma¬
tory response is likely to impair normal placental
function, contributing to abortion, as occurs during
infection of the ovine placenta.
Although PMNs may not necessarily control second¬
ary infection of C. abortus (de Oca et ah, 2000b) they are
crucial to the recruitment of other cells types that influ¬
ence the production of pro-inflammatory cytokines.
Recruitment of CD4+ and CD8+ T cells results in a
cell-mediated response, which is necessary for resolution
of chlamydial infection, probably via IFN-y, a product
of both cell types (Ramsey et ah, 2000). A Thl immune
response, which is vital for C. abortus resolution, has
been characterised in the pregnant mouse models, with
high levels of IFN-y detected and no IL-4 (a Th2 cyto¬
kine) identified in sera between days 3 and 7 post-infec¬
tion (de Oca et ah, 2000a).
Mouse models are continually providing new insights
into the disease and a recent focus has been the role of
natural killer (NK) cells, an important source of IFN-
y early in the immune response (Buendia et ah, 2004).
Increased numbers of NK cells are observed in spleen
and liver tissue during infection of pregnant mice with
C. abortus, and NK cells are also prevalent in the uterus
of mice infected with MoPn (Tseng and Rank, 1998).
The importance of these cells has been examined in mice
depleted of NK cells. As expected, increased bacterial
loads and a higher mortality rate were observed in
NK-depleted mice when compared with wild-type mice
following infection with C. abortus (Buendia et ah,
2004). Serum concentrations of IFN-y, which is crucial
for resolution of infection, were considerably reduced
in NK-depleted mice, suggesting that NK cells are an
essential source of this cytokine during infection. Future
studies of chlamydial infections and immune responses
in mice will undoubtedly provide information on why
abortion occurs and determine precise mechanisms of
immunity that will inform development of novel control
strategies for sheep infections.
6. Closing remarks
Despite the increasing knowledge on the immuno-
pathogenesis of C. abortus infections, the underlying
mechanisms responsible for abortion remain unclear.
Available evidence suggests that a combination of hor¬
monal changes, inflammatory response and pathological
damage endanger survival of the foetus in infected
mothers. Another unanswered question is that of why
sheep that have aborted are resistant to abortion in sub¬
sequent pregnancies. Resolution of these issues will
await further elucidation of protective immune re¬
sponses. In addition, although immune animals are pro¬
tected from further abortion, levels of immunity appear
to vary; some sheep apparently develop sterile immunity
post-abortion, others shed infectious organisms for up
to three years (Papp et al., 1994). The anatomical loca¬
tion of C. abortus during latent or persistent infections
remains unidentified and the mechanisms responsible
for control of infection during latency remains unclear.
Similarly, reasons behind recrudescence of infection dur¬
ing pregnancy have yet to be determined, although it is
likely to be associated with changes in hormonal levels
and immunosuppression. The stage of pregnancy at
which reactivation occurs is also unknown, as the organ¬
ism is not detected until day 90 of gestation in the
placenta.
In conclusion, although much has been learned about
the pathogenesis and control of C. abortus infection in
ruminants, many questions remain unanswered. Ulti¬
mately, the identification of the specific mechanisms of
acquired immunity will assist in the identification of vac¬
cine candidate antigens, which can be assessed in both
mouse models and the natural ovine host.
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